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ABSTRACT
y.*The principal aims of the work presented in this thesis were to investigate the structural 
heterogeneity o f the acute phase proteins from domestic animal species and to document 
the changes within the carbohydrate moiety during disease.
Alpha-1-acid glycoprotein (AGP) is a positive acute phase protein in many species, with 
its concentration in the plasma increasing 2 to 5 fold in a num&r of pathophysiological 
states. Human AGP is extensively glycosylated (45%) due to 5 N linked glycan chains. 
In normal serum, AGP does not exist in a single form but as a heterogeneous population 
of glycoforms. Heterogeneity arises through subtle structural differences in 
monosaccharide sequence and linkages, degree of branching and extent of fucosylation 
and sialylation. The existence of structurally distinct glycoforms implies a functional 
diversity since the properties of a glycoprotein are influenced by the structures of its 
oligosaccharide chains. During pathological conditions in humans, not only may the 
total concentration of AGP be altered but the relative proportions of the normal AGP 
glycoforms can change and abnormal glycoforms are expressed.
A method for the isolation of feline AGP from serum and ascetic fluid was developed 
which maintained the structural integrity of the glycan chains. Feline AGP was isolated 
from serum or ascitic fluid from 17 individual cats that were diagnosed to have feline 
infectious peritonitis (TIP), a disease known to cause an increase in AGP 
concentrations, and also isolated from pooled serum from æiimals without inflammatory 
disease. Following isolation of fAGP the monosaccharide composition and 
oligosaccharide profile was analysed by high pH anion exchange chromatography and 
pulsed amperometric detection. It was found that AGP from cats with FIP expressed 
significantly more (p <0.05) N-acetylglucosamine and galactose residues than AGP 
isolated from pools of serum from cats without FIP or other inflammatory disease. 
Fucose residues were present on the fAGP glycan chains of cats 5 and 9. In the 
presence of FIP, fAGP carried both disialylated and trisialylated glycan chains while 
fAGP from cats without FIP only expressed disialylated glycan chains.
11
The structural heterogeneity o f bovine AGP in bovine mastitis was examined by lectin 
binding with Sambucus Nigra, Concanavalin A, Maackia Amurensis or Aleuria 
aurantia lectins that bind a 2-6 linked sialic acid, diantennary chains, a  2-3 sialic acid 
and fucose residues respectively. Bovine AGP from cows suffering from mastitis was 
hypersialylated with more diantennary chains compared to AGP from control cows. It 
was also found that bovine AGP had no detectable a2-3 sialic acid or fucose residues.
A novel isoform of bovine p-haptoglobin was detected in milk during bovine mastitis. 
Investigation using PNGase F and lectins showed that the difference between the novel 
isoform and liver derived form was due to glycosylation changes. The novel isoforms 
of pHp was 3kDa heavier than serum Hp, however following removal of N-linked 
glycan chains by PNGase F both forms of Hp had a molecular weight o f 30kDa. Fucose 
was expressed on the glycan chains o f the novel isoforms o f pHp while no fucose 
residues were detectable on the serum form of pHp.
Finally a comparative study looking at the glycan chain of AGP from cat, cow, sheep 
and man revealed distinct differences between the different species although AGP from 
the ruminants was more similar than AGP from man or cat. Fucose was expressed 
within the glycan chains of human AGP only, while only AGP from sheep expressed N- 
acetylgalactosamine residues. Alpha-1-acid glycoprotein from cat, cow and sheep 
expressed N-acetyl neuraminic acid as well as N-glycolyl neuraminic acid, while human 
AGP expressed N-acetylneuraminic acid only.
Overall the findings detailed in this thesis indicated that the structural heterogeneity of 
AGP from domestic species is influenced by the disease status of the host.
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CHAPTER 1
1. Introduction
The objective o f the studies in this thesis was to investigate the glycosylation o f serum 
proteins in domestic species and the effect of disease on their glycosylation patterns 
during the acute phase response. This introduction therefore describes the nature o f 
protein glycosylation, the acute phase response and the serum proteins known to be 
affected by disease, namely the acute phase proteins.
1.1 Glycosylation
Glycosylation is a term used to describe the covalent incorporation of carbohydrate 
moieties in the form of oligosaccharide chains into macromolecules, resulting in the 
formation of glycoconjugates. Glycoconjugates are classified according to the 
macromolecule that they are attached to i.e. if  the oligosaccharide binds to a protein 
then it is referred to as a glycoprotein and, when it is a lipid that the oligosaccharide 
chain binds, it is referred to as a glycolipid. The oligosaccharide chains of
glycoconjugates are highly organized structures constructed from monosaccharide 
residues. Several studies into the function of glycans have shown that they profoundly
influence the biological activities of the macromolecule to which they are bound 
(Paulson & Colley 1989;Varki 1993).
1.1.1 Monosaccharide
Monosaccharides are the simplest of carbohydrates and are based upon the empirical 
formula (CH2O) n, with n usually being between 3 and 9. Monosaccharides are made 
up o f one reducing (carbonyl group) and multiple hydroxyl functional groups. The 
monosaccharide can be classified according to the location o f their carbonyl group i.e. if 
the carbonyl group is located on Ci then the monosaccharide is described as an aldose 
while on the other hand when the carbonyl group is found on C2 then the 
monosaccharide is described as a ketose. Monosaccharides can exist as linear or cyclical 
structures however it is more common to find them in the ring form.
The favoured structure adopted by aldoses is a six membered ring which is referred to 
as a pyranose ring. Pyranose rings are formed by the reaction between the aldehyde 
group on Cl and the hydroxyl group on C5. On the other hand a ketose prefers to form a 
furanose ring which is a five membered ring resulting from the carbonyl group on C2 
reacting with the hydroxyl group of C5.
Monosaccharide can also be classified according to the number o f carbons they possess, 
such that monosaccharides which have four, five or six carbons are termed tetroses, 
pentoses and hexoses respectively. The most common constituents of glycans are 
monosaccharides comprising six carbons i.e. hexoses, hexosamines and deoxy hexoses. 
Hexoses are 6 carbon monosaccharides that have a neutral charge such as glucose,
galactose and mannose (Figure 1.1). Hexosamines are hexoses with an amino group at 
position 2 which can be free or more commonly N acetylated e.g. N acetylglucosamine 
(GlcNAc). Finally deoxy hexoses are hexoses with the hydroxyl group on position 6 
removed and replaced by a single hydrogen (H) atom. The carbonyl group o f a 
monosaccharide is able to react with one o f multiple hydroxyl groups of a second 
monosaccharide residue to produce a characteristic glycosidic bond. The glycosidic 
bond formed depends on the orientation o f the carbonyl group, such that if  the carbonyl 
group lies above the plane of the ring then a beta glycosidic bond will be formed 
whereas if  the carbonyl lies below the plane of the molecule then an alpha glycosidic 
bond will be formed. The two different linkages confer markedly different structural 
properties and biological functions. Consequently sixteen isomers can be generated 
from the bond between 2 monosaccharides depending upon the location and orientation 
o f the glycosidic bond and conformation of the ring structure. The continued addition 
o f monosaccharides results in the formation o f oligosaccharides (2-20  monosaccharides) 
and polysaccharides (>20  monosaccharides).
With the number of monosaccharides in existence and the number of individual 
linkages with which they can combine with other sugars it can be appreciated that 
oligosaccharides can offer great potential structural diversity. However studies carried 
out looking at the monosaccharide composition of glycoconjugates have shown that 
certain monosaccharides are more commonly found in glycoconjugates than others, and 
the composition of the monosaccharides is dependant on their source and that the 
linkages are dependant on the availability of the enzymes known as glycosyltransferases 
which are specific for the formation of certain types of glycosidic bond. The most 
commonly found monosaccharides seen in glycan chains of human glycoconjugates are
N-acetylglucosamine, mannose, galactose, N-acetyl galactosamine, fucose and sialic 
acid usually in the form of N-acetylneuraminic acid (Drickamer & Taylor 1998;Taylor 
& Drickamer 2003) (Figure 1.1).
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Figure 1.1 M o n o sa cch a r id es  c o m m o n ly  found in N -l inked  g lycan  chains
1.1.2 Glycolipids
Glycolipids are formed when glycans are covalently attached to the head group of 
lipids, which are usually the phospholipids embedded in the membrane bilayer. The 
glycolipids fall into two structural categories depending on their lipid content. Those 
that are built on ceramide are known as the glycosphingolipids and are the most 
common grouping o f glycolipids. On the other hand those glycolipids where the 
glycan is attached to phosphatidylglycerol are collectively known as glycophospholipids 
(Drickamer & Taylor 1998;Drickamer & Taylor 1998;Taylor & Drickamer 2003;Varki 
et al. 1999)
1 1.3 Glycoproteins
Glycoproteins are oligosaccharide chains covalently attached to the polypeptide 
backbone of proteins. Glycoproteins can be characterized according to the nature of the 
linkage between the amino acid chain and monosaccharide. When oligosaccharide 
chains are attached to the polypeptide backbone via the oxygen o f a hydroxyl group on 
the side chain o f a serine or threonine they are known as 0 -linked glycoproteins, 
alternatively when the oligosaccharide is attached to the polypeptide backbone via an 
amide group on the side chain of asparagines then the glycoprotein is referred to as an 
N-linked glycoprotein (Komfeld & Komfeld 1985). These two different types of 
glycosylation differ mainly in the core regions, whilst the monosaccharides composing 
the terminal elaborations are similar in both O and N-linked glycans.
1.1.3.1 N-Linked Glycoproteins
In animal cells the monosaccharide linked to an asparagine residue in the nascent 
polypeptide chain is almost inevitably N-acetylglucosamines and the linkage is always 
in the B-configuration. This linkage can only occur when the asparagine residue is 
within the consensus sequence Asn-X-Ser/Thr, where X is any amino acid except 
proline (Kasturi et al. 1995;Kornfeld & Komfeld 1985).
All N-linked glycans contain a common pentasaccharide core region as shown in Figure 
1.2. This common core arises because all N-linked glycans are derived form the same 
14 residue oligosaccharide lipid linked precursor which is transferred to the nascent 
peptide chain and then processed to form this structure (Komfeld & Komfeld 1985).
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Figure  1.2 S chem atic  d iagram  o f  the c o m m o n  penta sa cch a r id e  c o re  o f  N-l inked g lycan  chains.
N-linked glycans can be classified into three main categories depending on the degree 
of processing required for the elongation of the pentasaccharide core.
The simplest category of N-linked glycosylation is termed high mannose glycan and as 
the name suggests the pentasaccharide core region is elongated with 2-6 Man residues 
(Figure 1.3A). The second category involves intermediate processing of the
pentasaccharide core results in the formation o f a hybrid glycan (see Figure 1.3B). The 
name is attributed to the fact that these glycans contain both high mannose 
(unsubstituted mannose residues attached to the core Man 1, 6 arm) and complex 
(substituted bisecting GlcNAc attached to the inner B mannose) linkage. In the final 
category complete maturation of the glycan moiety results in the formation of complex 
glycan chains such that both Man a l ,  3 and Man a l ,  6 are substituted by GlcNAc 
residues. Complex glycans can be further elongated by the addition of Gal, Fuc and 
terminating SA residues. Complex glycans can be the source of great structural 
diversity for N-linked glycans as they can differ in chain length, composition and 
branching (see Figure 1.3C) (Taylor & Drickamer 2003;Varki, Cummings, Esko, 
Freeze, Hart, & Marth 1999). Figure 1.3 shows a diagrammatic representation of the 
three types of N-linked glycan chains.
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Figure 1.3 R epresen ta tion  o f  the three  types  o f  N l inked g lycan chains .  A) c o m p lex  type  B) hybrid  
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The biosynthetic pathway of protein N-glycosylation commences with the construction 
of a fourteen member, Man rich oligosaccharide on dolichol phosphate (Dol-P) (Kobata 
1992) ( Figure 1.4). Once all fourteen monosaccharide residues are attached to Dol-P 
the oligosaccharide moiety is transferred to an Asn residue located in the neeessary 
eonsensus sequence (Marshall & Walter 1972) by oligosaccharyl transferase (GST) 
(Sharma. Lehle, & Tanner 1981 ;Silberstein & Gilmore 1996). Oligosaccharyl 
transferase attaches the oligosaccharide to the Asn residues by forming a complex with 
the precursor molecule, then through formation of a hydrogen bond using the hydroxyl
group of the serine or threonine residue the lipid linked precursor is transferred to the 
protein. This process results in the cleavage of the high energy GlcNAc-P bond with 
release of Dol-diphosphate.
Following the covalent attachment of the 14 residue oligosaccharide unit from the 
dolichol carrier to the appropriate Asn residue a series of processing reactions occur. 
The first few processing steps appear to be conserved among all eukaryotic cells and are 
known to play key roles in regulating protein folding.
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Figure  1.4 D iagram m atic  representation  o f  the 14 res idue dolichol  carrier.
The first processing steps involve trimming of the 3 glucose residues by glucosidase I 
and II. The outermost a  1,2 linked glucose is removed by glucosidase I and the inner 
glucose residues are subsequently removed by glucosidase II. It has been proposed that 
the removal of the 3 glucose residues determines the retention time o f the glycoprotein 
in the rough endoplasmic reticulum (Tokunaga, Hara, & Koide 2003). Following 
trimming of the glucose residue at least one exposed mannose residue is removed by a 
specific a mannosidase which is found in the membranes of the rough endoplasmic 
reticulum (RER). It is at this stage that high mannose structures can appear if the 
glycan processing is terminated (Figure 1.5). At this point the newly synthesized 
oligosaccharide is transported to the cis Golgi cistemae by means of a vesicle. When 
the glycoproteins arrive in the Golgi, they traverse the stacks from the cis thiough 
medial to trans cistemae by vesicular transport (Figure 1.5). The high mannose 
oligosaccharide which arrives in the Golgi can be further processed by the actions of a 
Golgi specific a  1,2 mannosidase to yield Man5GlcNAc2 -A sn  stmcture. It is when 
glucosaminyltransferase I (GlcNAcT I) acts on this stmcture to add a 131,2 GlcNAc that 
a hybrid structure is produced. The resulting N-glycan product GlcNAc 
Man3GlcNAc2-ASN is the specific substrate for GlcNAcT-II which catalyses the 
conversion of hybrid to complex N-glycans. At this stage in glycan processing 
fiicosyItransferase may act to transfer a fucose to the innermost GlcNAc residue. The 
final steps of complex oligosaccharide synthesis occurs in the trans Golgi cistemae and 
consists of the addition of the outer chain galactose and sialic acid residues catalysed by 
galactotransferase and sialyltransferase respectively (Figure 1.5). The newly synthesized 
glycoproteins then exit the Golgi and are transported to their final destination.
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The final oligosaccharide structure assembled on a glycoprotein is dictated to a large 
extent by the order in which that glycoprotein encounters the processing glycosidases 
and glycosyltransferases and their specificity (Axford 1997).
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1.1.3.2 0-L inked Glycoprotein
The majority of 0-linked oligosaccharides found in nature attach to the polypeptide 
backbone via a N-acetylgalactosamine residue (GalNAc). This type of linkage was first 
described in mucins and is often referred to as mucin type glycosylation. Other types of 
O linkage such as 0-linked fucose (Fuc) and 0-linked glucose (Glu) have been 
described however they are less commonly found (Taylor & Drickamer 2003).
0-linked glycans range in size from one monosaccharide residue to twenty and exhibit 
great structural diversity. The monosaccharides commonly found in 0-linked glycans 
include GalNAc, GlcNAc, SA and Fuc.
0-glycan biosynthesis is simper than asparagine N-linked oligosaccharide generation in 
that a lipid-linked oligosaccharide precursor for transfer to the protein is not required. 
The initiating event in biosynthesis o f 0-glycans is simply the addition of a 
galactosamine (GalNAc) residue donated by UDP-GalNAc to serine/threonine. The 
transfer of the GalNAc to the serine /threonine residue is catalysed by a enzyme 
GalNAc transferase (Hanisch 2001). As yet no consensus sequence for this transfer has 
been elucidated, however a preponderance of adjacent proline residues has been 
associated with the site of 0-linked glycosylation. The prolines appear to influence 
protein conformation by breaking helix formation and promoting the formation of B- 
tums and B-sheets.
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0-glycans tend to be more variable in monosaccharide composition but less branched 
than N-linked glycans. 0-linked glycoproteins are involved in a wide variety o f cellular 
functions, with the oligosaccharide moiety playing an important role in biological 
activity (Varki 1993b;Varki, Cummings, Esko, Freeze, Hart, & Marth 1999)
Studies have shown that the oligosaccharide moiety o f 0-linked glycoproteins influence 
their secretion, function and interaction with other molecules. For example proper 
expression and activity of the IL-2 receptor, the antigenic protein of the Epstein Barr 
virus and the LDL receptor are all dependant upon O-linked glycosylation 
(Brockhausen et al. 1995;Hounsell, Davies, & Renouf 1996).
1.1.4 Functions of Glycoconjugates
Many bioactive molecules have been shown to be glycoconjugates. The glycan chains 
attached to these molecules have been shown to influence the biosynthesis, stability, 
action and turnover of these molecules in intact organisms. Many biological roles of 
oligosaccharides have been documented including masking of target structures, 
modulation of protein and cell-cell interactions and in maintaining structural integrity.
Glycans are located on the outer surface o f cellular and secreted macromolecules and so 
are in the ideal position to influence structure as well as mediate a variety of events in 
cell-cell and cell-matrix interactions that are crucial to the development and function o f 
complex multicellular organisms.
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There is little doubt that some oligosaccharides such as those o f the proteoglycans and 
the collagens are important in the physical maintenance of tissue structure, integrity and 
porosity. For example the heparin sulphated chains of proteoglycans interact with 
molecules such as fibronectin, laminin and collagen and are thus responsible for the 
organization of basement membranes and the extracellular matrix (Hook et al. 1984).
The role of glycans as masking structures on macromolecules has been well 
documented. Studies using testicular hyaluronidase (Lace, Olavesen, & Gacesa 1990b) 
and pancreatic ribonuclease P (Bernard, Newton, & Olden 1983b) have provided 
evidence that coating of proteins by glycans can protect the protein from recognition by 
proteases and antibodies. Studies carried out by Lace et <2/.,(1990) showed that when 
testicular hyaluronidase was deglycosylated there was improved recognition by 
antibodies. Furthermore removal of the oligosaccharide chains from pancreatic 
ribonuclease p made it more susceptible to proteases (Bernard, Newton, & Olden 1983).
Oligosaccharide involvement in protein folding in the endoplasmic reticulum (ER) and 
in subsequent maintenance of protein conformation is widely accepted as a function of 
the glycan chains attached to proteins. Many proteins that are glycosylated do not fold 
properly, fail to exit the ER and are consequently degraded. One such example is the 
CD4 protein. When this protein looses both glycosylation sites, it is retained in the ER 
and degradation occurs (Konig, Ashwell, & Hanover 1988;Tifft, Proia, & Camerini- 
Otero 1992).
Since all mammalian cells are covered with a dense coating of oligosaccharide 
structures, it has long been believed that oligosaccharides are vital determinants of cell-
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cell interactions. One o f the best documented examples is that of the selectin family of 
receptor proteins that mediate the adhesion of leukocytes to endothelial cells. The 
minimum carbohydrate moiety required is a sialylated, fucosylated glycan chain such as 
the tetrasaccharide Sialyl Lewis X (SLex). Lowe (1990) and Philips (1990) found that a 
member o f the selectin family known as E-selectin, which is involved in the recognition 
of leukocytes by stimulated endothelium binds the glycan chains o f a glycoconjugate on 
the surface of leukocyte it was subsequently discovered that the glycan that it bound 
was a sialylated, fucosylated polylactosamine chain known as SLeX. It was then 
revealed that the binding of this glycan to the E-selectin on the endothelium was 
responsible for primary adhesion o f granulocytes, monocytes and certain lymphocytes 
to acutely or chronically inflamed tissue (Lowe et al. 1990). It has been reported that 
modifications of glycosylation may act as an on-off switch converting the molecule 
from an active state to an inactive state and vice versa. The best documented examples 
of changes in glycosylation affecting the biological activity o f a molecule are 
haemopoietic growth factors such as GM-CSF and erythropoietin. Changes in their 
glycosylation alter their binding affinities and the biological activity of the 
glycoproteins (Oh-edaM  1990).
The hormone p-HCG is a glycoprotein which has N-linked glycans attached. It has 
been reported that these glycans are required for signal transduction and subsequently 
their removal results in the conversion to an antagonist which still binds to its receptor 
but fails to transmit the signal (Bielinska, Matzuk, & Boime 1989;Matzuk, Keene, & 
Boime 1989).
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In conclusion, it is clear that although all the roles of glycoconjugates are not 
completely understood it is apparent that carbohydrate moieties profoundly influence 
biological functions. However most examples detailed above have been reported with 
reference to human medicine and there is little information on the comparative 
glycobiology of domestic animals.
1.2 Acute Phase Response
Following a wide variety o f adverse stimuli including injury, trauma and infection a 
complex series of reactions are executed by the host in an effort to prevent ongoing 
tissue damage, isolate and destroy the infective organism and activate the repair 
processes that are necessary to return the host to normal function (Baumann & Gauldie 
1994). The host organisms’ first line of defence is non-specific and is generally 
characterised as the acute phase response. The acute phase response (APR) comprises a 
local and systemic reaction and is an integral part o f the innate immune system. The 
local reaction manifests as acute inflammation at and around the site of injury whereas 
the systemic reaction consists of neurological, endocrine and metabolic alterations that 
are expressed as fever, leukocytosis, increased release of several hormones, activation 
o f the clotting, complement and kinnin-forming pathways and dramatic rearrangement 
o f plasma protein synthesis (acute phase proteins (APP) (Koj 1996). Most of the studies 
discussed in this section have been carried out with respect to the human disease and the 
human immune system or in experimental rodents and differences may arise in other 
species and this will be highlighted if  and when appropriate.
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1.2 .11nitiation and progression
The acute phase response is initiated at the site o f injury by chemical patterns that are 
presented by invading microorganisms or revealed by tissue damage, (Coelho, 
Hogaboam, & Kunkel 2005) (Baumann & Gauldie 1994;Werling D 2004). These are 
recognised by the pattern recognition receptors such as toll-like receptors present on 
mononuclear cells such as tissue macrophages and blood monocytes, resulting in their 
activation and ultimately activation of the cascade o f events that constitute the APR. 
Once activated the macrophages release a broad spectrum of mediators such as 
cytokines including interleukins 1 + 6 (IL-1, IL-6) and Tumour necrosis factor-a 
(TNFa). These are regarded as the most important as they initiate the next series of 
events. Locally IL-1 and TNFa act on stromal cells such as fibroblast and endothelial 
cells to initiate the release of secondary cytokines which activate the cellular and 
cytokine cascades that are involved in the complex process of the APR (Baumann & 
Gauldie 1994g;Gabay et al. 1994;Gabay & Kushner 1999). At the systemic level 
secreted cytokines exert actions on various tissues such as the brain and liver, however 
the liver is the primary target (Baumann & Gauldie 1994i). The liver’s response to the 
systemic inflammatory mediators is characterized by changes in the transport o f ions 
and metabolites in the activities of most metabolic pathways. There is also the co­
ordinated stimulation of the acute phase plasma proteins (APP’s). The inflammatory 
mediators that induce the hepatic APR can be divided in to four categories: IL-6 like 
cytokines, IL-1 like cytokines, glucocorticoids and growth factors. 11-6 like cytokines 
have been recognised as the principal regulator of most APP genes in hepatocytes. 
Glucocorticoids and growth factors mainly act as modulators of cytokine action rather
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than directly inducing events of the hepatic APR (Baumann & Gauldie 1994a; Jensen & 
Whitehead 1998a;Moshage 1997e). APP genes can be divided into groups according to 
which cytokine is primarily responsible for inducing the cascade o f events which lead to 
transcription(Moshage 1997d). Type I APP genes including SAA, GRP and AGP are 
induced by ILl-type cytokines however IL-6 type cytokine have been known to 
synergize with IL-1 type cytokines in the induction of type I APP genes. On the other 
hand Type II APP genes of which haptoglobin and alpha-2-macroglobulin are members 
are induced primarily by IL-6 type cytokines with IL-1 type cytokines having no affect 
on the induction of type II APP genes and in fact a possible inhibitory effect has even 
been suggested.
1.2.1.1 IL-1 type cytokine induced sianallinQ
The liver is a principal target of inflammatory cytokines such as the IL-1 type cytokines. 
The hepatic APR is initiated by binding of cytokines to receptors on the membrane of 
the hepatocytes (Baumann & Gauldie 1994e). Two IL-1 receptors (IL-IR) have been 
characterised on the hepatocytes, type 1 is an 80kDA transmembrane glycoprotein and 
type 2 is a 60kDA glycoprotein. Both IL-IR belong to the immunoglobulin superfamily 
but represent different gene products (Moshage 1997c). Type I IL-IR is primarily 
responsible for transmission of the IL-I signal including induction of the APP type 1 
(Brint et al. 2002;Fitzgerald KA 2000;Moshage 1997b). In contrast IL-IR  type 2 does 
not transmit a signal when IL-1 binds to it and for this reason type 2 is often thought of 
as an inhibitor o f the IL-1 induced signalling as it competes with the type 1 IL-IR.
2 0
Type 1 and type 2 TNFa receptors (TNFaR) have also been described. Type 1 is 
55kDA while type 2 is approximately 75kDa and both TN FaR ’s also belong to the 
immunoglobulin superfamily. However they are not homologous to IL-1 receptors. The 
basal levels of expression of both are low but increase during the acute phase response. 
Induction of APP’s is mediated via the type 1 TNFaR which is also responsible for 
TNFa induced apoptosis (Moshage 1997).
In order for IL-I type cytokines to induce APP genes they must activate a cascade, 
which transduces the signal from the outer cell membrane to the nucleus of the 
hepatocytes. However cytokine receptors have no intrinsic tyrosine kinase activity so a 
second receptor associated molecule is required for high affinity ligand binding and 
transmission of the cytoplasmic signal (Baumann & Gauldie 1994). It has been 
documented that IL-1 like cytokines induce expression of AP genes through activation 
of the transcription factors AP-1 and/or NFkB.
1.2.1.2 IL 6 and IL 6 type cytokines
The IL6 type family o f cytokines are solely responsible for the induction o f type II 
APP’s and are capable of synergising with IL 1 type cytokines on type I APP’s. IL-6 
type cytokines such as, ILI I, LIF and GSM are structurally distinct from IL-6 however 
produce a similar qualitative pattern of APP regulation (Baumann et al. 1983). Like 
other cytokine receptors IL-6 type cytokine receptors have no intrinsic tyrosine kinase 
activity and so in order to transmit the signal from the outer membrane to the nucleus a
2 1
receptor associated molecule is needed. Each member the IL-6 family of cytokines 
signals through a unique receptor complex however a common feature to all is the 
involvement of gpI30 a signalling membrane glycoprotein. Following IL-6 association 
with the alpha subunit o f the IL6 receptor a complex is formed with 2 gpl30 molecules 
(Figure 1.6). It is the dimérisation o f gpI30 that is responsible for the cascade of events 
that lead to the induction o f APP genes. Following dimérisation of the gpI30 signalling 
molecules, cytoplasmic tyrosine kinases such as JAK are activated. Once activated, 
JAK phosphorylates the tyrosine residues within the cytoplasmic region of gpl30 and 
subsequently the tyrosine residues o f latent ST AT proteins. Phosphorylation of the 
ST AT proteins results in their dimérisation and consequently their translocation to the 
nucleus where they bind to IL 6 responsive elements and ultimately the induction of the 
type II APP genes.
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1.2.2 Resolution of the acute phase response
Most research on the APR has concentrated on the initiation and progression of the 
response however another aspect of the APR that is equally as intriguing and important 
is the termination o f the response. Prolongation of the APR and the associated 
inflammation may have detrimental consequences for the host and so an effective 
inhibitory mechanism is desirable. It has been suggested that the APR is simply turned 
off due to degradation of the initiating cytokines (Baumann & Gauldie 1994). 
However several natural inhibitory mediators have been described. Some affect 
cytokine receptor interactions to prevent further signal transduction, whereas others 
interfere with the intracellular signalling cascade.
1.2.2.1 Soluble cytokine recep tors and naturally occurring 
antagonists
In order for pro-inflammatory cytokines to elicit their response and induce the APR they 
must bind to their membrane bound receptors. Consequently inhibiting the binding of 
pro-inflammatory cytokines to their particular receptor would theoretically extinguish 
the APR. Soluble cytokine receptors for IL-1, IL-6 and TNFa have been described, 
which are thought to arise due to proteolytic cleavage of membrane bound receptors or 
by translation from an alternatively spliced mRNA (Koj 1998). Soluble cytokine 
receptors prevent further activation o f the APR through posing as a decoy for the 
particular agonist binding which would otherwise prolong the response.
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The IL-1 receptor antagonist (IL-lRa) is the only natural antagonist to be described. IL- 
IRa is a very powerful regulator of the APR as it competes with IL-1 for binding to 
cellular IL-1 receptors. This interaction can interfere directly with the ongoing cascade 
of inflammation, as binding o f the IL-lR a to IL-IR  does not elicit a response and so 
dampens the IL-1 response.
12 . 2.2 Anti-inflammatory cytokines
Pro inflammatory cytokines are vital in the induction of the APR; however evidence 
suggests that many cytokines have the ability to exert both positive and negative effects 
depending on the cell types they interact with and the nature o f the interaction. It is 
universally accepted that IL-6 plays a very important role in the initiation of the APR, 
however it has also been shown to exhibit some anti-inflammatory activities, including 
down regulating the gene expression and synthesis of other pro-inflammatory cytokines 
such as TNFa and IL-1 (Schindler et a i  1990). Furthermore it can stimulate the 
synthesis of naturally occurring antagonists such as soluble TNF receptors and IL-lRa 
(Tilg et al. 1994). In addition specific anti-inflammatory cytokines do exist and in 
particular IL-4 and IL-10 have this activity.
IL-4 is mainly produced by type 2 T helper cells (Th]) and its anti-inflammatory 
activities include inhibiting production of pro-inflammatory cytokines such as ILI, IL8, 
IL-6 and TNFa (Zurawski & de Vries 1994) as well as stimulating the release o f IL-lRa 
(Vannier, Miller, & Dinarello 1992). IL-10 is produced relatively late following
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activation o f the APR (de Vries 1995) by TH2 cells, B lymphocytes, monocytes and 
macrophages and acts to inhibit the synthesis o f pro-inflammatory cytokines including 
IL-1, IL-6, IL-8, TNFa and colony-stimulating factors (CSFs) as well as stimulating the 
release of IL-lRa.
1.2.2.3 Glucocorticoids
Glucocorticoids are produced in the adrenal glands after induction by 
pro-inflammatory cytokines and can have positive and negative effects on the APR. 
They can either enhance the effects of the pro inflammatory cytokines in the liver or 
provide a natural feedback loop by inhibiting the production o f many initiating and 
secondary cytokines by macrophages and stromal cells (Baumann & Gauldie 
1994;Jensen & Whitehead 1998), which ultimately results in the termination of the 
APR.
Most of the studies discussed above on the action of cytokines, cytokine receptors and 
soluble receptors have been performed either in vitro or in laboratory animals. The 
presumption is that this also occurs in man and domestic animals however it remains to 
be seen if  this is indeed the case.
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1.3 Acute Phase Protein
The APPs are a diverse group of plasma proteins synthesised predominately in liver 
parenchymal cells whose concentration in the blood is increased (positive) or decreased 
(negative) by at least 25% during acute inflammation (Kushner 1982). Resolution of 
the APP response usually occurs within 4 to 7 days after stimulation if no further 
stimulation occurs.
The function of most APPs has not been totally elucidated. The positive APPs are 
regarded as having general functions in opsonisation and trapping of micro organisms 
and their products, in activating complement, neutralizing enzymes, scavenging free 
haemoglobin and radicals and in modulating the hosts’ immune response.
The pattern o f the APP response is species-specific with the exceptions of fibrinogen 
which increases by 50-100% and serum albumin concentrations which decrease by 10- 
30% in all mammalian species.
The circulating concentrations of the APP are related to the severity of the disorder and 
the extent o f tissue damage in the affected animals. Quantification of their 
concentration can therefore provide valuable diagnostic and prognostic information.
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1.3.1 Negative acute phase proteins
The negative APPs are proteins the concentration o f which is decreased by at least 25% 
during an APR including albumin (all species) and transthyretin (human and pigs). It 
has been reported that the necessity for up-regulation of hepatic mRNA of the positive 
APPs results in decreased synthesis of normal blood proteins which result in the 
reduction in concentration of the negative APPs.
1.3.2 Positive acute phase proteins
Positive APPs can be subdivided based on their response pattern to inflammatory 
stimuli. Major positive APPs have very low or undetectable levels in serum of healthy 
animals but increase rapidly by more than 100 fold during an APR, whereas minor or 
moderate positive APPs are present in the serum of healthy animals and their 
concentrations increase during an APR but only up to 10 fold (moderate) and 1-2 fold 
(mild). However the moderate APP concentration remains elevated for a longer period 
after the challenge (Conner et al. 1988;Eckersall 1995;Gruys, Obwolo, & Toussaint 
1994). In man GRP and SAA are the major APPs of use in diagnostic biochemistry 
while Hp and AGP are moderate APPs. However AGP and Hp are known 
glycoproteins and as such are described in detail below.
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1.3.2.1 C-reactive protein
C reactive protein (CRP) a major APP, was first discovered in Oswald Avery’s 
laboratory during the course of studies of patients with Streptococcus pneumoniae 
infection, and named for its capacity to bind C polysaccharide o f Strep.pneumoniae 
(Tillett and Francis, 1930). C reactive protein is a positive APP featuring a 
homopentameric structure with Ca^^ dependant binding specificity for phosphocholine 
(PCh). The main biological function o f CRP appears to be host defence against 
bacterial pathogens and clearance of apoptotic and necrotic cells. Though human CRP 
is not glycosylated it is known that canine CRP has both a glycosylated and a non­
glycosylated subunit (Caspi et al. 1984).
1.3.2.2 Serum  Am yloid A
Another major APP is Serum amyloid A (SAA) is the collective name given to a family 
of differentially expressed apolipoproteins encoded by multiple genes in a number of 
mammalian species. The human SAA gene family comprises a tightly linked cluster of 
three hepatically expressed genes (SAAl SAA2 and SAA4) and fourth locus (SAA3) 
which is a pseudogene. All four loci are clustered on the short arm of chromosome 11 
(Sellar et al. 1994;Watson, See, & Woo 1994).
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The exact functional role of SAA proteins remains obscure; however various effects and 
proposed functions have been reported such as cholesterol metabolism and transport 
(Liang & Sipe 1995).
1.3.2.3 Haptoglobin
Haptoglobin (Hp) is an alpha 2 acidic glycoprotein with haemoglobin (Hb) binding 
capabilities. In humans Hp is a normal constituent of plasma and is present at relatively 
high levels (0.9-1.3 mg/ml) (Langlois & Delanghe 1996). Some animals notably 
ruminants such as cattle do not constitutively express haptoglobin (Heegaard et al. 
2000). Haptoglobin is a positive APP and in humans its concentration increases 2-10 
folds (moderate APP) during an APR while in cattle it can raise 10-100 fold (major 
APP). Like other glycoproteins it is not just the concentration o f haptoglobin that is 
under the influence of the APR as the oligosaccharide chains attached also undergo 
subtle changes.
1.3.2.3.1 Structure and Expression
Human Hp is a tetramer consisting of 2 a and 2 glycosylated p subunits covalently 
associated by inter-chain disulfide bonds (Turner 1995). The a  1 and P chains of Hp 
contain 83 and 245 residues respectively (Kurosky et al. 1980).
Variations in the a  subunit o f Hp exists in humans and gives rise to three major Hp 
phenotypes Hpl-1, Hp2-1 and Hp 2-2 (Yee & Brown 1999) . These phenotypes are 
genetically determined by two alleles: Hpl and Hp2. Although Hp is found in serum of
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all mammals this polymorphism has only been demonstrated in humans (Barnett, 
Bowman, & Lee 1972;Brune et al. 1984;Kurosky et al. 1975;Kurosky, Hay, & Bowman 
1978)
Several functional differences between the phenotypes have been demonstrated and 
appear to have important biological and clinical consequences (Bamm et al. 
2004;Delanghe et al. 1999;Langlois & Delanghe 1996). For example patients with 
phenotype 1-1 are less prone to the development o f inflammation related cardiovascular 
diseases and diabetes (De Bacquer et al. 2001;Hochberg et al. 2002). These effects are 
explained by a phenotype dependant modulation of oxidative stress and prostaglandin 
synthesis.
The liver is the primary site of synthesis however extra hepatic expression has been 
reported. In addition to the liver haptoglobin has also been found to be synthesised in 
the lung (Yang et al. 1995), adipocytes (Friedrichs et al. 1995) and the uterus (Hoffman 
et al. 1996).
Inflammatory cytokines such as IL-6 significantly alter glycosylation of acute phase 
response proteins synthesised by hepatocytes and human hepatoma cell lines including 
Hp (van Dijk, Turner, & Mackiewicz 1994).
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1.3.2.3.2 Carbohydrate moiety
The carbohydrate content of hepatic Hp is approximately 20% of the p chain mass 
(Black & Dixon 1970) and is found external to the protein, exclusively as N-linked, 
complex oligosaccharides chains (Kurosky et al. 1980;Tumer 1992).
The p chains o f human Hp each have four Asn-X-Ser/Thr sequences (Asn 23, Asn 46, 
AsnSO, Asn 80) all of which may be occupied with glycan chains (Kurosky et al. 
1980c).
Analysis of glycans derived from immunopurified human Hp by High Pressure Liquid 
Chromatography (HPLC) revealed the presence o f diantennary complex glycans in a 
neutral, monosialylated and bisialylated forms and lower amounts of triantennary 
complex glycans that were present in disialylated and trisialylated forms. About 75% of 
charged Hp glycans were of diantennary complex structure some of which had one 
terminal sialic acid missing. Triantennary structures made up 25% of the glycome and 
highly branched glycan pools did not exceed 1% (Ferens-Sieczkowska & Olczak 
2001b).
Microheterogeneity of the carbohydrate moiety Hp has been described (Katnik 1984). 
1.3.2.3.3. Structural heterogeneity
Like other glycoproteins the heterogeneity o f Hp is dependant on the pathological 
condition of the patient, several studies have revealed unique and characteristic changes 
in fucose content, sialic acid content and linkage going from a2-6 to a2-3 and glycan 
branching which are associated with different diseases as well as leading to novel
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modifications in the Hp function (Baseler & Burrell 1981;Baseler & Burrell 1983;Oh et 
al. 1987;Oh, Pavlotsky, & Tauber 1990a) (Table 1.1).
Increased fucosylation is a common finding and can be used to differentiate between 
different diseases or stage of disease. Fucosylated Hp is useful for discriminating 
between active and inactive rheumatoid arthritis (RA) with 94% of patients with active 
RA having high fucose content on Hp versus 5% of patients with inactive RA 
(Thompson et al. 1989). Further examples are given in Table 1.1
Fucosylated Hp has also shown potential as a prognostic marker as it can be used to 
monitor disease activity in cancer. Abnormally fucosylated forms of Hp have been 
measured in blood specimens from women with carcinoma of the ovary or breast who 
are undergoing chemotherapy. The proportion of fucosylated Hp increased if the 
women had progressive disease and decreased if  they showed complete response to 
therapy (Thompson, Dargan, & Turner 1992).
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Disease Heterogeneity reference
Rheumatoid arthritis Increased fucosylation 
Increased sialylation 
Increased branching
(Thompson et al. 
1989;Thompson et al. 
1993)
Ovarian cancer Increased fucosylation 
Increased branching
(Thompson, Dargan, & 
Turner 1992;Tumer, 
Goodarzi, & Thompson 
1995)
Crohns disease Increased sialylation 
Increased branching 
Increased fucosylation
(Turner 1992;Turner 1995)
Alcoholic liver disease Increased fucosylation (Chambers et al. 
1993;Mann et al. 1994)
Acute and chronic 
Inflammation
Expression o f Sialyl Lewis 
X
(Brinkman-van der Linden 
et al. 1998)
Breast cancer Increased fucosylation 
Increased Branching 
Increased sialylation
(Thompson & Turner 
1987)
T a b le  1.1 R ep o r ts  o f  stru c tu ra l h e tero g en e ity  o f  h a p to g lo b in  in v a r io u s  h u m a n  d iso rd ers
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1.3.2.3.4 Functions
The exact functional role of Hp remains elusive nonetheless it is generally accepted that 
haptoglobin plays an important part in the scavenging of free haemoglobin.
1.3.2.3.4.1 Binding of Haemoglobin (Hb)
The binding of Hb to Hp is the strongest non-covalent interaction known among the 
transport proteins in plasma and is not reversible. Hp binds Hb in a ratio of 1:1 with an 
association constant greater than 10''^ M (Dobryszycka 1997).
Efficient removal of free Hb following haemolysis of erythrocytes is essential since free 
Hb can accelerate lipid peroxidation, leading to production of toxic molecules. After 
destruction of erythrocytes, free Hb in the circulation passes through the glomerular 
filter and renal damage may occur. Haptoglobin effectively reduces the loss of Hb and 
iron because the Hp-Hb complex is not filtered through the glomeruli but is retained in 
the body. It was hypothesized that the complex is transported to the liver where the Hp- 
Hb complex can be broken down in the parenchymal cells (Kino et al. 1980;Kino et al. 
1987), the mechanisms leading to the removal of the Hp-Hb complex from the blood 
remained elusive until the recent discovery of a novel Hb scavenger receptor protein 
known as CD 163. This membrane protein found exclusively on 
monocytes/macrophages was identified as the receptor that engulfs Hb by mediating 
endocytosis of Hp-Hb complexes. GDI63 will only bind Hp and Hb in complex 
suggesting that a neo-epitope is presented by this interaction (Kristiansen et al. 2001).
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The receptor ligand interaction is calcium dependant and o f high affinity. 
Internalisation of Hp-Hb in macrophages is followed by lysosomal proteolysis of 
globulin and conversion of haem to iron and bilirubin.
During inflammatory conditions the Hp-Hb and CD 163 system might be co-ordinately 
induced, thereby enhancing the Hb clearance capacity in response to injury (Gordon 
2001).
The carbohydrate moiety of haptoglobin has been shown to be important in the capture 
of haemoglobin as total removal o f sialic acid diminished the haptoglobin-haemoglobin 
complex formation by 15% while further removal of 25% of galactose residues totally 
inhibited the ability of haptoglobin to bind haemoglobin (Kaartinen & Mononen 1988).
1.3.2.3.4.2 Other functions of haptoglobin
Although the capture of haemoglobin is the most documented function of haptoglobin a 
variety of other putative biological functions have been ascribed to Hp. However some 
of the roles outlined in the Table may be a direct consequence of haemoglobin binding 
(Table 1.2).
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Role Reference
bactero static (Barclay, Clark, & Thomas 1985)
Inhibits Neutrophil respiratory burst (Oh, Pavlotsky, & Tauber 1990)
Inhibits cathepsin B (Snellman & Sylven 1967;Snellman & 
Sylven 1974)
angiogeneis (Cid et al. 1993;Cockerill, Gamble, & 
Vadas 1995)
T a b le  1.2 F u n ctio n s o f  H p  a p a rt from  h aem o g lo b in  b in d in g .
1.3.2.4 Alpha-1-acid glycoprotein
Alpha-1-acid glycoprotein (AGP) formerly known as orosomucoid is a plasma 
glycoprotein. Alpha-1-acid glycoprotein was initially characterised in 1950 by two 
research groups headed by Schmid and Weimer respectively (Schmid 1950;Weimer, 
Mehl, & Winzler 1950). Since its discovery AGP has been the subject o f many studies, 
which have highlighted unique physio-chemical properties such as its high carbohydrate 
content, its low pi value and its high solubility.
The concentration of AGP found in normal human plasma usually falls within the range 
of 0.36-1.46 mg/ml (Blain et al. 1985). However AGP has been found to be an acute 
phase glycoprotein and falls in to the class II positive acute phase protein group 
(Routledge 1989). The levels of AGP are increased two to five fold in both acute and 
chronic inflammatory conditions.
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1.3.2.4.1 Amino Acid sequence
Using protein-sequencing Schmid et a/.,(1973) reported that the polypeptide moiety o f 
human AGP was a single chain composed o f 181 amino acids (Schmid et al. 1973). 
However studies carried out by Dente (Dente et al. 1987;Dente, Ciliberto, & Cortese 
1985;Tomei et al. 1989) established that AGP actually had 183 (Figure 1.7 ) amino acids 
with two disulphide bonds that link residues cys5 + cysl47 and cys72+cysl64. 
Twenty-four possible amino acid substitutions exist within the AGP amino acid 
sequence, with each only involving two residues (Dente, Ciliberto, & Cortese 1985).
1.3.2.4.2 Genetic variants
Since the initial discovery o f the structure o f AGP many variant forms have been 
detected, with differences identified in the amino acid sequence and heterogeneity of the 
oligosaccharide chains described.
Human AGP is the product o f a cluster o f 3 adjacent genes termed AGFA, AGPB and 
AGPB" which are all located on chromosome 9. These three genes have been shown to 
encode two polypeptide variants of AGP known as ORMl and 0RM 2. ORMl is the 
major component of serum AGP it is encoded by AGFA and actively expressed in 
human liver. AGPB and A G P B ’ are identical, probably as the result o f a recent gene 
duplication. AGPB and AG PB’ genes differ from the AGFA gene by 22 base 
substitutions and code for 0RM 2. AGFA can be induced by acute phase stimuli whilst
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AGPB  and B ’ cannot. O f the twenty four known possible amino acid substitutions 
twenty-two are due to the difference between AGP-A and AGP-B/B’ (Dente, Pizza, 
Metspalu, & Cortese 1987;Dente et al. 1988;Foumier, Medjoubi, & Porquet 
2000b;Schmid, Emura, Nimberg, Ikenaka, & Schmid 1973;van Dijk, Havenaar, & 
Brinkman-van der Linden EC 1995).
Although some degree of variability is produced by these amino acid substitutions 
alterations in the glycosylation profile induce far greater structural heterogeneity.
Ile-Pro-Leu-Cys-Ala-Asn-Leu-Val-Pro-Val-Pro-Ile-Thr-Asn*-Ala-Thr-Leu-Asp-
Arg/Gln-Ile-Thr-Gly-Lys-Trp-Phe-Tyr-Ile-Ala-Ser-Ala-Phe/Ala-Arg-Asn-Glu-Glu-
Tyr-Asn*-Lys-Ser-Val-Glu-Glu-Ile-Gln-Ala-Thr/Ala-Phe-Phe-Tyr-Phe-Thr-Pro-
Asn*-Lys-Thr-Glu-Asp-Thr-Ile-Phe-Leu-Arg-Glu-Tyr-Gln-Thr-Arg-Gln-Asp/Asn-
Gln-Cys-Ile/Phe-Tyr-Asn*-Thr/Ser-Thr/Ser-Tyr-Leu-Asn-Val-Gln-Arg-Glu-Asn*-
Gly-Thr-Ile/Val-Ser-Arg-Tyr-Val/Glu-Gly-Gly-Gln/Arg-Glu-His-Val/Phe-Ala-His-
Leu/Asn-Leu-Ile/Phe-Leu-Arg-Asp-Thr-Lys-Thr-Leu/Tyr-Met-Phe/Leu-Gly/Ala-
Ser/Phe-T yr/Asp-Leu/V al-Asp/Asn-Asp-Glu-Lys-Asn-T rp-Gly-Leu-Ser-Phe/V al-
Tyr-Ala-Asp-Lys-Pro-Glu-Thr-Thr-Lys-Glu-Gln-Leu-Gly-Glu-Phe-Tyr-Glu-Ala-
Leu-Asp-Cys-Leu-Cys/Arg-Ile-Pro-Arg/Lys-Ser-Asp-Val-Met/Val-Tyr-Thr-Asp-
Trp-Lys-Lys-Asp-Lys-Cys-Glu-Pro-Leu-Glu-Lys-Gln-His-Glu-Lys-Glu-Arg-Lys-
Gln-Glu-Glu-Gly-Glu-Ser-COOH
Asn* = N-linked glycosylation site 
Xxx/xxx = possible amino acid substitutions.
F igu re  1.7 T h e  am in o  ac id  seq u en ce  o f  hu m an  A G P
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1.3.2.4.3 Carbohydrate Moiety
Human AGP has a molecular weight of 41-44kDa, 45 % which is made up of 5 complex 
type N-linked glycan chains. These are located on asparagines 15, 38, 54, 75 and 85 
(Figure 1.7).
Differences in the glycosylation profile of AGP can arise in the complexity of 
oligosaccharide chain branching as the oligosaccharides chain can contain 2, 3 or 4 
branches. Differences may also arise in the degree and type of outer chain substitutions 
thus they may have different degrees o f sialylation and fucosylation, as well as through 
attachment of different oligosaccharides to each of the sites. Theoretically the 
glycosylation profile o f AGP offers the potential o f 10  ^ different glycoforms of AGP 
each bearing a unique combination of glycans at the 5-glycosylation sites. However in 
nature only 12-20 glycoforms have been found in normal human serum. This is due to 
the fact that glycosylation site 1 never carries a tetra-antennary glycan, glycosylation 
site 2 never carries glycans containing fucose, glycosylation site 4 never carries a bi- 
antennary glycan and only glycosylation sites 4 and 5 carry tetra-antennary glycans with 
more than 1 fucose. However this micro-heterogeneity has been shown to be dependant 
on the pathophysiological conditions. (Elliott et al. 1997;Foumier, Medjoubi, & Porquet 
2000;Mackiewicz & Mackiewicz 1995;Ryden et al. 1997;Smith et al. 1994;van Dijk, 
Havenaar, & Brinkman-van der Linden EC 1995). The glycosylation pattern of AGP 
seen at any time point is dependant on the pathophysiological condition of the tissue 
(Rydenetal. 1997;Smith et al. 1994).
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1.3.2.4.4 Hepatic and extra-hepatic synthesis
Alpha-1-acid glycoprotein is one of many plasma proteins that are synthesised by the 
liver. The cells primarily responsible for its synthesis are the hepatocytes. Once AGP 
has been synthesised by these cells it is distributed in body fluids such as plasma, 
mucus, gastric juice, cerebrospinal fluid, ascitic fluid and peritoneal effusions. 
Although AGP is mainly synthesised in the hepatocytes, extra-hepatic synthesis has 
been reported.
Alpha-1-acid glycoprotein was initially reported extra-hepatically in 1977 in normal 
breast and colon tissues (Twining & Brecher 1977). In 1982 extra hepatic synthesis of 
AGP was reported in human breast epithelial cells (Gendler et al. 1982). Since then 
AGP synthesis has been reported in a variety of cells and tissues that include 
granulocytes, monocytes, endothelial cells, lung breast and alveolar type II epithelial 
cells as well as alveolar macrophages. (Fournier, Medjoubi, & Porquet 2000;Gahmberg 
& Andersson 1978).
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1.3.2.4.5 Structural Heterogeneity in inflammation
Despite the extensive variation possible from the glycosylation profile of AGP only 12- 
20 glycoforms o f AGP are observed in normal human plasma. However this can 
change due to the pathophysiological condition o f the subject. It has been reported that 
the glycosylation profile of AGP in human sera is subject to marked changes during 
acute inflammation as a result of the cytokine-induced acute phase response. In 
situations o f acute inflammation such as bacterial infection, surgery and trauma, there is 
an increase in AGP glycoforms containing bi-antennary chains (De Graaf et al. 
1993;Mackiewicz et al. 1987;Pawlowski, Mackiewicz, & Mackiewicz 1989;Pos et al. 
1990;van Dijk, Havenaar, & Brinkman-van der Linden EC 1995). On the other hand in 
situations o f chronic inflammation such as alcoholic liver cirrhosis and rheumatoid 
arthritis, the opposite is seen, and there is an increased appearance of tri and tetra- 
antennary structures (Biou et al. 1989;Jezequel et al. 1987;Serbource-Goguel et al. 
1986;Seta et al. 1997;Seta et al. 1986).
In rheumatoid arthritis (RA) the variation in glycan branching of AGP is indicative of 
both the severity and the progression of the disease (Hrycaj et al. 1993;Hrycaj et al. 
1993;Mackiewicz et al. 1987;Pawlowski, Mackiewicz, & Mackiewicz 1989). 
Differences have been detected between the glycoform population seen in the early and 
late stages of the disease. Patients with early RA, displayed an increase in bi-antennary 
glycoforms, which persisted over the first year however as the disease progressed to the 
chronic stage an associated decrease in bi-antennary and hence an increase in tri and 
tetra-antennary glycoforms was observed.
In addition to the heterogeneity in the branching pattern of AGP, variations also occur
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in the minor heterogeneity o f the oligosaccharide chains during both acute and chronic 
inflammation. Increased fucosylation has been observed in acute inflammation 
including bums, liver cirrhosis and RA (De Graaf et al. 1993;Elliott et al. 1997;Poland 
et al. 2001;Ryden et al. 2002;Turner 1992). This increase in fucosylation is in part due 
to an increase in the expression o f the antigenic structure Sialyl Lewis X (SLex) (De 
Graaf et al. 1993;Poland et al. 2001). The expression of this antigen on AGP is very low 
in control semm and upregulation in inflammation is associated with the presence o f tri 
and tetraantennary stmctures. The SLex antigen is composed of the sequence 
NeuAca2-3GaIpl-4(Fucal-3) GlcNAc-, and thus contains both a l-3  fucose and a2-3 
linked sialic acid. Consequently, if  there is an increase in the appearance o f SLex on 
AGP in acute inflammation then it is likely that there would be an increase in sialic acid 
and fucose levels.
The effect of inflammation on the extent of sialylation of AGP is somewhat confused as 
while some reports describe a decrease in level of sialylation in liver disease 
(Serbource-Goguel et al. 1983;Serbource-Goguel et al. 1986) and rheumatoid arthritis , 
whilst others have reported an increase. The inconsistency in these findings may be due 
to different methods of purification and assessment of sialic acid content as harsher 
methods of purification can lead to the degradation o f the terminal sialic acid. Further 
examples of disease related glycosylation modifications are given in Table 1.3
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Disease Effect on AGP Reference
Cancer Increased expression of diantennary 
chains
(Rudman et al. 1974)
Increase bi-antennary: decrease sialic 
acid: increase fucose
Tamura a/., 1988
Lung cancer Increased expression of diantennary 
chains
(Hansen, Larsen, & 
Boghansen 1984)
hypersialylation (Moule et al. 1987)
Chronic
leukemia
Increased expression o f tri and 
tetraantennary chains
(Treuheit & Hal sail 1992)
Diabetes Increased fucose expression (Poland et al. 2001)
Pregnancy Increased expression o f tri and 
tetraantennary chains
(Raynes 1982)
Pneumonia Increased expression of diantennary 
chains
(Treuheit & Hal sail 
1992b)
Inflammation Increased expression o f tri and 
tetraantennary chains in lung 
inflammation
(Hansen, Larsen, & 
Boghansen 1984)
acute
inflammation
Increased expression of diantennary 
chains with increased fucose content
(Higai et al. 2005)
RA Increase expression of tri and 
tetraantennary chains
(Elliott et al. 
1997f;Pawlowski, 
Mackiewicz, & 
Mackiewicz 1989; Smith 
et al. 2002)
T a b le  1.3 R ep o rts o f  g ly co sy la tio n  ch a n g es on h u m an  A G P  in d isea se .
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1.3.2.4.6 AGP Functions
Despite extensive investigation, the precise functional role of AGP remains to be 
elucidated. Several parameters can influence the function of AGP, which makes it 
difficult to interpret the way AGP functions in vivo, as AGP has been shown to exert 
different activities depending on the cell type it interacts with and it can display several 
activities on one cell type, with the activity it display on a certain cell dependant on the 
stimulus. The glycosylation profile can influence its activity while some effects o f AGP 
can be concentration dependant.
1.3.2.4.6.1 Drug Binding
For many years it has been known that AGP has drug binding capabilities and is thought 
to be one of the major drug binding molecules in plasma along with albumin. Due to a 
high proportion of sialic acid found in AGP, it carries a large negative charge. 
Consequently, it preferentially binds basic drugs with pKa values of 8 or higher as these 
will then have a positive charge at physiological pH. However AGP has also been 
shown to bind certain steroids and acidic drugs (Kremer, Wilting, & Janssen 
1988;Piafsky et al. 1978;Sadler et al. 2001).
It was originally thought that AGP only had one binding site but further studies have 
characterised seven binding sites each with varying affinities and capacities. Drugs that 
are known to bind AGP preferentially include amitiptylin, cocaine, erythromycin, 
imipramine, methadone, rifampicin, thalidomide, verapamil. Changes in the plasma 
concentration of AGP seen in the acute phase response can therefore significantly
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influence the free plasma concentration and consequently both the pharmacokinetics 
and pharmacodynamics o f the drug (Israili and Dayton, 2003)
1.3.2.4.6.2 Immunomodulatory Effects
1.3.2.4.6.2.1 Effects of AGP on lymphocytes
Human AGP has been shown to influence lymphocyte proliferation as AGP at 
physiological concentrations inhibited lymphocyte proliferation in vitro (Cheresh, 
Haynes, & Distasio 1984). The inhibitory effect of AGP was found to be at the level of 
both the mitogen and the lymphocyte. Alpha-1-acid glycoprotein has been shown to 
interact directly with lymphoid membrane (Cheresh, Haynes, & Distasio 1984). The 
degree o f inhibition exerted by AGP was found to be dependant on its glycosylation 
profile (Bennett & Schmid 1980) as it was shown that non-reactive Con A and fully 
sialylated forms of AGP were more effective at inhibiting the anti-CD3-induced 
proliferation of human peripheral blood mononuclear lymphocytes than Con A reactive 
forms and disialylated forms o f AGP (Pos et al. 1990). The importance o f the 
carbohydrate moiety of AGP on its ability to inhibit lymphocyte proliferation was 
confirmed by Shiian and co-workers (1994). They showed that when the glycan chains 
of AGP where transferred to a synthetic matrix which mimicked the polypeptide moiety 
of AGP the same degree o f inhibition was observed (Shiian et al. 1994).
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1.3.2.4.6.2.2 Effect of AGP on neutrophils
Neutrophils are among the first leukocytes to respond to infection and injury and 
accumulate at the pathological site. Once neutrophils are activated they are responsible 
for destroying invading organisms by phagocytosis. They can also release cytotoxic 
compounds such as proteases and reactive oxygen species into the environment. This 
action can be detrimental to the host as well as advantageous, because if  the neutrophils 
are activated at the wrong location or are excessive then they can then damage healthy 
tissue, whereas if released at the right location they can act to clear the organism. 
Alpha-1-acid glycoprotein has been shown to inhibit several activities of neutrophils 
such as the chemotactic response, superoxide generation and at doses above 0.5mg/ml it 
inhibits neutrophil aggregations (Hochepied et al. 2003). All these activities imply that 
AGP may act to switch off or downregulate the immune response.
1.3.2.4.6.2.3 Effects of AGP on Platelets
Alpha-1-acid glycoprotein has been shown to inhibit platelet aggregation in a dose- 
dependant manner. Initial studies that revealed AGP as an inhibitor of platelet 
aggregation used concentrations greater than the physiological concentration range 
(Snyder & Coodley 1976). However further studies carried out by Costello et al.,{\919) 
showed that AGP could inhibit platelet aggregation at concentrations seen in inflamed 
serum (Costello et al. 1979). Costello also reported that desialylation of the AGP 
increased its inhibitory effect. The inhibitory effect exerted on platelet aggregation by 
AGP was found to be directed against the secondary wave o f platelet aggregation, 
which suggests that AGP may contribute to the down regulation of the further
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recruitment of platelets and so in some way may exert an anti-thrombic function.
1.3.2.4.6.2.4 Effects in vivo
In 1983 Friedman proposed that AGP exerted non-specific anti-infectious activities 
(Friedman 1983). This arose from the finding that AGP was able to inhibit the ability of 
Plasmodium falciparum  to infect red blood cells. This inhibitory effect was shown to 
be glycosylation-dependant as desialylation removed the inhibitory activities of AGP. 
It was suggested that inhibition resulted from the interaction of AGP with a sialic acid 
receptor on the parasite, preventing uptake into the host erythrocytes and reduced 
infection (Friedman 1983).
Support for Friedmans proposal of AGP being a non-specific anti-infectious agent came 
when Hochepied et al, (2000) reported that AGP was involved in the induction of non­
specific resistance to infection when Kleibsiella pneumonia was used as a model of 
bacterial shock in mice. These studies revealed that mice that had received AGP prior 
to a lethal challenge by Kpneumonia  were protected. This protection was shown to be 
at the level of bacterial spread and clearance as mice pre-treated with AGP showed less 
bacteria in their blood and different tissues. The protective role exerted by AGP in this 
study may be due to AGPs ability to alter capillary selectivity and hence control the 
transport of molecules through the endothelium (Hochepied et al. 2000).
In vivo, AGP infusion was shown to protect mice against lethal shock induced by TNF a 
(Libert, Brouckaert, & Fiers 1994) but not against LPS induced lethality (Muchitsch, 
Auer, & Pichler 1998). Muchitsch et a l, 1998 suggested that the partial protective 
effect of AGP in different rodent models of shock may be explained by enhancing the
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capillary barrier function and thereby maintaining the perfusion o f vital organs. 
However the protective activities exerted by AGP may also be due to its inhibitory 
activities on platelet aggregation, chemotaxis and oxidative metabolism o f neutrophils.
Therefore although many studies support that AGP may act in vivo as a non-specific 
anti-infectious agent, the exact mechanism behind this ability has not been elucidated.
1.3.2 APP response in various species
Since the discovery of GRP as an acute phase protein in humans many studies have 
been carried out to discover other acute phase proteins and the role they play in the 
innate immune response. Studies however have not just been aimed at human acute 
phase proteins but have moved into the veterinary research. Although most species 
express the same acute phase proteins as humans the response o f each APP is dependant 
on the species. For example GRP which is a major positive acute phase protein in 
humans, although expressed by cows it is only a minor APR in this species. There have 
been a number o f excellent reviews in the recent past on the APR in companion animals 
(Geron, Eckersall, & Martinez-Subiela 2005;Jacobsen et al. 2005) and production 
animals. Table 1.4 gives an outline of the APP response in various animal. In addition 
the introduction to the experimental chapters o f this thesis was considered the more 
appropriate location for information on the APR and APP in the species and condition 
being investigated.
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Human Cat Cow Sheep Horse Dog Pig Rat
a-1 acid 
glycoprotein
++ +++ ++ ++ ++ -t-+ NA ++
Haptoglobin ++ ++ +++ +++ ++ ++ ++
C-Reactive 
protein
+++ NA con +++ +++
Serum 
Amyloid A
+++ +++ +++ +++ +++ +++
Albumin - - - - - - - -
Transthyretin - NA -
A-2
macroglobulin
NA + +++
ceruloplasmin NA ++ ++
T a b le  1.4 T h e  a cu te  p h a se  p rote in  resp o n se  in v a r io u s  an im a l sp ec ies . + + + =  m a jo r  A P P  
+ + = m o d era te  A P P , + =  m in o r  A P P , N A =  n o t a v a ila b le , co n =  c o n stitu tiv e ly  exp ressed  based  on  
(C ero n , E ck ersa ll, &  M a rtin ez-S u b ie la  2 0 0 5 ;J a co b sen  et al. 2 0 05)
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1.3.3 APP’s  in veterinary medicine
The significance o f APP’s as non-specific variables to monitor infiammation activity 
has been extensively reviewed.
Acute phase proteins can be used as non specific markers of clinical and subclinical 
infections to discriminate between acute and chronic disease and for prognostic 
purposes, since the duration and magnitude of the response reflect the severity of the 
disease (Hulten et a i , 1991; Saini and Werbert, 1991; Peltola, 1982) and the effect of 
treatment (Hulten et al. 2002).
1.3.3.1 Haptoglobin in veterinary m edicine
Numerous studies have highlighted the significance of Hp as a clinically useful 
parameter for monitoring the occurrence and severity of infiammation responses in 
cattle with mastitis (Hirvonen, Pyorala, & Jousimies-Somer 1996), pasteurellosis 
(Conner et al. 1989;Horadagoda et al. 1999), bovine respiratory syncytial virus 
(Heegaard et al. 2000) and pneumonia (Heegaard et al. 1998;Wittum et al. 1996). 
Bovine haptoglobin levels have been correlated to the severity o f experimental 
infections with foot and mouth disease (Hofher et al. 1994).
In pigs haptoglobin measurements can be used to differentiate between normal pigs and 
pigs that will have low rates of weight gain due to subclinical infection (Eurell et al. 
1992;Pineiro et al. 2007;Sorensen et al. 2006).
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1.3.3.2 SAA in veterinary m edicine
In horses measurement of SAA levels is shown to be useful in the diagnosis of viral 
infections or surgical trauma (Pepys et al. 1989) and in equine influenza infection 
(Hulten et al. 1999). Elevated SAA levels have also been found in cows with 
experimentally induced (Hirvonen, Pyorala, & Jousimies-Somer 1996c) and naturally 
occurring (Eckersall et al. 2001) mastitis and found to be related to the severity of the 
disease (Hirvonen, Pyorala, & Jousimies-Somer 1996).
1.3.3.3 A P P  in bovine m astitis
There has been particular interest in the use of APPs in diagnosis o f bovine mastitis. In 
dairy herds mastitis is a production disease of major importance. Cows with clinical 
signs of mastitis are easily identified by experienced dairymen, however subclinical 
infection may not be detected and remain untreated. Serum levels of Hp and SAA are 
elevated in bovine mastitis however it is non specific as the levels of bHp and SAA 
levels are increased in various experimental and natural occurring inflammatory 
conditions. However Hp and SAA have been detected in milk during mastitis. Higher 
Hp concentrations have been found in infected quarters compared to opposite non­
infected quarters and to milk from cows without mastitis (Eckersall et al. 2001). 
Similarly cows suffering from mastitis caused by field infections had significantly 
higher SAA concentration in their milk from infected quarters compared to non-infected
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quarters (Eckersall et al. 2001). The concentration of SAA in milk samples increased 
prior to the increase in somatic cell counts (SCC) in cows experimentally infected with 
Streptococcus uberis (Pedersen et al. 2003).
Thus there is growing evidence that measuring Hp and SAA in milk can be used to 
identify clinical and subclinical mastitis.
1.3.3.4 A G P  in veterinary m edicine
Feline infectious peritonitis (FIP) is the leading infectious cause o f cat mortality and 
early identification o f the disease is very difficult as clinical signs are very general. 
However it has been shown that cats suffering from FIP had elevated AGP levels 
(Duthie et al. 1997), and that cats with FIP had significantly higher levels of AGP than 
cats suffering from other inflammatory conditions which can cause raised AGP. Since 
the publication of this study the feline laboratory at the University of Glasgow has 
incorporated the measuring of AGP levels into the panel of tests performed for 
diagnosing FIP (personal communication Dr D Addie).
Feline infectious peritonitis and bovine mastitis are clinically important in their 
respective species. Feline infectious peritonitis is a clinically important disease due to 
the debilitating symptoms and the difficult diagnosis. Mastitis is not only clinically 
important but is also economically important as a financial penalty is paid for milk from 
cows suffering from mastitis.
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Several studies have shown AGP to be a moderate APP in both cats and cows with 
concentrations rising 2-5 fold during times of inflammation. Further information on the 
APPs from these species is contained in chapter 2 and 4 respectively. Human studies 
have shown that the glycosylation fingerprint of AGP is dependant on the physiological 
condition of the patient and a potential for diagnostic and prognostic markers has been 
suggested. However there have been few investigations of the glycosylation patterns of 
the APPs during disease in the domestic species.
The objective of the work presented in this thesis was to examine the structure of the 
glycan moieties attached to AGP from domestic animals with an ultimate aim being the 
use of its structural heterogeneity in clinically important disease as a method of 
diagnosis. We set out to investigate this possibility firstly by looking at differences 
within the glycan chains o f feline AGP (fAGP) isolated from the peritoneal fluid of cats 
with confirmed FIP and comparing it to the glycan chains attached fAGP isolated from 
the serum from animals that have no signs of FIP or other inflammatory process. To 
achieve this objective a method had to be developed for the isolation of fAGP. Once 
isolated the carbohydrate moiety of fAGP was determined using High pH anion 
exchange chromatography with pulsed amperometric detection (HPAEC-PAD). 
Subsequently the structural heterogeneity of bovine AGP in mastitis was examined 
using lectin based methods which allowed initial assessment of glycan structure for this 
species and the effect o f disease. A novel isoform of bovine Hp was detected in milk 
during mastitis and shown to be caused by modification o f the carbohydrate moiety. 
Finally a comparison was made between the glycan moiety and pi o f AGP from cat, 
cow, sheep and man by lectin blotting and isoelectric focusing (lEF).
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CHAPTER 2
2. Isolation of feline aipha-1-acid 
glycoprotein
2.1 Introduction
Glycosylation is a functionally and clinically significant post translational modification. 
The majority of proteins in plasma are glycoproteins and it is now recognized that the 
oligosaccharide chains attached to these proteins are important factors in the biological 
functions exerted by the protein (Bernard, Newton, & Olden 1983;Lace, Olavesen, & 
Gacesa 1990). Alpha-1-acid glycoprotein is a positive acute phase protein in cats 
(Ceron, Eckersall, & Martinez-Subiela 2005;Duthie et al. 1997;Giordano et al. 2004). 
Many studies looking at AGP in human disease have reported changes within the 5 N- 
linked glycan chains attached to AGP (Anderson et al. 2002;Elliott et al. 1997;Smith et 
al. 1994;Smith et al. 2002). This has lead to the hypothesis that oligosaccharide 
composition of AGP is dependant on the health status of the host. Although numerous 
studies have looked at the importance of the glycosylation pattern o f AGP in human 
disease, the veterinary field of research is trailing in knowledge as far as this subject is 
concerned. Therefore it was the aim of this project was to venture into the field of
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veterinary glycobiology by looking at the glycosylation pattern o f AGP in clinically 
important diseases such as feline infectious peritonitis (FIP).
2 .1.1 Feline infectious Peritonitis
2.1.1.1 Introduction
Feline infectious peritonitis (FIP) is a fatal immune mediated viral disease of domestic 
and wild cats, characterized by protein rich effusions in body cavities and 
granulomatous inflammatory lesions in several organs. The causative agent is part of 
the coronavirus family (Ward 1970) and is often referred to as FIP virus (FIPV) 
however feline coronavirus (FCoV) is a more accurate definition.
International studies have shown that more than 50% of cats that are frequently in a 
multiple cat environment test positive for the presence of FCoVs (Horzinek & 
Osterhaus 1979;Sparkes et al. 1992). Susceptibility to FIP depends on individual 
factors, such as age, sex, breed and genetic disposition. A cat of any age can develop 
FIP; however disease occurs most often in cats from 6 months to 5 years of age with the 
majority of cases occurring in cats of 1 year of age or less.
Feline infectious peritonitis is now considered to be the most important viral disease of 
cats taking over this position from the feline leukemia virus. Approximately 1 in 200 
new cases presenting to American teaching hospitals represent a cat with FIP (Rohrbach 
et al. 2001). FIP is a major problem for veterinary clinicians due to difficulties in
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definitive diagnosis, which arise from non-specific clinical signs, lack of 
haematological, and biochemical abnormalities as well as low sensitivity and specificity 
o f diagnostic tests.
2.1 .1 .2  Coronaviruses
Members of the coronavirus family occur in many animal species (e.g. mouse hepatitis 
virus, canine coronavirus) including humans (e.g. severe acute respiratory syndrome 
(SARS)), causing respiratory, gastrointestinal, cardiovascular and neurological diseases, 
though many coronavirus induced disease are restricted to a single organ system 
(Hoskins 1993).
The family coronaviridae represents a group of enveloped, positive stranded RNA 
viruses with prominent surface projections known as spikes or peplomers (Pedersen et 
al. 1981); which give the coronavirus its distinctive appearance when examined under 
an electron microscope. The RNA genome of coronaviruses is approximately 30 
kilobases in length which is the largest of all RNA genomes described to date.
The organization of the genome of all coronaviruses are similar such that the gene order 
from the 5’ end to the 3’ end is polymerases, spike protein (S protein), membrane 
protein (M protein) and nucleocapsid protein (N protein) with nonstructural protein 
genes variably dispersed (Lai 1990). Some coronaviral genomes also encode a fourth 
structural protein known as HE however this has not yet been described in the feline 
coronavirus.
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2.1 .1 .3  Feline Coronaviruses
Two coronaviruses have been described in cats, feline enteric coronavirus (FECV) and 
Feline infectious peritonitis virus (FIPV). FECV infections are generally subclinical 
however in immunosuppressed individuals such as kittens a mild or moderate enteritis 
may develop. In contrast FIPV infection causes a chronic and usually fatal vasculitis. 
Although FECV infections and FIPV infections differ greatly in their pathogenic 
potential more than 98% of their genomes are indistinguishable (Vennema et al. 1998) 
which suggests a common ancestry between the two coronaviruses. It is now believed 
that FIPV is merely a virulent variant of FECV caused by sporadic mutations within a 
specific individual rather than a separate virus. As a consequence of these reports it is 
more accurate to refer to the previously known FECV and FIPV as FCoVs. The exact 
location of the mutations that gave rise to the virulent form of FCoV that causes FIP has 
not been established however deletions in the non-structural genes 3C and 7B have been 
suggested (Vennema et al. 1998).
Until recently it was believed that the main difference between the avirulent non­
mutated FCoV and the virulent mutated FCoV is the invasive nature o f the mutated 
FCoV (Hoskins 1992;Pedersen 1987;Pedersen 1987;Vennema et al. 1998). Avirulent 
FCoV replicates primarily in the enterocytes o f the intestines whereas the virulent FIP 
causing FCoV also infects blood monocytes and spreads and infects various organ 
systems. However a recent study has outlined the ability of avirulent FCoV to infect 
macrophages with the spike protein being the determinant for efficient 
macrophage/monocyte infection (Rottier et al. 2005).
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2.1.1.4 Transmission
FCoVs are distributed worldwide in domestic and wild cats. The virus is endemic 
especially in environments such as catteries, shelters and multicat homes where cats live 
in close proximity to each other. In the UK 82% of show cats, 53% of cats in breeding 
institutes, and 15% in single cat homes have antibodies to FCoV (Hartmann 
2005;Horzinek & Osterhaus 1979;Sparkes et al. 1992). FCoV infected cats shed the 
virus in their faeces, which can consequently infect other cats that come in contact with 
the faeces. Naturally infected healthy carrier cats can shed the virus in their faeces for 
up to 10 months (Herrewegh et al. 1995). However some cats may become chronic 
shedders for several years or even life long (Gut et a i ,2002). The ingestion and 
inhalation o f virus particles in faeces are believed to be the primary routes of infection 
(Evermann et al. 1981;Fiscus, Rivoire, & Teramoto 1987). Transplacental transmission 
has been suggested as FIP has been found in a 4 day old kitten and in stillboms and 
weak newborns bom to a queen that had FIP during the later stages o f pregnancy (Addie 
& Jarrett 1990).
All cats are usually infected with the avimlent non-mutated FCoV, through FCoV 
containing faeces shed by a cat with FCoV infection. The manifestation of the infection 
after a cat becomes infected with FCoV is dependant on the specific host. Most cats 
infected with the vimlent FCoV that developed FIP also shed FCoV (Addie et al. 1996) 
however the vims load in faeces seems to decrease after a cat has developed FIP (Gut et 
al, 2002). So far there have been no reports o f the mutated form of FCoV that brings
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about FIP being detected in the secretions or excretions o f FIP infected cats other than 
faeces.
2.1 .1 .5  D isea se  D evelopm ent
Although the exact mechanism of disease development remains unknown it is generally 
accepted that FCoV is mutated within a specific region of its genome (Herrewegh et al. 
1995;Herrewegh et al. 1995). The mutation leads to changes in the surface structures of 
the virus that allow the virus once phagocytosed by macrophages to bind to the 
ribosomes in these macrophages (Hartmann 2005). Hence the mutated virus can 
survive and replicate within the macrophages; this is considered to be the key event in 
the pathogenesis of FIP as pathogenic FCoV can then be transported within the 
monocytes/macrophages to various tissues throughout the body.
There are two common hypotheses concerning the events that occur after viral 
dissemination from the intestines. The first proposed mechanism is that FCoV infected 
monocytes leave the bloodstream enabling the virus to enter the tissues. The virus then 
attracts antibodies, complement is fixed, and more macrophages and neutrophils are 
attracted to the lesion (Hartmann 2005) and as a consequence typical granulomatous 
changes develop. The other hypothesis is that FIP occurs as a result of circulating 
immune complexes exiting from the circulation into the blood vessel walls, fixing 
complement and leading to the development o f the granulomatous changes (Hartmann 
2005). Complement fixation leads to the release of vasoactive amines, which cause 
endothelial cell retraction and thus increased vascular permeability. Retraction of 
capillary endothelial cells allows exudation of plasma proteins, hence the development
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of characteristic protein-rich exudates (Mochizuki et al, 1997) seen in effusive FIP. The 
immune mediated vasculitis leads to activation of the coagulatory system and to 
disseminated intravascular coagulation (DIG). It is not the virus itself that causes major 
damage but the cats own immune reaction that leads to the fatal consequences that 
accompany FIP.
The immune response to the mutated FCoV appears to be largely cell mediated. The 
type and strength o f the immune response also determines the disease form. Feline 
infectious peritonitis can manifest in three forms effusive, noneffusive and a mixed 
form. It has been suggested that effusive FIP occurs in cats that mount a humoral 
immune response but fail to develop concurrent protective cell mediated immunity and 
noneffusive FIP is thought to occur in cats that produce partial cellular immunity 
sufficient to limit the spread and degree o f virus (August 1989;Barlough 1985;Hoskins 
1993).
2 .1 .1 .6  D iagnosis
2.1.1.6.1 Clinical Signs
A definitive diagnosis of FIP antemortem can be extremely difficult in many clinical 
cases because clinical signs of FIP are non-specific (e.g. weight loss, chronic fever and 
anorexia) and variable, as many organs, including the liver, kidneys, pancreas and eyes 
as well as the CNS can be involved. The clinical signs that occur in FIP are a direct
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result of the vasculitis and organ failure that result from damage to the local blood 
vessels.
As mentioned previously three different forms o f FIP have been identified; an effusive 
(wet) form, a noneffusive (dry) form and a mixed form. The effusive form is 
characterized by a fibrinous peritonitis, pleurisies or pericarditis. The non-effusive form 
is characterized by granulomatous changes in different organs including the eyes and 
CNS. In cats without effusions, signs are often vague and include fever, weight loss, 
lethargy and decreased appetite. Abdominal palpitation may reveal enlarged mesenteric 
lymph nodes and irregular kidneys.
The effusive (wet) form of the infection is commonly associated with swelling o f the 
abdomen; however a study carried out on cat effusions revealed that less than 50% of 
cats presenting with swollen abdomens were diagnosed with FIP.
Laboratory findings provide some help in diagnosis of FIP but these are also general 
and may be seen in other clinically similar diseases.
2.1.1.6.2 Laboratory Findings
There are a number o f laboratory tests which yield abnormal results in cats with FIP 
however FIP cannot be diagnosed on these findings, as they are not pathognomic. In 
many cases diagnosis of FIP can only be established with histopathological testing o f 
biopsy or necropsy samples, which would usually reveal granulomatous lesions in 
several organs.
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The most accurate laboratory test for diagnosis of FIP involves staining for the presence 
o f coronavirus in the macrophages in effusions or tissues; in the event of a positive 
result it has a sensitivity of 100%. However recent evidence suggests that the avirulent 
FCoV may also be able to infect macrophages depending on the host (Dewerchin, 
Comelissen, & Nauwynck 2005) which may lead to false positives and a specificity of 
less than 100%.
The most consistent laboratory finding in cats with FIP is an increase in total serum 
protein concentration. The increase in total protein is due to increased globulins, mainly 
y globulins and also leads to a decrease in the albumin-to-globulin ratio. However these 
changes can be seen in most inflammatory based diseases so has a low specificity.
Blood cell counts are often analyzed when FIP is suspected; lymphopenia and 
neutrophila are typical results for cats with FIP. Measuring antibody titers is 
extensively used in the diagnosis o f FIP however a large percentage o f cats that have 
high antibody titers to FCoV never develop FIP so the results must be interpreted with 
caution. It has been suggested that, if effusions are present then it is more important to 
measure antibody titers in the effusive fluid rather than in blood as it has a much higher 
diagnostic value. However the presence of effusion itself is not diagnostic.
Measurement o f acute phase proteins and in particular AGP is considered helpful in the 
diagnosis o f FIP as discussed in section 2.1.2. However APPs are increased in many 
other diseases and are not specific to FIP.
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Due to the lack of a single diagnostic test to differentiate FIP from other clinically 
similar disease, clinicians must consider a variety of different factors in order to 
diagnose FIP such as antibody titers, clinical signs at presentation, history of FIP in cats 
in the patient’s environment, albumin-globulin ratio and AGP levels. It is only with all 
the relevant information that a diagnosis can be considered.
2 .1 .1 .7  Treatm ent
In the majority of cases FIP is fatal as there are no effective cures. Most treatments for 
FIP are symptomatic and are aimed at suppressing the immune system because FIP is an 
immune mediated disease (Hartmann et al. 2003;Hartmann 2005). Human interferon is 
being used more often in the treatment of FIP however it has shown no significant 
decrease in mortality although in some cases survival times were significantly increased 
(Hartmann et al. 2003;Hartmann 2005)
2 .1.2 Feline Acute Phase Proteins
Serum amyloid A, Hp and AGP have been identified as positive acute phase proteins in 
cats (Duthie et al. 1997;Giordano et al. 2004;Kajikawa et al. 1999). Kajikawa et al., 
(1999) measured SAA, Hp, AGP and CRP in the sera of clinically normal cats; cats post 
surgery and cats following induction of inflammation by turpentine oil injection. It was 
reported that SAA, Hp and AGP concentrations rose 7-11 times in cats following
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induction of inflammation and in post surgery cats, SAA concentration were the first to 
rise. C reactive protein concentrations were not significantly altered in cats post surgery 
or following inflammation, induction when compared to control cats.
As mentioned above AGP, is a positive acute phase protein in cats and is considered 
diagnostically important in FIP being commonly used in the panel o f tests used to 
differentiate FIP from other clinically similar diseases (Duthie et al, 1997). Duthie et 
a l,\9 9 1  measured the levels of AGP in cats with naturally occurring FIP, Feline 
immunodeficiency disorder (FIV) and clinically health cats. It was found that AGP 
concentrations were significantly raised in both FIP and FIV compared to healthy cats. 
Alpha-1-acid glycoprotein concentrations in blood and effusions are generally greater 
than 1.5g/L (Duthie et al. 1997) in cats with FIP compared to 0.02-1.48 g/L for cats 
with FIP like diseases and an AGP assay was suggested as being useful in 
distinguishing FIP from other clinically similar conditions.
In agreement with Duthie et a/., 1997, Giordano et a/.,2004 reported that cats exposed to 
FCoV had increased concentrations of AGP and that cats that developed the clinical 
form of FIP had the higher concentrations of AGP than animals with clinically similar 
diseases. The increased APP response in cats exposed to FCoV was transient whereas 
the high AGP response persisted in cats that developed the clinical form of FIP 
(Giordano et al. 2004a)
Correa et a l ,2001 showed that concentration o f AGP was raised in cats suffering from 
lymphoma however the levels did not return to normal when in remission, which led to
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the author concluding that AGP levels could not be used to monitor progression of the 
disease (Correa et al. 2001).
2 .1.3 Isolation of Feline AGP
In order to study the glycosylation pattern o f fAGP a method was required for the 
isolation of this protein from feline serum and effusions. Many studies have reported 
methods for the isolation o f human AGP however only a few studies have describe the 
isolation of fAGP. Most of the studies that describe the isolation o f fAGP required the 
isolation for antibody production or standards for assays (Bence, Addie, & Eckersall 
2005) and for these purposes maintaining the structural integrity of the carbohydrate 
moiety was not essential and such methods have included precipitation at low pH. The 
exception, to this were Ceciliani et a/.,(2004) and Pocacqua et a l, (2005) who isolated 
AGP from the 0.5-1ml of serum by initially precipitating non-soluble protein at pH4 by 
dialysing against a pH 4 citrate-phosphate buffer. The remaining serum proteins were 
then continually kept at pH4 throughout the remainder of the isolation procedure, which 
involved anion exchange followed by cation exchange chromatography (Ceciliani et al. 
2004;Pocacqua et al. 2005).
Bence et al, (2005) described the isolation of fAGP to be used as a standard in an 
immunoturbidimetric assay for the measurement of fAGP. In this instance fAGP was 
isolated by initial precipitation with 1.2M perchloric acid followed by anion exchange 
using a salt gradient to separate out the proteins (Bence, Addie, & Eckersall 2005).
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As discussed in section 1.3.2.4.5 the glycan residue structure on AGP is known to be 
altered in a number o f diseases in humans. There is also evidence from lectin blot 
studies that glycosylation on fAGP may be altered in FIP (Ceciliani et al. 2004).
The aim of this study was to analyse the carbohydrate moiety of AGP from cats with 
FIP and compare it to the AGP from cats without FIP in order to characterise the 
oligosaccharide chains attached to fAGP and identify any differences induced by FIP 
that could be potential diagnostic markers or influence the functions of fAGP. It was 
therefore necessary to isolate AGP from the serum or effusions of cats with and without 
FIP prior to glycosylation analysis. For this purpose a fractionation scheme was 
devised which enabled sufficient AGP for glycan analysis to be isolated from the ascitic 
fluid or serum of individual cats with increased concentrations of AGP (> 1 g/1). A 
problem for the investigation was in the acquisition o f AGP from normal cats to act as a 
control as these have a relatively low AGP concentration. Therefore a higher volume of 
starting material was required. To avoid unnecessary bleeding of healthy cats, normal 
pools were prepared combining the serum and effusions o f residual sample submitted to 
the Diagnostic service o f the Faculty of Veterinary Medicine, University o f Glasgow in 
which the concentration of AGP was in the reference range for healthy cats i.e. less than 
0.45g/L. These pooled samples were used as the starting material for the isolation of 
normal AGP.
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2.2: Materials and methods
2.2.1 Materials
Reagents were obtained from Sigma (Poole, UK) unless otherwise stated.
2.2.1.1 S am ples
Ascitic fluid collected from 17 cats (cats 1-17), 11 o f which were confirmed as having 
FIP, were kindly gifted by Dr D Addie o f the Feline Virus Laboratory, Faculty o f 
Veterinary Medicine, University of Glasgow. Serum samples from non-FIP infected 
cats (n=49) with normal AGP concentrations < 0.45g/L were provided by the Clinical 
Pathology laboratory of the Faculty of Veterinary Medicine, University o f Glasgow as 
well as Dr D Addie. The serum from the non-FIP cases were combined into four pooled 
samples (NP1-NP4). These samples had been submitted from a variety of cases with 
suspected hyperthyroidism or with suspected FIP in which all criteria for this disease 
was not present and AGP was in the normal range. The ascitic fluid and serum was not 
taken for experimental purposes but for clinical investigation with the residue after 
analysis being used for this investigation.
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2.2.1.2 AGP isolation
Polyethylene glycol (PEG) Mwt 3350 and 8000, Trizma base, sodium chloride (NaCl), 
sodium acetate were used in the purification of AGP. Pre-packed Hitrap Blue 5ml 
column Hitrap Mono Q and Mono S 5ml columns were used on the AKTA FPLC 
system and were purchased from Amersham Pharmacia Biotech (Buckinghamshire, 
UK) and controlled by a Compaq deskpro EN, which ran Unicom version 4 software. 
Acetic acid was obtained from BDH (Poole, UK). Centricon, centrifugal filter units 
were supplied by Millipore Corporation (Massachusetts, USA).
Dialysis tubing used for buffer exchange was purchased from Medicell.
2.2 .1 .3  G el electrophoresis and W estern blotting
Sodium dodecyl sulphate (SDS), ammonium persulphate (APS), Trizma base, 
bromophenol blue, mercaptoethanol, N,N,N',N'-Tetramethylethylenediamine (TEMED), 
coomassie blue, NaCl and Tween 20. Hydrochloric acid (HCl), methanol and acetic acid 
were supplied by BDH. Glycerol was purchased from Fisher scientific (Loughborough, 
UK).
30% Acrylamide mix. Standard marker, nitrocellulose and the 4-chloro-1 -naphthol 
(4CN) substrate were all purchased from BioRad (Hercules, USA). The sheep anti 
AGP and horseradish peroxidase labelled sheep AGP were supplied by Dr Laura Bence, 
division of APPH, Faculty o f Veterinary Medicine, and University of Glasgow.
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Gel electrophoresis was carried in a Miniprotean II electrophoretic tank and protein 
transfer to nitrocellulose was carried out following the manufacturers’ instruction in 
mini trans-blot electrophoretic transfer tank, both were supplied by BioRad (Hemel- 
Hempstead, UK).
2.2.2 Methods
2.2.2.1 Optimisation o f PEG precipitation
In order to optimise the initial precipitation step in the isolation of fAGP, 1ml aliquots 
o f peritoneal fluid from cat No 17 had 300, 400 and 500 |ug of PEG 8000 or 300, 400, 
450 and 500 pg o f PEG 3500 added before vortexing and incubation at 4°C overnight. 
The supernatant was then collected following centrifugation at 3000g for 30 mins. An 
aliquot of the supernatant (lOp.1) was added to lOpl of SDS-PAGE sample buffer 
containing mercaptoethanol and run on an SDS-PAGE gel (section 2.2.23)
2. 2.22  Feline A G P  Isolation
Optimisation of PEG precipitation showed that the addition of 400pg o f PEG 8000 
caused the maximum precipitation of non-AGP protein with least loss of AGP (see 
section 2.3.2). Therefore in the first step of fAGP isolation low solubility protein in 
samples (2-5 ml) were precipitated by addition of 400pg per I ml of sample (40%w/v) 
o f PEG Mwt 8000 followed by incubation overnight at 4°C before centrifugation at 
3000g for 30 mins with the supernatant, containing AGP, removed for further 
purification.
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The isolation o f AGP from feline ascitic fluid or serum was performed with the 
following procedure.
As cities (2-5ml)
V
PEG Precipitation 
40%w/v PEG Mwt 8000
Supemant
V
Affinity chromatography 
5ml Cibacron blue eolumn (SOmMTris HCl pH 7.4)
Unbound fraction
V
Anion exchange chromatography 
5ml Mono Q column (SOmMTris HCl pH 7.4)
First eluted Bound fraction
V
Cation exchange chromatography 
5ml Mono S column (O.IM Acetate pHS)
Unbound fraction
V
Isolation confirmed 
SDS-PAGE/Western blot
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In the chromatography steps, peaks containing AGP identified by SDS-PAGE, were 
retained and either frozen (-80°) and lyophilised or concentrated with Centricon 
centrifugal filter devices (3000 Da cut off) to a volume of approximately 1ml then 
dialysed overnight against the equilibration buffer for the next step. In all of the 
chromatography runs the eluate was monitored at 280nm and protein containing peaks 
collected
The supernatant retained from the PEG precipitation step was dialysed against buffer 
lA  (Table 2.1 ) overnight at 4®C and then applied to a 5ml prepacked HiTrap blue 
column that was equilibrated with 2-3 column volumes (CVs) of buffer lA  at a flow 
rate of 5 ml/min. This initial chromatography step removed albumin from samples. The 
column was washed with buffer lA  and the initial breakthrough peak was eluted and 
collected. After the absorbance at 280nm returned to baseline the albumin bound to the 
column was eluted with 4-5 CVs o f buffer IB. The AGP containing breakthrough peak 
was then frozen and lyophilised, re-dissolved and applied to a 5ml Mono Q column 
equilibrated with 2 CVs of buffer 2A (Table 2.1) at a flow rate 5 ml/min. After the 
sample was injected, the column was washed with 2 column volumes of buffer 2A 
before a continuous gradient with buffer 2B was applied. The gradient used was 0-50% 
buffer 2B over 15 CVs and protein containing peaks were retained. The column was 
regenerated using 2-5 CVs of 100% buffer 2B (Table 2.1). Gel electrophoresis of an 
aliquot of each protein peak was carried out to determine which peak contained AGP. 
Fractions containing AGP were lyophilised, re-dissolved and dialysed against buffer 3A 
overnight at 4°C and then applied to a 5 ml High trap SP column. AGP was not 
retained by the SP column and eluted with the equilibration buffer (3A) (Table 2.1).
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Proteins bound to the column were eluted using 100% of buffer 3B (Table 2.1). 
Occasionally samples had to be reapplied to the SP column. Purity was checked by 
SDS-PAGE and the purified AGP was then desalted using centricon centrifugal filter 
devices.
Column used Buffer used Sample Buffer
5 ml HiTrap blue lA  50mMTrisHCl pH 7.4
IB IM  NaCl, SOmMTris HCl pH 7.4
SOmMTrisHCl
pH7.4
5 ml Mono Q 
(anion exchange)
2A SOmMTrisHCl pH 7.4
2B IM NaCl, SOmMTris HCl pH7.4
SOmMTris HCl 
pH7.4
5 ml Hitrap SP 
(cation exchange)
3A lOmMNaOAc, acetic acid pH5 
3B 1 MNaCl, 1 OmMNaOAc, acetic acid
pH5
1 OmMNaO Ac/acetic 
acid pHS
T able  2.1 S e q u en ce  o f  c o lu m n s  a nd  bu ffers  used for A G P  isolation A G P
2 2 . 2.3 Gel electrophoresis and W estern Blotting
SDS -PAGE was carried out according the method of Laemmli, (1970) using a 4% 
stacking gel and a 10% separating gel. Gels were stained with Coomassie blue 0.2% 
(w/v) protein stain made up in 20%(v/v) methanol, 8% (v/v) acetic acid or electroblotted 
onto nitrocellulose for antibody based detection. After staining the proteins were 
visualized by destaining in 20% (v/v) methanol, 8% (v/v) acetic acid solution. Western 
blotting was performed by transfer o f separate protein onto a nitrocellulose membrane 
according to the method of Towbin (1974). Following electrotransfer of the proteins 
from the gel to the nitrocellulose membrane, the membrane was blocked using 10% 
(w/v) dried milk reconstituted in TBS tween (buffer composition in appendix). The
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AGP on the western blot was detected with a 1:1000 dilution in TBS Tween of a 
polyclonal antibody to fAGP raised in sheep (primary antibody). The membrane was 
incubated with the primary antibody for 1 hour at room temperature. A 1:1000 dilution 
in 0.5M Tris buffered saline pH 7.4 + 0.1% Tween 20 (TTBS) of a horseradish 
peroxidase (HRP) conjugated secondary antibody to sheep IgG was used to detect the 
binding of the primary antibody to fAGP (gift from Dr L. Bence). The nitrocellulose 
was incubated with the secondary antibody for 1 hour at room temperature. The 
membrane was washed 3 times with TTBS between each step. A 4CN (Biorad, UK) 
substrate was then used to visualize the electroblotted AGP.
2.2 .2  4 Radial immunodiffusion
A  radial immunodiffusion (RID) technique (Mancini, 1965) was used to determine the 
quantity of AGP in each sample. A standard 2% (w/v) agarose type lllA  (supplied by 
sigma) solution in 0.2M phosphate buffered saline pH 7.4 was heated in the microwave 
until the solution turn clear, allowed to cool to 37°C then 8% v/v sheep anti AGP (gift 
from Dr L. Bence) was added and the mixture was allowed to set at room temperature 
on horizontal plates. Wells (5 pi) were punched in the gel and samples (5pi) were 
applied. Standards of AGP (kindly supplied by Dr L. Bence) at concentrations o f 2, 1, 
0.5, 0.25 and 0.125 mg/ml were also applied to the RID gel. The gel was then 
incubated overnight at 37°C in a humidity chamber and the diameter of the precipitate 
rings measured. A calibration curve from the results of the standards (diameter (mm) vs 
concentration (mg/ml)) was drawn to determine the AGP concentrations in the samples.
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2.3 Results
2.3.1 Samples
Effusions (ascites) from 11 cats (cats 1-11) with histopathologically confirmed FIP were 
analysed. In addition cats 12 and 13 had high AGP levels and from the clinical 
examination FIP was suspected but not confirmed by histopathology examination. Cats 
14, 15 and 16 also presented with suspected FIP. These animals were included in the 
FIP group despite having AGP concentrations within the normal range as they had 
positive antibody titres; FIP was not confirmed by histopathology examination due to 
the absence of tissue. The AGP concentration in each sample was determined by a RID 
method and the results are listed in Table (2.2). Cats with confirmed FIP had a mean of 
1.65±0.28 g/L as compared to a mean of 0.18±0.05 g/L for the cats pooled to represent a 
normal population.
Four pools of feline serum samples with 4-20 samples were pooled with a total volume 
of (2-5ml) and cat 17 were used to represent a non-FIP population. The samples in the 
pools were classified as non acute phase by measuring their AGP concentration. An 
AGP concentration of less than 0.45g/L, which is the upper level of the normal range 
(Duthie et al, 1997), was used to confirm that the samples were not from cats during an 
acute phase reaction.
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Cat Number AGP level (g/L) FIP/Non
1 1.35 confirmed
2 0.6 confirmed
3 1.3 confirmed
4 2.5 confirmed
5 NA confirmed
6 NA confirmed
7 2.2 confirmed
8 1.7 confmned
9 2 confirmed
10 2.86 confirmed
11 3 confirmed
12 3.5 suspected
13 1.1 suspected
14 0.45 suspected
15 0.3 suspected
16 NA confirmed
17 NA suspected
18 0.25 fibrosarcoma
NP 1 (n=6) O.liO Non FIP
NP 2 (n=8) 0.16±0.02 Non FIP
NP3 (n-15) 0.32±0.03 Non-FIP
NP 4 (n= 20) 0.14±0.02 Non-FIP
T a b le  2.2  T h e  c linical data  from  sa m p le s  used th ro u g h o u t  the  ex p e r im en ts  reported  w ith in  this  
thesis.  N A =  not  ava i lab le  N P = n o rm a l  pool
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2.3.2 PEG Precipitation
The high solubility o f AGP was exploited in the first step of the isolation procedure in 
which proteins o f low solubility were precipitated by PEG. Polyethylene glycol Mwt 
8000 was more effective at precipitation o f non-AGP serum proteins. At 
concentrations of 30, 40 and 50% w/v o f PEG 8000 the main band on SDS-PAGE of 
supernatant was AGP (lanes 6-8 Figure 2.1). There was contamination with a protein at 
60kDa which was reduced at 50% PEG 8000 but at this concentration the yield of AGP 
was considerably reduced. With PEG 3500 considerable non-AGP protein remained in 
the supernatant at PEG concentrations of 30, 40, 45 and 50% w/v (lanes 2-5 Figure 2.1). 
Even at 50% w/v of PEG 3500 contaminating protein at 60kDa was apparent in the 
SDS-PAGE of the supernatant. Thereafter 40% (w/v) PEG 8000 was chosen to 
precipitate non-AGP serum proteins.
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FAGP
F igure  2.1 S D S -P A G E  o f  lO^ils su p ern a ta n t  o b ta ined  fo l low in g  precip itat ion  with various  
con cen tra t io n s  o f  PEG M w t 33 5 0  and PEG M w t 8 0 0 0  Lanes 1 sh o w s precision plus protein  
m o lecu lar  w e ight  m arkers  L anes 2-5: 30 ,  40, 45,  and 5 0 %  PEG  M w t 3 3 5 0  respectively .  Lanes 6-8:  
30, 40 and 5 0 %  PEG M w t 80 0 0  respectively.
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2.3.3 Purification of feline AGP
As examples, the purification of AGP from cats 14 and 9 through the FPLC 
chromatographic steps is shown in Figure 2.2 A. B.C and D.E.F respectively. When the 
supernatant from the PEG precipitation was applied to the Cibacron blue column 
(Figure 2.2A) the AGP was found by SDS-PAGE in the break through peak with a 
small peak eluting with high salt buffer B. The AGP containing fraction from the 
Cibacron blue column was concentrated and applied to a mono Q column. AGP was 
retained but eluted using a NaCl gradient (Figure 2.2 B+E). AGP was eluted when the 
gradient reached approximately 20% of buffer 2B that is approximately 0.2M NaCl. 
Two peaks were obtained the first was found to the AGP containing peak whilst the 
second peak was found to contain mostly albumin. The final step in the isolation 
method was cation exchange on a Mono S column. The AGP containing fractions 
collected from the anion exchange was dialysed against buffer 3B and applied to the 
mono S column in a more acidic buffer (pH 5) in order to take advantage o f AGPs 
highly acidic nature. The AGP was collected in the break through peak (Figure 2.2 
C+F) while other contaminants such as final traces of albumin where retained by the 
column. Purification of AGP was confirmed using SDS-PAGE and western blotting 
using a polyclonal antibody raised in sheep against fAGP (Figure 2.3). The SDS-PAGE 
gel showed three main bands in the supernatant after precipitation with PEG 8000, this 
was reduced to 2 bands after Cibacron blue and a final band after mono Q and mono S 
columns. The western blot with anti fAGP revealed that the single protein band at 
approximately 50kDa in the break through peak after mono S is fAGP (Figure2.3B). Cat 
9 had two breakthrough peaks with the SP column both where AGP containing peaks
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however only the second peak had no contaminating proteins. The whole isolation 
procedure had a yield o f AGP of approximately 26% (Table 2.3). O f this 22% was due 
to PEG precipitation. 30% lost after Cibacron blue column, 29% lost to mono Q 
column and 3% loss on the SP column. This procedure was applied to all samples 
(Table 2.2) yielding the purified AGP necessary for the investigation of Chapter 3.
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Figure  2.2 1 C h r o m a to g r a p h y  for the isolation o f  feline A G P  asc ites  from cat No 14 A)  
C ib a cro n  blue affin ity  co lum n B) M o n o Q  anion e x ch a n g e  c o lu m n  C) M o n o  S cation  e x ch a n g e  
c o lu m n.  m A lI= m il l i  ab so rb a n ce  unit.  T h e  data series sh o w n  in blue is the O D  at 2 8 0 n M  and the  
data series in pink is the percentage  o f  e lution buffer  runn ing  at that time.
Indicates the A G P  conta in ing  peak
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Figure 2..2  2 C h r o m a to g r a p h y  for the isolation o f  feline A G P  from  asc ites  o f  cat No 9 D) 
C iba cro n  blue affinity co lum n E) IMonoQ anion exch a n g e  co lu m n  F) M o no  S cation e x ch a n g e  
co lu m n. m A U = m ill i  ab so rb a n ce  units
^ Indicates the A G P  conta in ing  peak
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Step AGP mg/ml ml AGP mg % recovery
Start 0.45 10 4.5 100
PEG 0.13 28 3.64 80
Blue 0.15 14 2.1 47
Q 0.56 2.3 1.3 29
SP 3.9 0.3 1.2 26
T a b le  2.3 T he  recovery  o f  A G P  from each step o f  the isolation proced ure .  Data from  purification  
o f  A G P  ascites o f  cat 14.
A 1 
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F igure  2.2 A) S h o w s  the S D S -P A G E  o f  the A G P  conta in ing  fraction  co llected  from each  step  o f  the  
iso lation p ro ced u re  from  cat 14 Lane I M w t m arkers .  Lane 2 su p e rn a ta n t  a fter  4 0 %  PEG  
precipitat ion  IMwt 8 0 0 0  lane 3 T hro u g h p u t  collected  from C ib a cro n  blue co lu m n lane 4 A G P  
fraction  collected from  anion e xch ange  co lum n. L ane  5 isolated A G P  fo l low in g  cation ex ch a n g e  
c o lu m n.  B) S h o w s th e  western blot o f  isolated fe line A G P  from cats 10, II and 14.
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2.4 Discussion
In order to comprehensively analyse the monosaccharide and oligosaccharide 
composition of fAGP during FTP it was necessary to isolate the AGP from effusions.
Effusions from FIP confirmed patients (cats) had an average concentration of 1.65±0.28 
g/L with a range o f 3.5-0.25 g/L which was significantly higher compared with 
0.18±0.05 g/L for the non-FlP samples which ranged from 0.1-0.32 g/L and which were 
combined in 4 pools to represent the normal population. Effusion in FIP is exudative in 
nature, so the protein content o f the effusion should be representative of the blood 
levels. It was for this reason that effusions from cats with FIP instead of serum or 
plasma were used. It has been shown that effusions are a result of leakage from the 
blood and can be considered a good representation of the serum (Hartmann 2005).
In healthy cats the reference range for AGP concentration has been reported to be 0.1- 
0.48 g/L. Levels of AGP greater than 1.5 g/L in serum plasma or effusions are reported 
to be o f greater value than the albumin:globulin ratio in distinguishing field cases o f FIP 
and clinical similar diseases (Duthie et al. 1997). Measuring of AGP levels has now 
been introduced to the panel of tests involved in diagnosing FIP at the Feline virus 
laboratories of Glasgow University.
Pools o f non-FlP samples had to be used to represent a control population instead of 
true normals as this was not a study with a convenient cohort o f healthy control animals 
and only samples submitted to the diagnostic labs for testing were used. It was difficult 
to obtain samples from healthy cats and indeed it was deemed unethical to obtain 
samples from healthy cats in the necessary volume. The volume of sample required to
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isolate sufficient AGP for analysis meant that using single samples from cats without an 
acute phase response was not possible.
Many techniques for isolation of human AGP from plasma have been reported however 
very little data is available regarding the isolation of fAGP. Previous techniques to 
isolate human AGP utilize acid precipitation followed by the application of 
chromatographic techniques using diethylaminoethyl and or carboxymethyl-cellulose 
columns to successfully purify the glycoprotein (Kishino & Miyazaki 1997). More 
recently Azzimonti et a/., (2003) reported a one step method using Cibacron blue F3 -  
GA and various buffers in an FPLC system to isolate AGP and separate AGP into its 
genetic variants through the change in pH (Azzimonti et a l 2003).
Although these previous investigators report higher yields of AGP with recovery than 
the technique used in the present study it was desirable to avoid the use of highly acidic 
buffers which could result in the destruction of the sialic acid residues present on the 
termini of the glycan chains and hence hinder complete analysis of the carbohydrate 
moiety. For this reason the previously described techniques were considered unsuitable 
for the purpose o f this study.
Bence et a l, (2004) described a method recently used for the isolation o f fAGP. This 
involved a harsh acidic precipitation with perchloric acid which was followed by an 
application to a mono Q column. This method was ruled out as a possible means of 
isolating fAGP for the purpose of this study as these harsh acidic conditions could result 
in removal of the terminal sialic acid residues (Bence et a l, 2004).
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Ceciliani et a l, (2004) also reported a method for the isolation o f fAGP which exploited 
the solubility and acidity of AGP. The method involved initial precipitation with pH4 
which was followed by anion exchange chromatography and subsequently cation 
exchange chromatography, however no attempt was made to monitor the integrity o f the 
glycan chains was reported (Ceciliani et al. 2004). In contrast the lowest pH in the 
present method was pH5 used in the mono S column and it was considered that the 
glycan structure would be minimally affected by this method.
For this research a modification of the low pressure chromatography technique 
developed by Smith et a/.,(1994) was selected for the purification of AGP (Smith, 
Davies, & Hounsell 1994). The procedure reported by Smith et ûf/.,(1994) has since 
been shown to purify AGP without dénaturation, desialylation and without detrimental 
effect to the oligosaccharide moiety as measured by HPAEC-PAD (Elliott et al. 1995). 
Since the buffers used by Smith et a l, (1994) have not been altered it has been assumed 
that this method would also be without detrimental effects to the oligosaccharide chains 
o f fAGP. The successful purification of AGP was confirmed using SDS-PAGE and 
western blotting.
Fractional precipitation using polyethylene glycol (PEG) 8000 was the first step in the 
isolation of fAGP and the use of this procedure for human plasma was reviewed by 
(Ingham 1990). Polyethylene glycol is a water soluble polymer which forms micelle­
like structures around soluble proteins rendering them insoluble thus removing them 
from solution, while highly soluble proteins such as AGP remain in the supernatant. 
PEG does not tend to denature or interact with proteins even at high concentrations 
(Ingram1990) as it is chemically inert. Ingram (1990) reported that PEG polymers with
86
molecular weights greater than 6000 offered no advantage over smaller molecular 
weight preparations when used to precipitate insoluble constituents of human plasma. 
However it was found that in the case of feline effusions, PEG 8000 was more effective 
as an initial fractionation step than PEG 3350 as more contaminating proteins remained 
even with 50% of PEG 3350 compared to PEG 8000. All samples where therefore 
subjected to precipitation with PEG 8000 with the supernatant retained for further 
purification.
Albumin is the most abundant protein in plasma and is also highly soluble meaning it 
was not completely removed by PEG 8000 precipitation and therefore it had to be 
removed by chromatography. Hence the supernatant from the PEG precipitation was 
applied to a Cibacron blue column. Cibacron blue is a sulphonated polyaromatic dye 
that has been shown to remove up to 98% of human serum albumin (Travis et al. 1976). 
It has been reported that the Cibacron blue dye binds albumin through the bilirubin 
binding site although little or no binding to the bilirubin binding sites of rabbit, sheep, 
cow or horse serum albumins was reported. However interaction with the hydrophobic 
fatty acid anion binding domains of the serum albumins from these species has been 
described (Leatherbarrow & Dean 1980). As with these animal species Cibacron blue 
did not completely remove the feline albumin present in the samples but the majority of 
the albumin was retained by the column while all other proteins including AGP present 
in the supernatant from the PEG precipitation were eluted in the breakthrough peak. 
This fraction was therefore collected and further purified. Albumin constitutes the 
majority of the protein concentration in feline effusions and was obviously present in 
the supernatant from PEG treatment. For this reason the Cibacron blue column was a 
necessary step as in preliminary experiments it was found that the Mono Q and Mono S
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columns were rendered ineffective for AGP purification in the presence of an 
abundance of albumin.
Q Sepharose is a strong anion exchanger with quaternary ammonium functional groups 
attached to a 6% cross linked agarose beads. Proteins are separated on the basis of 
charge with the quaternary ammonium functional groups with positive charge. 
Therefore the negative charge on the sialic acids of AGP is the cause of the binding of 
AGP to this column. The application of an increased sodium chloride concentration 
results in differential release of the proteins bound to the column on the basis o f charge. 
This was found to divide the fraction eluted from the Cibacron blue column into three 
separate peaks, two where eluted in quick succession at approximately 20-25% of IM 
NaCl and a third was eluted with 100% of IM NaCl. AGP was found in the first peak 
eluted at approximately 20% of IM NaCl, while the second peak which followed 
quickly afterward was found to contain predominantly albumin. The AGP containing 
fraction was assessed by SDS-PAGE and it was found to be still contaminated with 
trace amounts of albumin and at least 2 other unidentified proteins. Therefore a strong 
cation exchanger column (Hitrap SP) was employed to exploit the highly acidic nature 
of AGP in an effort to isolate fAGP from minor contaminants still present. An acetate 
buffer at pH 5 was used. Alpha-1-acid glycoprotein is known to have a pi below 5 so it 
did not bind to the column at the pH used while the other contaminants with higher pi 
bound to the column and were eluted using a 1M NaCl solution. Isolation of fAGP was 
confirmed via SDS-PAGE and western blotting (see Figure).
The combination of PEG precipitation and chromatographic technique used here have 
been shown to be successful due the lack of degradation to the glycan chains however
the procedure is long and requires a lot of steps and only 26% of intact AGP is 
recovered from the procedure. However when characterising the monosaccharide and 
oligosaccharide structures of glycoproteins as in the following chapter it is essential that 
the isolation procedure does not interfere with structure and composition o f the 
carbohydrate moiety.
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CHAPTER 3 
3. Analysis of the glycan chains of feline 
AGP
3.1 Introduction
3.1.1 Carbohydrate influence on the biological 
functions of AGP
The exact functional role of AGP remains elusive, though many in vitro roles have been 
reported. The most documented of these is AGPs immunomodulatory properties. This 
activity predominantly resides in the glycan moiety (Bennett & Schmid 1980;Routledge 
1989) and therefore glycosylation changes seen in pathological diseases may result in 
an alteration of the function of AGP.
It has been reported that the glycan chains attached to AGP are responsible for AGPs 
ability to suppress the proliferative response of lymphocytes (Bennett & Schmid 
1980;Pos et al. 1990). Furthermore a study performed by Pos et a/., (1990) on anti CD3 
stimulated lymphocytes concluded that Con A non reactive forms and sialylated 
variants of AGP exerted a stronger inhibitory effect on the proliferation of lymphocytes 
than Con A reactive forms (Pos et al. 1990;Pukhalsky et al. 1998).
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The structure of the glycan chains attached to human AGP has been shown to influence 
AGPs ability to modulate cytokine production in vitro (Shiyan and Bovin 1997). This 
study described the synthesis of a pseudo AGP were the glycan chains were cleaved 
from AGP and attached to an inert polyacrylamide carrier. The pseudo AGP exerted the 
same effect on cytokine production as normal AGP which lead to the conclusion that 
the glycan chains and not the polypeptide backbone of AGP was responsible for this 
function (Shiyan & Bovin 1997). The effect of various AGP glycoforms separated on 
the basis of branching was then investigated revealing that all glycoforms o f AGP can 
stimulate TNF production but that glycoforms carrying only tri and tetra antennary 
oligosaccharide chains suppressed the production of ILl by monocytes while lower 
diantennary branched glycoforms stimulated ILl production (Vasson et al. 1994).
AGP has been reported to inhibit human neutrophil aggregation and superoxide anion 
generation induced by a variety o f stimuli. However it has been shown that the 
inhibition is dependant on the glycoforms present as inhibition was reversed when the 
terminal sialic acid and penultimate galactose residue were removed (Costello et al. 
1979;Costello, Gewurz, & Siegel 1982)
Hyperfucosylation of AGP has been reported in rheumatoid arthritis (RA). The fucose 
residues are part of the sialyl Lewis X (SLeX) moiety. As described in chapter 1 SLeX 
is the minimum antigen required to bind E selectin and facilitate the movement of 
leukocytes across the capillary epithelium. Thus AGP carrying the tetrasaccharide 
antigen (SLeX) may influence the binding of blood cells to E-selectin. A study aimed 
at testing this hypothesis was conducted by Jorgensen et a l, (1998), which found that 
hyperfucosylated AGP isolated from plasma of patients suffering from RA inhibited
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Sialyl Lewis X binding to E-selectin and could reduce the transport of WBC across the 
capillary epithelium (Jorgensen et al. 1998).
Friedman (1983) demonstrated the ability of AGP in vitro to inhibit the multiplication 
of the malarial parasite Plasmodium Falciparum by 80%. The activity depends on AGP 
blocking parasite-erythrocyte interaction and therefore parasite multiplication. The 
inhibitory activity o f AGP was found to be reliant on high serum concentration and 
sialylation. Friedman has hypothesized that “by binding virus-cell interactions and 
attenuated viraemias, AGP could modulate infection by any virus that recognises sialic 
acid containing cell surface components, including influenza, measles and herpes” 
(Friedman 1983).
It is widely accepted that the structural heterogeneity of plasma glycoproteins is 
dependant on the pathological condition of the individual. Many studies have been 
carried out to examine at the glycan chains of different plasma glycoproteins in a variety 
of human diseases to investigate the possibility of their value as diagnostic or prognostic 
markers. To date there is limited information on the composition o f the carbohydrate 
moiety of glycoproteins in animals.
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3.1.2 Structural heterogeneity of serum glycoproteins 
in disease
3.1.2.1 Liver d ise a se
One of the most widely studied diseases in which the structure of the carbohydrate 
moieties o f glycoproteins is altered is liver disease (Table 3.1). Studies looking at 
glycoproteins in liver diseases have examined various proteins and numerous hepatic 
diseases including alcoholic liver disease (ALD). Transferrin, a glycoprotein involved 
in the transport o f iron in the circulation, has been investigated as a marker of alcohol 
abuse, and is regularly monitored in diagnosis. Transferrin isolated from alcoholics has 
a high isoelectric point suggesting a lack of sialic acid residues. A reduction in the 
levels o f galactose and N-acetylglucosamine has also been reported. This form of 
transferrin is termed carbohydrate deficient transferrin (Landberg et al. 1995;Tumer 
1992). The glycans of Hp have also been investigated in ALD and it was reported that 
glycan chains attached to Hp from patients with this disease express more fucose and N- 
acetylglucosamine residues than normal Hp (Mann et al. 1994).
Studies analysing the glycan chains of AGP in ALD revealed an increase in the 
proportion of tri-tetra-antennary oligosaccharides (Anderson et al. 2002;Jezequel et al.
1988). Increased branching of the oligosaccharide o f AGP was also observed in 
patients with cirrhosis and hepatitis along with elevated levels o f lucosylation of the 
glycoprotein in some hepatitis patients and all cirrhosis patients studied (Biou et al.
1989). A study o f a range of liver diseases, including ALD, hepatitis B and C and 
cirrhosis was conducted by Anderson et al, (2002). In cirrhosis patients, AGP had an
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increased proportion o f tri-tetra antennary chains compared to normal subjects. The 
most significant increase in tri and tetra antennary chains was observed in hepatitis C. 
Monosaccharide analysis of AGP from various liver diseases revealed the presence o f N 
acetylgalactosamine on the AGP isolated from the plasma of patients suffering from 
Hepatitis C. The fucose content of AGP from all liver disease was increased however 
the greatest increase was seen in hepatitis B and C. In hepatocellular disease, decreased 
sialylation of AGP was observed by Bordas et a l, (1982) (Bordas et al. 1982)
Yamashita et a l, 1989 found that the glycans chains attached to transferrin were also 
modified in patients with hepatocellular cancer. It was reported that there was an 
increased proportion o f tri and tetra antennary chains with the addition of fucose 
residues on both the peripheral N-acetylglucosamine and the pentasaccharide core. 
Sialic acid was also noted to be higher than that seen in the normal population 
(Yamashita e ta /. 1989).
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Disease Protein Altered glycosylation
Alcoholic liver disease Transferrin
Haptoglobin
AGP
i  sialic acid 
T fucose TGlcNAc 
T branching
Cirrhosis AGP T fucose T branching
Hepatitis AGP T fucose T branching
Hepatocellular cancer Transferrin T fucose T branching 
T sialic acid
T a b le  3.1 T he  g lycosy la t ion  cha ng es  o f  seru m  prote ins  rep orted  in specif ic  l iver  diseases.
3 .1 .2 .2  C ancer
Plasma glycoproteins expressed in patients with cancer also undergo disease specific 
changes in glycosylation. For example increased levels o f fucose have been noted in 
Hp in ovarian and breast cancer patients, as well as in the a  1 proteinase inhibitor in 
ovarian cancer (Turner 1992).
An earlier study comparing fucose and sialic acid levels in AGP oligosaccharides chains 
in cancer revealed that fucose levels were raised more often in advanced disease than in 
restricted tumours whereas sialic acid concentrations were found to be similar in both 
groups. The report stated that the combined use of serum fucose and sialic acid levels 
may have value in monitoring patients with cancer: the sialic acid providing an index of 
the acute phase response and the fucose a measure of tumour spread (Turner et al. 
1985). A study conducted by Hashimoto et al, (2004) also recorded hyperfucosylated 
glycoforms of AGP agreeing with the finding of (Turner et al. 1985). As well as a
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difference between the diseased group and the normal groups the recent study found 
that fucosylation was dependant on the clinical status of the host. It was concluded that 
patients with highly branched and fucosylated glycoforms of AGP had a poor prognosis 
(Hashimoto et al. 2004).
3 .1 .2 .3  Rheum atoid arthritis
In RA the alterations in the oligosaccharide branching of AGP are indicative o f both the 
severity and the progression of the disease (Pawlowski, Mackiewicz, & Mackiewicz
1989). AGP in patients with rheumatoid arthritis displayed a decrease in di-antennary 
glycoforms, however differences have been detected between the glycoform population 
seen in the early and late stages of the disease. Patients with early RA actually 
displayed an increase in di-antennary glycoforms, which persisted over the first year of 
the condition. As the disease progressed to the chronic stage an associated decrease in 
di-antennary and hence an increase in tri and tetra-antennary glycoforms was observed.
Clearly the heterogeneity of AGP due to variation in glycoforms is considerably altered 
in many disease states, especially inflammatory diseases and has also been observed in 
physiological changes such as pregnancy. These alterations in heterogeneity may serve 
as useful markers for disease progression. However it is useful to remember that factors 
such as concurrent infection can alter the expected glycosylation profiles o f AGP in 
particular disease.
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3.1.3 Structural heterogeneity of AGP in veterinary 
species
There have been few reports on glycosylation o f AGP in animals but recently Ceciliani 
et al., (2004) reported that AGP purified from cats diagnosed with FIP displayed 
decreased levels of sialic acid when compared to AGP from non-diseased cats. This 
study probed the carbohydrate chains of fAGP from cats with and without FIP using 
lectins to look at the branching, fucosylation and sialylation. A similar method was 
used by Pocaque et al. (2005) who reported an increased expression of sialic acid 
residues on fAGP from cats infected with Feline leukaemia virus. Studies using lectin 
binding gave valuable information on the glycosylation of AGP but was limited to 
specific motifs. In order to fully characterise the glycan residues of glycoproteins it is 
necessary to remove the glycan and chemically identify their composition.
3.1.4 Methods of glycomics
Oligosaccharide profiling of glycoproteins has become a common tool in both academic 
laboratories, as well as in the commercial environment. Most techniques employ 
enzymatic digestion to release the N-linked oligosaccharides; however, methods have 
been employed to investigate intact glycoproteins such as ID and 2D gel 
electrophoresis (Schulenberg, Beechem, & Patton 2003) followed by lectin binding 
studies and lectin affinity chromatography.
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There are various methods used for the detection of enzymatically released 
oligosaccharides. These include analysis of fluorescently labelled oligosaccharides by 
capillary electrophoresis (Lacunza et al. 2006) or high-performance liquid 
chromatography (HPLC), along with analyses of the unlabeled oligosaccharides by 
high-performance anion-exchange chromatography (HPAEC) and mass spectrometry.
The resolution of monosaccharides by HPAEC is achieved by exploiting the weakly 
acidic nature of the hydroxyl groups of the monosaccharides to form oxyanions in the 
basic environment created by a NaOH gradient. Individual monosaccharides can be 
separated due to slight differences in pKa arising from positioning of the individual 
hydroxyl groups. Following elution from the column the oxyanions can be detected 
using pulsed amperometric detection which allows for detection in the pmolar range.
HPAEC-PAD is also capable of determining differences in oligosaccharide profiles 
between individual samples (McGuire, Douglas, & Smith 1996). Oligosaccharide 
chains are primarily separated according to sialic acid content. Thereafter the resolution 
of peaks within each charge band was on the basis of many subtle differences such as 
fucosylation, branching type of linkage between sialic acid and the galactose residue.
The aim of this study was analysis the carbohydrate moieties of AGP isolated from cats 
with FIP and compare it to the AGP from cats without FIP in order to characterise the 
carbohydrate motif and analyse the alteration, if any within the oligosaccharide chains 
in disease. In order to examine the biological function o f a glycoprotein it is necessary 
to fully understand the carbohydrate moiety and changes that arise in disease.
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3.2 Materials and methods
3.2.1 Materials
3.2.1.1 S am ples
Sufficient isolated AGP from the serum or ascetic fluid of Cats 
2,5,6,7,8,9,10,13,16,17,18 (as described in 2.2.1) and N Pl and NP2 was available for 
monosaccharide composition analysis and from cats 3,4,6,7,8,10,12,15,18 and NP3 and 
NP4 for oligosaccharide analysis. Sample 18 was from a non-FlP cat all other 
individuals had FIP.
3.2 .1 .2  M onosaccharide analysis
HPLC grade trifluoroacetic acid and hydrochloric acid were purchased from Pierce 
(Illinois, USA). Dowex -  50 W hydrogen form strongly acidic cation exchanger (4% 
cross-linked, dry mesh 200-400) was obtained from Sigma (Poole UK).
Galactose, mannose, 2 deoxygalactosamine, glucosamine, mannose, were supplied by 
Sigma (Poole, UK). 50% sodium hydroxide (NaOH) was purchased from BDH (Poole, 
UK) and the HPLC grade water was obtained from Rathbum (Walkerbum, UK).
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3.2 .1 .3  Oligosaccharide Analysis
PNGase F (EC number 3.5.1.52), lOx G7 buffer, 10% (v/v) NP-40 were purchased as a 
kit from New England Biolabs (Herts, UK). HPLC grade water was obtained from 
Rathbum (Walkerbum, UK).
3.2.2 Methods
3 .2 .2 .1 1solation o f A G P
The monosaccharide and oligosaccharide analysis used samples of fAGP isolated from 
semm or ascetic fluid as described in section 2.2.
3 . 2.22  M onosaccharide Analysis
Monosaccharide analysis was performed on Dionex DX-600 High pH anion exchange 
chromatography system (Dionex, Califomia, USA) using pulsed amperometric 
detection. This system utilizes a GP50 gradient pump and an ED40 electrochemical 
detector controlled by a Dell desktop computer running Peaknet software.
After the last steps of the AGP purification procedure, 66p,g of each sample was 
desalted in centricon centrifugal tubes, dried under vacuum and then resuspended in a 
solution consisting of 50pls of 4M HCl and lOOpls of 2M TEA. Samples were then 
placed in a reacti vial and heated at 100°C for 4 hours. The hydrolysed sample was then
1 0 0
passed through Dowex 50 cation-exchange column and eluted in a 2 ml fraction of 
HPLC grade water. This fraction was then dried under vacuum to dryness and 
resuspended in 20pl of HPLC grade water ready for analysis on the Dionex HPLC 
system.
Monosaccharide analysis was carried out by high pH anion-exchange chromatography 
with pulsed amperometric detection (HPAEC-PAD). Separation was carried out on a 
Carbopac-100 ™ column and guard column (250x4mm and 50x4mm respectively) 
using an isocratic gradient of 30mM NaOH over 35minutes. The column was then 
regenerated using 0.5M NaOH for lOmins before equilibration with 30mM NaOH. 
Monosaccharide concentration was determined using a calibration curve based on a 
standard monomix which consisted of 5 mg/ml mannose, fucose, galactose, N-acetyl 
glucosamine and 2-deoxygalactose (Sigma, Poole, UK).
Identification o f individual monosaccharides peaks was achieved using an internal 
standard, 2-deoxy-D-galactose as although the retention time o f particular 
monosaccharides may vary between runs the position of the peak is constant relative to 
that o f the other peaks including the internal standard (IS). The identity o f unknown 
peaks is calculated by dividing the retention time given for the unknown peak with the 
retention time o f the IS which can then be compared with the ratios for 
monosaccharides in a standard mix.
The amount of each monosaccharide present in a sample mixture can also be calculated 
directly from the chromatogram, due to a linear relationship between the area under the
1 0 1
peak and the quantity of monosaccharide. The area under the peak is then compared to 
previously constructed standard curves (Figure 3.3).
3. 22.3 Oligosaccharide analysis
Oligosaccharide analysis was also carried out on a Dionex DX-500 High pH anion 
exchange chromatography system using pulsed amperometric detection, which utilizes a 
GP40 gradient pump and an ED 40 electrochemical detector controlled by a desktop 
computer running Peaknet software.
After desalting 50p,g of AGP was dried under vacuum and reconstituted in lOOpl of 
HPLC grade water and incubated at 100°C for 30-60 mins. Thereafter 10 pis o f 10% 
(v/v) NP 40, 10 pis of sodium phosphate buffer (supplied with enzyme) and 100 units of 
PNGase F were added and the mixture incubated at 37°C overnight. The cleaved 
oligosaccharides were separated from the protein by ethanol precipitation, in which 
500pl of ice cold ethanol was added to the mixture and centrifuged at 3000g for 10 
mins, this was then repeated and the supernatant containing the oligosaccharides was 
dried under vacuum and reconstituted in 20pl of HPLC grade water.
Oligosaccharide analysis was then performed on the HPAEC-PAD and the separation 
was carried on a carbopac-100 column and guard column. Solvents were degassed 
using helium. The column was equilibrated with a mixture of 10% of IM  NaOH 
(solvent A), 5% of IM acetic acid (solvent B), 85% of HPLC grade water (solvent C), 
These conditions were continued for 10 minutes after sample injection and there after a
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linear gradient of 10% A, 5%B, 85%C to 10%A, 20%B, 70%C was achieved after 40 
mins and maintained for a further 5 minutes before the column was regenerated with 
50% A 50% C for 10 minutes (Figure 3.1 ).
A B C
F igu re 3.1 T he bu ffers and p ercen tage  at each  stage  o f  the o lig o sa cch a r id es sep a ra tio n . A -  IM  
N aO H . B =1M  A cetic  acid . C =  H PL C  grade w ater.
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3.3 Results
3.3.1 Monosaccharide analysis
Prior to HPAEC aliquots o f 66qg of isolated fAGP were hydrolysed using TEA and 
HCL to degrade the glycan chains into their component monosaccharides which were 
then analysed by HPAEC-PAD. A typical trace obtained by the separation of a 
standard monosaccharide mixture can be seen in Figure 3.2.
The monosaccharide composition of fAGP isolated from 11 individual cats and two 
pools was determined by measuring the area under each o f the peaks in comparison to a 
previously established standard curve for each individual monosaccharide Figure 3.3 
shows the standard curves used to calculate the number of moles of each 
monosaccharide present. The trace of a normal pool (NP2) and examples of 3 cats (Nos 
5, 7 and 9) are shown in Figure 3.4, identification of peaks in these samples are in Table 
3.2. The quantity of each monosaccharide from the examined samples is expressed as 
moles of monosaccharide per moles of AGP hydrolysed assuming a molecular weight 
of 47kDa for AGP is shown in Table 3.3. Due to a shortage of sample it was only 
possible to run each sample once.
Table 3.3 shows the individual cat monosaccharide composition from this we see that 
cats 5 and 9 had a detectable fucose concentration (the chromatograms for these cats can 
be seen in Figure 3.3) whereas the other eight cats which were included in the FIP group
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had no detectable fucose residues. Cat number 18 and the two non-FIP pools which 
made up the non-FIP group had no detectable fucose present within their 
oligosaccharide chains. All cats in the included in the FIP group had increased numbers 
o f GlcNAc and Gal residues with means of 18.8±1 mol/molAGP and 17.8+1.4 
mol/molAGP respectively compared with a means of 7+2 mol/molAGP and 5.8+1.4 
mol/molAGP in the non-FIP group respectively (Table 3.4). Two from ten cats in the 
FIP group (cats 6 and 9) had very low levels o f mannose residues with 3 and 1 
mol/molAGP respectively.
Using a Mann-Whitney statistical test it was calculated that cats with FIP had 
statistically significantly higher levels of GlcNAc and Gal residues present within the 
glycan chains attached to AGP compared to the non-FIP group (p<0.05 for both). No 
statistically significant differences were found for the mannose residues p=0.13 or for 
the fucose p=0.67.
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F igure 3 ,2  A rep resen ta tiv e  H P A E C -P A D  ch ro m a to g ra m  o f  a sta n d a rd  m o n o sa cch a r id e  m ixture. 
F u c= F u co se  IS = ln te rn a l stan dard  G lcN A c -  N acety l g lu co sa m in e  G al =  G a la c to se  M an =  
M annose.
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Cat No Peak No Monosaccharide
N P 2 1 Solvent front
2 Internal standard
3 N -acetylglucosam ine
4 G alactose
5 G lucose
6 M annose
C a t? 1 Solvent front
2 Internal standard
3 N -acety lg lucosam ine
4 G alactose
5 M annose
Cat 5 1 Solvent front
2 Fucose
3 Internal standard
4 N -acetylglucosam ine
5 G alactose
6 M annose
Cat 9 1 Solvent front
2 Fucose
3 Internal standard
4 N -acetylg lucosam ine
5 G alactose
6 M annose
T a b le  3 .2  Id en tifica tio n  o f  th e  p eaks p resen t in th e  ch ro m a to g ra m s sh ow n  in F ig u re  3 .3
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F igu re 3 .3  1 S tan d ard  curves for ga la cto se  and m ann ose resp ectiv e ly  w h ich  w ere  used to ca lcu la te  
the con cen tra tio n  o f  m on o sa cch a rd ie  resid ues in each  in d iv id u a l sam p le .
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C at No F I?  or
Non
FIP
AGP
Cone
Mol/mol AGP
mg/ml Fucose GlcNAc Gal M an
5 FIP NA 0.35 22 27 11
6 FIP NA 0 15 13 3
9 FIP 2 0.16 16 12 1
7 FIP 2.2 0 23 22 13
8 FIP 1.7 0 22 16 10
2 FIP 0.6 0 17 17 14
10 FIP 2 j # 0 19 20 14
17 FIP NA 0 14 16 14
13 FIP 1.1 0 17 16 11
16 FIP NA 0 23 19 14
18 Non 0.25 0 5 6 6
N Pl Non 0.1±0 0 11 8 5
NP2 Non 0.16±0.02 0 5 3 3
T a b le  3 .3  T h e  ca lcu la ted  co n cen tra tio n s o f  each  m o n o sa cch a r id e  in in d iv id u a l sa m p les
mol/mol AGP
Fucose GlcNAc Gal M an
FIP 0.051±0.04 18.8±1 17.8±1.4 10.5±L5
Non-FIP n=3 0±0 7±2 5.8±1.4 4.7±0.89
T a b le  3 .4  T h e m ean ±  sta n d a rd  erro r  o f  each  m o n o sa cch a r id e  for  d isea se  grou p s.
I l l
3.3.2 Oligosaccharide analysis
The HPAEC-PAD profile o f oligosaccharides from bovine fetuin is shown in Figure 
3.5.1 to show the elution times of the standard sialylated glycoforms. Following 
PNGaseF action on the fAGP it was found that AGP from pools 3 + 4 carried solely 
disialylated glycan chains (Figure 3.5.2). The oligosaccharide profiles for each 
individual cat within the FIP group (cats 6 ,7 , 10,11, 12) are shown in Figures 3.5.3 - 
3.5.5 all have two major peaks, one in the disialylated (retention time 20-30 mins) range 
and one in the trisialylated (retention time 30-40mins) range which are eluted 8-9 mins 
apart for all samples. Cat 18 which was also used in the non-FIP group however had a 
different oligosaccharide profile to both the pools and the FIP group in that three major 
peaks where detected, one in monosialylated range, one in disialylated and one in the 
trisialylated range.
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3.4 Discussion
The oligosaccharide chains covalently attached to glycoproteins are essential for a 
number of important functions including cell-cell interactions and a role in non-specific 
immunity. Therefore in order to fully elucidate the structure function relationship 
within a glycoprotein it is necessary to gain a complete understanding o f their 
glycosylation pattern which should include analysis of the monosaccharide composition 
of the oligosaccharide chains as the presence or absence of terminal monosaccharides 
such as fucose and sialic acids can have marked effect on the physio-chemical 
properties of the glycoprotein and could changes its the function and antigenic 
properties. Compositional analysis of the monosaccharide composition o f AGP using 
HP AEG is only achieved after prior acid hydrolysis of the intact glycoprotein. 
Incubation with 2M TFA and 4M HCl for 4 hrs at 100° attains optimal conditions for 
cleavage of all the intrachain linkages in oligosaccharides and with the exception of Neu 
5 Ac which is destroyed (McGuire, Stewart, & Smith 1999). TFA releases all neutral 
monosaccharides including fucose, galactose and mannose but poorly cleaves the amino 
sugars due to their high acid resistance. In particular it fails to hydrolyse the bond 
between the asparagines residue and the innermost GlcNAc residue in N-linked 
glycoproteins (Fan et al. 1994). The solution to this problem is to use hydrochloric acid 
which easily cleaves the bonds with the amino sugars, in combination with TFA. It 
should be noted however using HCl can result in decomposition o f neutral 
mono saccharide s. TFA hydrolysis has also been shown to give a low yield in mannose 
using this procedure (Hardy & Townsend 1988;McGuire, Stewart, & Smith 1999).
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Post hydrolysis, the hydrolysate is applied to an acidic cation exchange resin (Dowex 
50) in order to prevent interference of amino acids, peptides or salt with the separation 
o f the monosaccharides (Hardy & Townsend 1988).
HPAEC allows for highly specific resolution of monosaccharides including those that 
are anomeric or have positional isomers with a successful resolution of galactose, 
mannose and glucose despite the similarities in size and number of hydroxyl groups 
(Lee 1996). Hydroxyl groups act as weak acids in highly basic conditions therefore 
monosaccharides which are polyhydric compounds will also be weakly acidic with a 
pKa o f between 12 and 14. This fact is exploited in HPAEC by eluting the 
monosaccharides with strong, isocratic alkaline gradient which causes the 
monosaccharides to become negatively charged through the formation of oxyanions.
The monosaccharides are detected as oxyanions and it has been found that the elution 
order o f the compounds correlates well with the pKa values (Hardy & Townsend 
1994a). The difference in pKa value for each monosaccharide is explained through 
differences in the positions o f the hydroxyl groups. It is the subtly different pKa values 
of the oxyanions and their different interactions with the strong anion exchange groups 
that results in the monosaccharides having different elution times. While most of the 
acidity of monosaccharides is due to the anomeric hydroxyl group, the final pKa is 
dependant on a number of other factors including the acidity o f other hydroxyl groups 
which is not uniform. The 2-OH is the most acidic with the other groups in the order 6- 
OH >3-0H > 4-OH (Lee 1990).
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HPAEC-PAD has been successfully applied to the study o f glycoproteins including 
hAGP (Anderson et al. 2002;Elliott et al. 1997). Therefore it has been employed in this 
investigation to determine the monosaccharide composition of fAGP using the 
previously described method of Smith et a l, (1994).
Previous studies have revealed that fucose content on AGP displays the greatest 
variability in disease conditions (Biou et al. 1987;Listinsky, Slegal, & Listinsky 1998). 
It is generally accepted that fucose is an inflammatory marker and a possible measure of 
tumour growth (Thompson & Turner 1987;Turner et al. 1985)(Tumer et al, 1985; 
Thomson et al, 1987). However fAGP from only 2 (cats 5 +8) o f the cats with FIP 
contained fucose residues. Possible explanations for the AGP from these two cats 
expressing fucose residues may be either due to a more advanced stage of the disease or 
the presence of an underlying disease that was masked by the clinical signs of the FIP.
Theoretically each complex type diantennary chain N-linked chain would give 
4molGlcNAc, 3molMan and 2molGal while all tetra-antennary chains would give 6 
molGlcNAc, 3molMan and 4molGal. Therefore it is expected that if  only complex type 
N -linked glycans chains are attached to fAGP then a 3:2 ratio o f GlcNAc:Gal residue 
would be obtained when diantennary and tetraantennary chains are present. However 
analysis o f monosaccharides from fAGP did not follow the theoretical expected pattern 
as four of the cats were found to have more detectable galactose residues resides per 
mol of AGP than GlcNAc while one sample had equal numbers of GlcNAc and 
galactose.
N acetyl glucosamine is found within the peripheral branches and the pentasaccharide 
core of glycan chains. Therefore the increase in N acetyl glucosamine such as was
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found for all 10 of the FIP compared to the three non-FIP could be due to an increase in 
branching or the addition of an another chain on the polypeptide backbone.
Galactose is only found in the outer branches o f AGP oligosaccharide chains and never 
in the core region of N-linked glycan chains. Thus in a manner similar to N acetyl 
glucosamine, if  AGP galactose levels were increased, this would suggest there was a 
corresponding increase in the proportion of tri and tetra antennary oligosaccharides 
present on AGP. However the addition of another chain to the polypeptide would also 
result in increased Gal residues.
Unlike GlcNAc and Gal, mannose is not found in the peripheral branches of complex 
type N-linked chains, so any change found in the expression of mannose would be due 
to the addition or removal o f chains from the polypeptide backbone.
Since AGP from FIP had significantly higher expression of GlcNAc and galactose 
residues accompanied by no significant increase in mannose expression, it would seem 
more likely that that the increase seen in the GlcNAc and Gal residues is due to 
increased branching and not the addition of glycan chains to the polypeptide backbone. 
However these results must be interpreted with caution because, as stated previously 
studies have shown that hydrolysis method used to remove the monosaccharide residues 
from the protein, may degrade some of the mannose residues (Hardy & Townsend 
1988;Hardy 1989;McGuire, Stewart, & Smith 1999). Though not statistically different 
from normal pools the mannose was higher in 9 o f 11 samples from FIP cats and 
analysis o f a greater sample o f the population might have yielded significant results.
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HPAEC-PAD can also be successfully applied to the study of intact oligosaccharides as 
well as the investigation of constituent monosaccharides. HPAEC coupled with PAD 
can efficiently resolve positional isomers of oligosaccharides, including those differing 
in just a single linkage, in the pmolar range with no prior need for derivatization (Hardy 
& Townsend 1988). The principal o f separation of the intact oligosaccharides is 
identical to that described for monosaccharide analysis. The charge on the 
oligosaccharide chains varies not only with the composition of the monosaccharide 
constituents but also the linkages they form. The involvement o f certain hydroxyl 
groups in the formation of glycosidic bonds between the monosaccharides can alter the 
overall charge o f the oligosaccharide such that they can be resolved by HPEAC-PAD. 
Thus oligosaccharides with identical monosaccharide content but with a difference in 
one linkage can be successfully separated.
The use o f HPEAC-PAD in the analysis of glycan chains is not quantitative but rather 
allows a qualitative determination of the pattern of N-linked oligosaccharides in 
comparison to a library sample of bovine fetuin (Smith et al, 1997).
N-linked glycan chains were released from the polypeptide backbone of isolated fAGP 
using peptide-N4-(N-acetyl P-D-glucosaminyl) asparagines amidase (PNGaseF EC 
number 3.5.1.52), which is an amidase that catalyses the hydrolysis of the glycosidic 
bond between the asparagine and the innermost GlcNAc residue of N-linked glycan 
chains (Davies et al. 1993). The cleavage results in the formation of a gly cosy lamine as 
the amino group of the asparagine residue remains attached to the oligosaccharide 
(Hardy & Townsend 1994).
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The initial separation of the oligosaccharide, and thus the major determinant of their 
elution times, is the formal negative charge on the oligosaccharide principally 
determined by the number of terminal sialic acid residues present on the chain. The 
greater the number of sialic acid residues the stronger the interaction with the resin. An 
acetate gradient is required to displace the sialylated oligosaccharide chain. The greater 
the number of sialic acid residues present on the oligosaccharide the greater the 
interaction with the resin and the higher the concentration of acetate required to displace 
the oligosaccharide chain. For example trisialylated glycans are retained on the column 
longer than disialylated glycans. Within each charge band with the same charge further 
separation is on the basis of size, intermonomeric linkages and fucosylation (McGuire, 
Douglas, & Smith 1996).
Non-FIP samples were analysed in order to determine any changes which occurrence of 
FIP induces in the oligosaccharide pattern as determined by HPAEC-PAD. It was 
shown that AGP isolated from 2 pools of non-FIP serum had only disialylated 
oligosaccharides chains attached in contrast although each individual cat in the FIP 
group had a unique oligosaccharide profile all had 2 major peaks one in the disialylated 
range and one in the trisialylated which were eluted 8-9 mins apart. Overall the extent 
of structural heterogeneity within the glycan chains of fAGP from FIP patients is greater 
than that observed within the glycan chains of fAGP from non-FIP patients.
In summary, it was found that the presence of FIP had a profound effect on the 
carbohydrate moiety of fAGP, with increased expression o f Gal, GlcNAc and 
trisialylated glycan chains. If the increased expression of Gal and GlcNAc residues is in 
fact due to increased branching of the glycan chains this may have a significant effect
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on the functions o f fAGP. Although very little is actually known on the function of 
fAGP if it has similar functions to hAGP then increased branching of the glycan chains 
o f fAGP may result in an increased ability to inhibit proliferation o f lymphocytes as, it 
has been reported that highly branched glycoforms of hAGP have a greater inhibitory 
effect on this function of AGP (Pos et al. 1990).
124
CHAPTER 4
4. Alpha-1-acid glycoprotein and bovine 
mastitis
4.1 Introduction
Bovine mastitis arises through intramammary infection with many different pathogens 
and remains the principal economical problem for dairy farmers worldwide. Many 
studies have been carried out in an effort to identify a diagnostic marker for mastitis that 
can be used to positively identify mastitis quickly and reliably (Conner et al. 
1986;Conner et al. 1988;Eckersall et al. 2001;Eckersall et al. 2006;Gronlund et al. 
2003;Martin et al. 2002;Mottram et al. 2007;Paape et al. 2002). At present the most 
effective measurement is the somatic cell count (SCC) which is the measure of somatic 
cells per ml of milk. Recently studies have targeted the acute phase proteins as possible 
diagnostic markers and in these studies it has been found that serum alpha -1 acid 
glycoprotein behaves as in humans as a moderate acute phase protein with serum levels 
rising 2-5 fold in mastitis (Conner et al. 1988). As has been described in previous 
chapters AGP undergoes remarkable structural changes with in the glycan moiety in the 
presence of specific diseases in humans and cats. These findings have enormous 
implications on the functioning of AGP and offer the potential o f diagnostic and 
prognostic markers for diseases such as rheumatoid arthritis, cancer and feline
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infectious peritonitis (Anderson et al. 2002;Ceciliani et al. 2004;Hashimoto et al. 
2004;Pawlowski, Mackiewicz, & Mackiewicz 1989). It is possible that similar 
phenomenon occurs with serum AGP in cows with mastitis.
4.1.1 Mastitis
Mastitis simply means inflammation of the udder. Most farmers associate mastitis with 
an inflamed udder quarter together with a change in the appearance o f the milk. 
Symptoms usually include redness, tenderness, heat and clumping of the milk. These 
changes are due to the effect o f the cow’s inflammatory response to infection. However 
mastitis can also occur in a subclinical form. This means that although infection is 
present in the udder there are no visible external changes to indicate its presence and 
this can persist for days leading to a large loss of production. Over 200 different 
organisms have been reported to cause bovine mastitis and there are substantial 
differences in epidemiological and predisposing factors with different types of infection 
(Dodd 1970). ‘Contagious mastitis’ and environmental mastitis’ are labels used to 
classify the epidemiology of pathogens that cause intramammary infections in dairy 
cows (Bramley & Dodd 1984;Smith & Hogan 1993). Contagious mastitis is transmitted 
from cow to cow during milking, whereas exposure to environmental pathogens can 
occur at any time during a cow’s life (Smith & Hogan 1993).
It is unlikely that mastitis will ever be eradicated. There are too many different bacteria 
involved many o f which are continually present while antibiotic treatment has varying 
degrees o f effectiveness. The approach to management of mastitis must therefore be to
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control the disease and with increased milk production rates producing ever higher 
susceptibility, control will become increasing important in the future with detection and 
diagnosis being of the utmost importance.
4.1.2 Clinical mastitis
Clinical mastitis is characterised by abnormal milk of varying degrees depending on the 
severity of mannnary gland inflammation. Signs of inflammation include heat, pain, 
redness, swelling and loss of function of the mammary gland (O'Rourke 1992). Clinical 
signs alone are considered to be insufficient to differentiate between infections caused 
by Gram positive and Gram negative bacteria with certainty; although recent work 
indicates that some clinical signs are more likely to be associated with certain types of 
pathogens (Milne et al. 2002).
4.1.3 Subclinical mastitis
Subclinical mastitis occurs when the mammary gland is infected and the number of 
leukocytes in the milk (SCC) is increased, but where there is no visible abnormality of 
the milk and there are no clinically detectable signs of inflammation in the mammary 
gland (Cullor 1996;Sears et al. 1993). Subclinical infections are, therefore, difficult to 
detect and repeated or persistent bouts may lead to fibrosis of the mammary tissue, 
resulting in further reduction in milk production (Cullor et al 1996).
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4.1.4 Contagious pathogens
Contagious mastitis is caused by organisms that colonise the mammary gland and can 
be spread during the milking process (Cullor et al 1996). Colonies become established 
at the teats and slowly grow through the canal over a few days. For the most part, 
successful control o f contagious mastitis is by dry cow therapy and post milking 
dipping. The most commonly found contagious pathogens are Staphylococcus aureus. 
Streptococcus agalactiae, Streptococcus dysgalactiae (Bramley 1984).
Staphylococcus aureus is a haemolytic gram positive coccus often visualised as white 
colonies on blood agar. Staphylococcus aureus is a coagulase positive bacteria and as so 
is often referred to as the coagulase positive staphylococci (Blowey & Edmondson 
2000b). Staphylococci are notoriously difficult to treat for two reasons. Once infection 
has been established in the udder they become surrounded by a fibrous tissue which 
makes penetration with antibiotics more difficult. Staphylococcus aureus also has the 
ability to infect macrophages and epithelial cells which makes them inaccessible to 
antibiotics. Infection with S. aureus usually gives rise to a chronic subclinical infection 
however cases o f mild and moderate clinical infection can occur (Cullor & Smith 1996). 
Under certain circumstances S. aureus can also cause an acute gangrenous mastitis. 
This occurs following the production o f a large quantity of toxin. In most cases cows 
suffering for gangrenous mastitis would be culled.
In contrast to S. aureus, Strep, agalactiae is a non-haemolytic coccus gram positive 
bacteria and is a highly contagious cause of mastitis. Streptococcus agalactiae is 
visualized as small colonies which are blue in appearance on Edwards medium. The
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primary reservoir of infection is in the udder although it may colonise the teat canal and 
even the teat skin. Unlike S aureus, Strep agalactiae responds well to antibiotic 
treatment and almost all antibiotics are effective. The level of Strep, agalactiae 
infection in an individual cow is closely associated with cell counts. Although Strep, 
agalactiae is mainly colonised in the udder it has been reported that it can survive in the 
environment.
Streptococcus dysgalactiae is the third major cause o f contagious mastitis, like 
Staphylococcus aureus, streptococcus dysgalactiae is a haemolytic gram positive 
coccus and can be seen as small colonies green in appearance on Edwards medium. 
Streptococcus dysgalactiae can survive well in the environment and for this reason 
some consider it be an environmental pathogen as well as contagious pathogen. 
Streptococcus dysgalactiae is most commonly found on the teat skin particularly when 
the integrity of the skin is compromised. This bacteria is also commonly found on the 
tonsils and so licking may be a route of infection.
4.1.5 Environmental Pathogens
Environmental mastitis is caused by pathogens that do not necessarily colonise the 
mammary gland and exposure is not limited to the milking process. Dry cow therapy is 
o f no value in the control of environmental mastitis as they do not persist subclinically 
and are not carried from one lactation to the next. Gram negative coliforms and 
Streptococcus uberis are the predominant environmental pathogens (Smith, Todhunter, 
& Schoenberger 1985).
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Escherichia coli is the prevalent environmental organism causing mastitis. Escherichia 
coli are gram negative bacilli of which there are haemolytic and non-haemolytic strains. 
Escherichia coli can be visualised as creamy white mucoid colonies on blood agar. It is 
present in large numbers in faeces and hence infection occurs primarily in housed 
animals. The symptoms of typical E.coli mastitis are a hard, hot swollen quarter with a 
watery discharge. The toxic effect o f E.coli mastitis is due to the release of an 
endotoxin, which is a lipopolysaccharide (LPS) derived from the bacterial wall. Most 
cases of E.coli mastitis are restricted to the teat and gland cistern. If E.coli reaches the 
smaller ducts and lactiferous sinuses of the main gland, then a massive multiplication of 
bacteria occurs, and this leads to a severe response in the cows.
Streptococcus uberis is a widely occurring environmental organism causing mastitis and 
is particularly associated with straw yards. Streptococcus uberis is a non-haemolytic 
gram positive coccus which appears as brown colonies on Edwards medium due to the 
splitting of aesculin. Streptococcus uberis is responsible for the majority of clinical and 
subclinical cases of mastitis in the UK (Hillerton et al. 1993). Unlike E.coli high 
numbers o f Strep, uberis are not found in the faeces however it is found naturally on 
mucous membranes and skin (Blowey 1990). Mastitis caused by Strep, uberis is often 
sudden in onset, giving a hard, swollen quarter, clots in milk and a high or very high, 
body temperature. In most instances of this infection response to antibiotic treatment is 
good.
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4.1.6 Detection of mastitis
Detection of clinical mastitis by visual inspection and palpation is relatively easy, but 
diagnostic problems arise when dealing with sub-clinical mastitis, where an increased 
SCC is the only finding. The SCC is the number of somatic cells present per ml of 
milk. It is used as an indicator of udder infection. Somatic cell counts are made up o f a 
combination of white blood cells and epithelial cells (Nickerson 1985). White blood 
cells enter milk in response to inflammation which may occur due to disease or 
occasionally injury. Epithelial cells are shed from the lining of the udder tissue. White 
blood cells make up nearly all of the somatic cells.
Despite more than 30 years of research into mastitic diagnostics, there are few 
alternatives to the SCC in practical use for identification of subclinical mastitis apart 
from the California mastitis test which is an on farm test that only give qualitative 
results.
Dairy cooperatives give farmers a premium quality payment to encourage low SCC. 
Furthermore EC directive 853/2004 states that the SCC of the bulk tank milk must be 
less than 400,000 cells/ml. Somatic cell count measurement is the most common tool 
used in mastitis diagnostics as somatic cells in the milk give a good indication as to the 
degree of infection in the udder (Sears, Gonzalez, Wilson, & Han 1993), however the 
SCC can remain elevated for weeks after the infection is eliminated and the gland is 
recovering (Petersen, Nielsen, & Heegaard 2004).
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Mastitis is by far the most important factor that causes increased SCC. When mastitic 
causing agents enter the udder, the defence mechanisms send vast numbers of white 
blood cells to the area to try and kill the bacteria. If the infection is eliminated the cell 
counts will return to normal levels. If the white blood cells fail to eliminate the 
infection then a subclinical infection is established. White blood cells are continually 
transferred in to the milk leading to the increased cell count. For some organisms there 
is a relationship between cell counts and the level of infection in the udder.
There are a number o f ways in which SCC can be measured. The most informative but 
perhaps less practical way is at the quarter level when individual milk samples from 
each udder quarter of a cow is analysed i.e. individual quarter SCC (IQSCC). This 
method has the ability to identify which individual cow is infected and in which quarter. 
Somatic cell counts can also be measured at the cow level where a composite sample 
made up of equal volumes of milk from each quarter is analysed i.e. individual cow 
SCC (ICSCC). This method o f SCC is also very informative in that it can identify 
which cows are infected and so they can be withdrawn form the herd. However as it is 
known that each quarter is immunologically completely separate and there is no flow 
between each quarter then ICSCC can mask individual quarter counts and so may mask 
infection. More often than not SCC is analysed from the bulk tank i.e. bulk milk SCC 
(BMSCC). This is useful in identifying the prevalence o f infection in the herd but the 
BMSCC is limited as it is unable to identify individually infected cows or quarters.
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4.1.6.2 California mastitis test
This is a simple test that is useful in detecting subclinical mastitis by crudely estimating 
the cell count of milk. The CMT test does not give a numerical result rather an 
indication whether the count is high or low. The California Mastitis test is based on 
bromcresol-violet reacting with nuclear content of the somatic cells to give a viscous gel 
(Bramley, 1992). The benefits of CMT are that is cheap to use, it can be carried out by 
the milker during milking and results are available immediately and it gives an 
indication of the level of infection in each quarter.
4.1 .6 .3  The total bacterial count (TBC) or B actoscan
The bacterial count of milk is a measure of the bacteria grown from an aliquot of milk 
over a fixed period of time (Blowey & Edmondson 2000). The bactoscan measures the 
number of bacteria in the milk using an electronic method. High TBCs effect the farmer 
in two ways directly in the form o f financial penalties and indirectly through the 
production of a poor quality milk, and are measured regularly by the dairy companies. 
However the benefits to the farmer are limited as they are unable to identify the bacteria 
present or the source. There are four main sources of bacteria in the milk; mastitis 
causing organisms, environmental contaminants, dirty milking equipment and failure to 
refrigerate. Mastitis should be suspected if the TBC fluctuate dramatically. When 
quarters become infected with clinical or subclinical mastitis the numbers of bacteria 
can increase substantially. Streptococcus agalactiae and Strep, uberis in particular are 
shed in extremely high numbers.
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4.1.6.4 APPS in detecting Mastitis
Acute phase proteins such as Hp, SAA, and AGP have been identified as markers of 
inflammation in cattle. Many studies have reported increased serum levels of the 
mentioned APPs in mastitis caused by various pathogens (Eckersall et al. 
2001;Gronlund et al. 2003;Hirvonen, Pyorala, & Jousimies-Somer 1996;Horadagoda et 
al. 1999). Haptoglobin and SAA are major APPs in cattle with serum concentration 
increasing 100 fold for Haptoglobin and 5-20 fold for SAA: AGP is a moderate acute 
phase protein in cattle, which has a low relative rise and indicates more chronic 
inflammation (Eckersall et al. 2001 ;Eckersall & Conner 1988). However Hp, SAA and 
AGP are also raised in the serum in the presence of other infections and trauma making 
them non-specific and reduce their value in the diagnosis of mastitis.
Acute phase proteins Hp, SAA and AGP have been found in the bovine milk during 
mastitis implying that it is possible that measuring APP’s in milk will be of more use 
than measuring APPs in the serum for diagnosis o f mastitis (Ceciliani et al. 
2005;Gronlund et al. 2003;Hirvonen, Pyorala, & Jousimies-Somer 1996). This will be 
discussed in more detail in Chapter 5
The main objective of this study was identifying any changes within the carbohydrate 
moiety o f bovine serum AGP that are due to the presence of mastitis. In order to 
achieve this objective the serum obtained from control cows and cows with mastitis had 
to be prepared in such a way as to enrich the AGP concentration present in the serum. 
This was achieved by fractionation precipitation with polyethylene glycol followed by
134
anion exchange chromatography. Once the samples where successfully prepared they 
where probed with lectins specific for defined antigens within the glycan chains 
attached to bovine AGP.
135
4.2 Materials and methods
4.2.1 Materials
4.2.1.1 Sam ples
All samples were kindly provided by Dr F Young, Department of Clinical Studies, 
Faculty of Veterinary Medicine, University of Glasgow and detailed in Eckersall et al 
2001)
All reagents were obtained from Sigma (Poole, UK) unless otherwise stated.
4.2.2 Sample preparation
Polyethylene glycol (PEG) Mwt and 8000, Trizma base, sodium chloride (NaCl). A 
5ml Hitrap Mono Q chromatography column was used on the AKTA FPLC system and 
was supplied by Amersham Pharmacia Biotech UK. Centricon, centrifugal filter units 
were supplied by Millipore Corporation (Massachusetts, USA).
Dialysis tubing used for buffer exchange was purchased from Medicell (London, U K ). 
The Akta Fast Protein liquid chromatography system was supplied from Amersham 
Pharmacia Biotech (Buckinghamshire, UK) and controlled by a Compaq deskpro EN, 
which runs Unicom version 4 software.
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4.2.1.2 Lectin Blots
Sodium dodecyl sulphate (SDS), ammonium persulphate (APS), Trizma base, 
bromophenol blue, mercaptoethanol, TEMED, Coomassie blue, NaCl, Tween-20, 
magnesium chloride, manganese chloride, calcium chloride, and bovine serum albumin 
were all supplied by Sigma (Poole, UK). Hydrochloric acid (HCl), methanol and acetic 
acid were supplied by BDH. Glycerol was purchased from Fisher Scientific 
(Loughborough, UK). Fluorescein labelled Sambucus Nigra, Concanavalin A, Maackia 
Amurensis and biotin labelled Aleuria aurantia lectin where purchased from Vector 
laboratories (California, USA).
30% Acrylamide mix. Standard marker and nitrocellulose membrane were purchased 
from BioRad (Hemel-Hempstead, UK).
4.2 .1 .3  M easurem ent o f A G P  concentrations.
AGP concentration in bovine serum samples were measured using a commercially 
available radial immunodiffusion kit supplied by the Institute for Metabolic Ecosystems 
(Seratoni, Japan). SAA was measured by ELISA and Hp was measured by colorimetric 
assay on a MIRA biochemical analyser. Kits for Hp and SAA were obtained from 
Tridelta Development (Eire).
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4.2.2 Methods
4.2.2.1 S am ples
Serum samples from 8 healthy control cows, 7 cows diagnosed as suffering from mild 
mastitis and 7 cows diagnosed with moderate mastitis were used in this study. Mild and 
moderate mastitis was graded on the basis that the presence of clots accompanied by 
visible signs of inflammation of the udder were in the moderate group whereas cows 
which only had clots in the milk and no visible signs of inflammation were grouped in 
the mild mastitis categoiy%
Somatic cell counts, SAA, Hp and AGP levels had previously been measured by Dr 
Fiona Young using methods detailed elsewhere (Eckersall et «/, 2001) with brief outline 
given below.
4.2 .2 .2  Som atic cell counts
Milk samples were taken from infected quarters and submitted to the Veterinary Science 
Division, Scottish Agricultural College, at Auchincruive for automated counting.
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4 . 2.23 Haptoglobin concentrations
Serum haptoglobin levels were determined using the ‘Phase’ haptoglobin kit on a 
MIRA biochemical analyser according to the manufacturers instructions
4. 2.24 SAA Concentrations
SAA concentrations were determined using a commercially available ELISA kit 
(McDonald, Weber, & Smith 1991) and run according to the manufacturer instructions.
4 .2 .2 .5  A GP concentrations
A  radial immunodiffusion technique (Mancini, Carbonara, & Heremans 1965) was 
used to determine the quantity of AGP in each sample. Standards of AGP at 
concentrations of 1, 0.5, 0.25 and 0.125 mg/ml were applied to the precast antibody 
containing gel. The gel was then incubated overnight at 37°C for 24-48hrs and the 
diameter of the precipitate rings measured. A calibration curve from the results of the 
standards (diameter (mm) vs concentration (mg/ml)) was drawn to determine AGP 
concentrations in the samples.
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4 .2 2 6  Sam ple preparation
In order to undertake a comparison of the glycan formation on bovine AGP the protein 
had to be partially purified from each sample. Depending on the concentration of AGP 
in the serum 2-5 ml of bovine serum was precipitated with PEG 8000 using 400mg of 
PEG per 1ml o f sample (40%w/v) then stored overnight at 4°C before being centrifuged 
at 3000g for 30 mins. The supernatant was aspirated for further purification.
The supernatant from the PEG precipitation was dialysed against 50mMTris HCl pH 7.4 
overnight at 4 C before being applied to a 5ml Mono Q column that was equilibrated 
with 2 CV of 50mM Tris HCl pH 7.4. Once sample was injected it was washed through 
the column with 2 CV of 50mM Tris HCl pH 7.4 before a continuous gradient o f buffer 
IM NaCl 50mMTrisHCl pH 7.4 was applied. The gradient used was 0-50% over 10 
CV and during this period 3 peaks eluted and were retained. The column was 
regenerated using 100%. 50mM Tris HCl IM  NaCl pH 7.4. Gel electrophoresis (SDS- 
PAGE) was carried out to determine which peak contained AGP. The middle peak after 
the initiation of the gradient was found to contain AGP so this fraction was retained and 
desalted using centricon centrifugal devices. The concentration of AGP present in each 
sample was then measured by RID.
4 .2 2 7  Lectin Blots
Following desalting the concentration of AGP was diluted appropriately to give I g/L 
solution. A lOpl of the 1 mg/ml solution was reduced in lOpl of sample buffer and lOpl 
was applied to each well of a SDS-PAGE gel and run according to the method described 
in Chapter 2 and transferred to nitrocellulose membrane (see 2.2.1.5).
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After electroblotting on to nitrocellulose, the nitrocellulose was then incubated in 0.5% 
(w/v) BSA diluted in TBS (0.15M NaCl 50mM Tris HCL pH7.5) for 30 mins at room 
temperature, the membrane was then washed twice with TBS containing 1% (v/v) 
Tween-20 (TTBS) and once with TBS containing ImM MnClz, ImM CaCli, ImM 
MgCl]. The membrane was then incubated with either 5|Lig/ml of fluorescein labelled 
Sambucus nigra lectin (SNA), lOpg/ml fluorescein labelled Maackia amurensis (MAA), 
or 25 pg/ml fluorescein labelled Concanavalin A lectins for Ihr in the dark. The 
membrane was again washed with TTBS and subsequently scanned at 580nm using a 
Storm 840 scanner (GE Health Care). To assess binding of Aleuria aurantia which was 
labelled with biotin the membrane was incubated for 1 hr with lOqg/ml of the Aleuria 
aurantia lectin and washed repeatedly with TTBS before being incubated with a 1:1000 
dilution o f fluorescein labelled Streptavidin and subsequently washed and scanned as 
above. The bands were quantified using the imaging programme called Scion Imaging, 
(http://www.scioncorp.com/^ giving a mean pixel density for each band. The mean 
pixel density was obtained by highlighting a defined area and measuring the intensity of 
the band.
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4.3 Results
4.3.1 Acute phase proteins in serum samples
The acute phase protein concentrations and SCC were measured in order to identify 
animals with mastitis so the animals could be grouped appropriately for glycan analysis. 
The acute phase protein concentrations and SCC data for the individual samples used in 
this study are given in Table 4.1 (courtesy o f Dr F Young Department o f Clinical 
Studies, Faculty of Veterinary Medicine, University of Glasgow). The samples were 
from 3 groups of cows control (no clinical signs of mastitis), mild mastitis (clots in the 
milk) and moderate mastitis (clots in milk accompanied with visible signs of 
inflammation in the udder). The mean values ± the standard error of each group is 
recorded in Table 4.2 and histograms of this data is shown in Figure 4.1. Control cows 
had a mean somatic cell count of 1183 ± 260 xlO^ cells/ml compared to 8251±2628 
xlO^ cells/ml and 10758±1477 xlO^ cells/ml for the mild and moderate mastitis groups 
respectively. Both mastitic groups had higher somatic cells when compared to the 
control group however only the moderate mastitis group had statistical significance with 
P<0.05 there was no significance difference between the mild and moderate mastitic 
subgroups (P== 0.61).
The mean AGP concentration levels o f 337±57.5, 503±90 and 619±41 |Lig/ml were 
measured for the control, mild and moderate mastitic groups respectively. Only the 
moderate group was statistically different from the control group with a P<0.05.
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C ow  N o Health status SCC
(lO Y ells/m l)
AG P (p g /m l) HP (p g /m l SA A  ( |ig /m l)
8c control 300 300 0 3.8
l ( 9 c ) control 1820 300 0 6.1
2 (10c) control 457 780 0 4
3 (12C ) control 1593 340 0 5.1
4 ( 1 3 C ) control 593 44 0 0 11
5 (1 5 C ) control 1398 150 0 5.1
6 (1 6 C ) control 2585 230 13.6 5.7
18c control 160 42 0 0 6.6
7 21C ) control 202 2 210 15 4 .9
8 (24C ) control 898 200 0 7.3
9 (11 A ) m ild 16053 49 0 67.5 15.3
1 0 (1 3 A ) m ild 400 350 0 8.6
11(14A ) m ild 9900 1000 27 .7 25.5
1 2 (1 8 A ) m ild 13900 280 33.2 13.4
13(19 A ) m ild 975 570 122 21 .7
14 (2 0 A ) m ild 1940 41 0 0 9.2
15 (2 8 A ) m ild 14590 420 173 14.4
16 (6B ) moderate 7150 640 833 5
17(9B ) m oderate 8622 540 320 15.5
18(12B ) m oderate 14428 540 638 18.9
1 9 (1 4 B ) moderate 10692 840 730 20 .4
2 0 (1 5 B ) m oderate 64 0 0 590 973 12.6
21 (1 8 B ) m oderate 17210 540 665 12.1
22 (2 4 B ) m oderate 10805 640 758 45
T ab le  4.1 T h e S C C  an d  a cu te  p h ase  p rote in  co n cen tra tio n  fo r  th e  in d iv id u a l a n im a ls  used  in th e  
stu d y  o f  g lycan  a n a ly sis
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SCC (x io r  
cells/m l)
Serum AG P  
(p g /m l)
Serum Hp 
(p g /m l)
Serum  SA A  
(pg /m l)
Control (n=8) 1183± 260 3 3 7± 57 .5 2 .8 6 ± 1 .9 5 .9 6 ± 0 .6 6
M ild m astitis (n=  7) 8 2 5 1 ± 2628 5 03± 90 138±49* 15.4±2.3*
M oderate
m astitis(n=7)
1 0758±1477* 619± 41* 7 0 2± 77*  ± 18.5±4.8*
T a b le  4 .2  T h e  m ean  ±  S ta n d a rd  erro r  (S E ) o f  th e  g ro u p s. * in d ica tes s ta tistica l s ig n ifica n ce  p < 0 .05  
c om p ared  to  co n tro ls .
Mean SAA levels of 5.96±0.66 pg/ml, 15.4±2.3 pg/ml and 18.5±4.8)ig/ml were 
recorded for control, mild and mastitic groups respectively. Both mild and moderate 
mastitic groups had statistically significant higher SAA levels with P<0.05 respectively 
there was no difference between the mastitic groups.
Mean Hp levels were 2.86±1.9 pg/ml, 138±49 pg/ml and 702±77pg/ml for control, mild 
mastitis and moderate mastitis groups respectively. As with SAA the Hp levels of mild 
and moderate mastitis groups where significantly higher than those o f the control group 
with P< 0.05. However unlike SAA, Hp concentrations in serum from the moderate 
mastitis group was statistically higher than the mild mastitis group with P< 0.05.
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4.3.2 Lectin blot analysis
A  blot of bAGP against SNA for the detection o f a2-6 sialic acid in control, mild and 
moderate mastitic groups can be seen in Figure 4.4A. The intensity of the bands from 
the animals in the mild and especially the moderate mastitic groups are visually more 
intense than those from the control group. Bovine AGP purchased from sigma was run 
alongside the samples to ensure the correct band was analysed. A similar pattern was 
seen when blotted with Con A (Figure 4.4B) however the reaction o f animals was less 
pronounced than that seen with SNA.
The individual mean pixels measured for each sample when blotted against Con A and 
SNA are shown in Table 4.3 and Table 4.4 shows the mean ± standard error o f the mean 
pixel density of each disease group. The mean pixel densities for Con A were 
calculated as 151±8.6, 195±5.2 and 199±4.4 for control, mild and moderate mastitis 
groups respectively. The density o f the AGP bands for mild and moderate mastitic 
patients when blotted with Con A being significantly higher than the control groups 
with P<0.05. However although blotted bands from samples in the moderate mastitic 
group had slightly higher pixel density values when compared the animals in the mild 
mastitic group this was not significant with P>0.05.
When bovine AGP was probed with SNA the mean pixel density where calculated as 
171±8.9, 189±4.4 and 196±8.15 for control mild and moderate mastitic groups 
respectively. Although mild mastitic samples had mean pixel densities high than the 
controls no statistical significance was found P>0.05 however samples in the moderate
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group showed significantly greater reactivity (p<0.05) with SNA than the controls. No 
significant difference was detected between the mastitic groups (p>0.05).
Bovine AGP was also probed with AAL and MAA lectin for the detection of fucose and 
a2-3 linked sialic acid. No reaction was found (Figure 4.4 C and D respectively). The 
blots contained positive controls which were run along side the bovine samples and 
showed positive reaction confirming that the procedure had worked. Human AGP was 
used as the positive control when blotting with AAL and fAGP was used as the positive 
control when blotting with MAA lectin and gave positive binding reaction with the 
respective fluorescent lectins.
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C ow  N o Health status AG P leve ls Con A  (mean  
pixels)
SN A  (m ean  
pixels)
1 (8 c ) control 300 136.03 136.46
2 (9 c ) control 300 106.36 222 .03
3 (1 0 c) control 780 123.92 158.76
4 (1 2C ) control 340 169.6 150.22
5(13C ) control 4 40 120.24 187.27
6(15C ) control 150 176.53 148.76
7 (1 6C ) control 230 175.25 na
8 18C control 420 171.64 189.77
921C ) control 2 10 153.6 162.2
10(24C ) control 200 179.43 182.4
l l ( l l A ) m ild 490 185.63 2 0 3 .9 4
12(13A ) m ild 350 2 1 0 .0 9 199.11
13(14A ) m ild 1000 198.88 182.4
14(18 A ) m ild 280 199.69 187.5
15(19a) m ild 570 198.3 170.57
16(20 A ) m ild 410 202 .15 195.26
17(28A ) m ild 420 168.34 180
18(6B ) moderate 640 183.58 195.95
19(9B ) m oderate 540 191.22 165.37
2 0 (1 2 B ) m oderate 540 205.41 199.48
2 1 (1 4 B ) m oderate 840 191.13 177.04
2 2 (1 5 B ) m oderate 590 195.93 190.25
2 3 (1 8 B ) m oderate 540 213 .28 212 .19
2 4 (2 4 B ) m oderate 640 2 1 3 .2 2 230 .39
T a b le  4 .3  T h e  m ean  p ixe l d en sity  o f  each  an im a l w h en  p ro b ed  w ith  C on A  and  SN A  lectins
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D isease group AGP pg/m l 
M ea n iS E
Con A (M PD ) 
M ea n iS E
SN A  (M PD ) 
M ea n iS E
Control 337± 57.5 151±8.6 171±8.9
M ild 503±90 195±5.2* 188±4.4
m oderate 619±41* 199±4.4* 196±8.1*
T a b le  4 .4  T h e m ean ±  SE o f  th e  m ean  p ixe l d en sity  o f  b o v in e  A G P  b a n d s w h en  p rob ed  w ith  C o n A  
an d  SN A  fo r  each  d isea se  grou p . * in d ica tes s ta tistica l s ig n ifica n ce  p < 0 .05  com p a red  to  co n tro ls
150
A210
B
200
190
180
170
160
150
165
160
155
150
% M5
c .c 140 
135 
130 
125 
120 
115
F igu re  4 ,3  H istogram  sh o w in g  m ean ±  SE va lu es for d en sity  o f  A ) SN A  B) C onA
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AC C C Mi Mi Mo Mo Mo Sigma
B
C C C C Mo Mo Mo Mo
C
50
37
Human AGP
D
75
50
37
FAGP
F igu re 4 .4  A ) A blot o f  bov in e  A G P  from  the three g ro u p in g s a g a in st SN A  B) a blot o f  b ov in e  A G P  
from  the th ree  g ro u p in g s a g a in st C on A C ) b lot o f  bovin e  A G P  sa m p les b lo tted  aga in st A A L , w ith  
hu m an  A G P  used as a p ositiv e  co n tro l D) b lot o f  bovin e  A G P  sa m p les b lotted  a g a in st M A A , w ith  
fe lin e  A G P  used as a p o sitive  con tro l. C  =  co n tro l. M i =m ild  m astitis , M o=  M o d era te  m astitis. 
Sigm a =  B ov in e  A G P  pu rch ased  form  S igm a.
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4.4 Discussion
Mastitis remains the greatest health related economical problem for dairy farmers and 
affects the farmer economically in two ways, both directly and none directly. Direct 
costs of mastitis include discarded milk, veterinary care and medication and indirect 
costs include penalties for decreased milk quality and decreased milk yield. Early 
diagnosis of mastitis is important in both economical and welfare terms as there would 
be reduced spread of disease, lower reduction in milk yield and treatment would be 
effective more quickly.
Somatic cell counts are used routinely in the diagnosis of subclinical mastitis. However 
they are less efficient in the diagnosis of clinical mastitis as the visible changes to milk 
such as clots make it difficult to measure SCC accurately via an automated system 
(Blowey & Edmondson 2000;0'Rourke 1992). The importance of SCC to the dairy 
companies can be seen from the large financial penalties that are imposed for having an 
increase in BMSCC. Therefore it is important that the farmer can take action to reduce 
the SCC. The relationship between bulk milk somatic cell counts (BMSCC) and the 
prevalence o f mastitis has been the focus of numerous studies. Holdaway et al (1996) 
reported a correlation of 0.84 (p<0.001) between BMSCC and the percentage of 
infected quarters. Consequently BMSCC have become universally adopted as a 
screening test for mastitis in herds (Holdaway, Holmes, & Steffert 1996). A EC 
directive requires bulk milk to have a total bacteria count <100,000 bacteria /ml and 
SCC <400,000 cells/ml. However BMSCC of <250,000 cells/ml is considered to be a 
realistic upper limit for UK herds with good mastitis control (Blowey & Collis 1992). 
Individual cows SCC are obviously more reliable than BMSCC at identifying increased
153
SCC levels however it is not practical to measure ICSCC regularly. Most ICSCC levels 
are obtained from experimental investigation and the level that is most often used as the 
upper limit is 100,000 cells/ml. The mean SCC count of the normal cows used in this 
study group was higher than expected and may be explained by the fact that foremilking 
was not performed during the collection of samples (Eckersall et al. 2001). Foremilking 
can be used to remove the non-mastitic bacteria from the teat canal before sampling. 
Bacteria was not isolated from the majority of the samples in the control group.
Haptoglobin is a major APP in cattle in which it has a negligible circulating level in 
blood o f normal animals (Conner et al, 1988), but increases up to 300 fold during the 
APR from a concentration of less than 0.01 g/L to reach 2-3 g/L within 48hrs of 
infection (Eckersall 1999). Heegaard et al (2000) even reported Hp levels o f up to 8- 
9mg/ml. In cattle and other ruminants, Hp has been the acute phase protein most 
commonly monitored as a marker of inflammation (Skinner, Brown, & Roberts 
1991;Wittum, et al 1996). Serum amyloid A is also a major APP in cattle with 
concentrations in serum ranging from 3.6-1 l|±g/ml in normal cows and raising rapidly 
to levels of 115p,g/ml (Eckersall et al. 2006). Alpha-1-acid glycoprotein is not a major 
APP in cattle but it falls into the moderate APP category will levels only raising 2-5 
fold.
The detection of SAA and Hp as well as high levels of AGP in serum from the mild and 
moderate mastitic groups indicate that an acute phase response was present and 
highlights the potential use of these parameters as diagnostic markers (Hirvonen, 
Pyorala, & Jousimies-Somer 1996). However although the moderate mastitis group 
tended to have higher serum concentrations of the acute phase proteins the finding that
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these where not significantly different rule out their use in the discrimination between 
the two groups. On the other hand although there were raised levels of AGP in the mild 
mastitic group statistical significance was not seen between the mild and control groups 
but was apparent when comparing the moderate and control groups suggesting that 
maybe AGP to differentiate the two categories of mastitis. However this can not be 
concluded from the present study due to small sample populations. The data is not in 
total agreement with Eckersall et al 2001 as they reported that AGP levels where 
significantly greater in mild and moderate mastitis when compared to control animals 
(Eckersall et al. 2001). The difference in the findings may be due to the fact that the 
sample population used by Eckersall et al 2001 was greater than that used in this study 
as only a random selection of samples were analysed here.
Most studies which have examined the structure o f the oligosaccharide chains of AGP 
and tracking disease associated changes within the chains have been carried using 
human AGP. Many studies in human disease have examined the extent of sialylation, 
fucosylation and branching of the glycans on AGP. The most common finding in 
human disease is the detection o f alterations in the extent of branching. In acute 
inflammatory conditions such as bacterial infection, surgery and trauma, there is an 
increase in AGP glycoforms containing bi-antennary chains (De Graaf et al. 
1993;Mackiewicz et al. 1987;Pawlowski, Mackiewicz, & Mackiewicz 1989;Pos et al. 
1990). In contrast chronic inflammatory conditions such as alcoholic liver cirrhosis and 
rheumatoid arthritis, an increased appearance of tri and tetra-antennary structures is 
observed (Elliott et al. 1997;Jezequel et al. 1988;Serbource-Goguel, Durand, Corbie, 
1986;Smith et al. 1994).
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Recently a few studies have examined the oligosaccharide chains of fAGP, and in 
particular the branching fucosylation and sialylation of the glycan chains. It was found 
that fAGP from cats suffering from FIP had decreased levels of sialic acid whilst cats 
infected with feline leukaemia virus had increased levels of sialic acid when compared 
to non diseased cats. Few studies have analysed the structure o f bovine AGP, though it 
has been reported that bovine AGP consists of multiple glycoforms as a result of having 
3 N-linked glycosylation sites (Hunter & Games 1995)and Choe et al 2000 reported that 
bovine AGP had a fourfold higher percentage of diantennary glycans chains compared 
to human AGP (Choe et al. 2000).
Nakano et al (2004) has also shown that bovine AGP has di-anntenary chains as its 
major oligosaccharide chains (Nakano et al. 2004). However hyperasialylated di- 
anntenary chains were detected, some having four sialic acid residues and even more 
surprisingly glycan chains were found with four N glycoyl neuraminic acid (NGNA) 
residues. Triantennary glycan chains were a lot less abundant than the di-anntenary 
chains however these too were hypersialylated with the occurrence of triantennary 
chains carrying five NGN A residues.
The present study investigated the structure of the glycan chains attached to bovine 
AGP in clinically healthy dairy cows as well as those suffering from mild and moderate 
mastitis.
The lectins Con A, SNA, MAA and AAL were chosen to look for changes within the 
oligosaccharide chains of bovine AGP during an acute phase response caused by the 
presence of mastitis. Con A was used to look at branching, SNA and MAA were used
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to analyse sialic acid content and AAL was used to probe for the presence of fucose 
residues. Sambucus nigra (SNA) preferentially binds a 2-6 bound sialic acid whilst 
MAA preferentially binds a 2-3 sialic acids. Nakano et al (2004) showed using mass 
spectrometry that bovine AGP contains novel sialic acid containing bi antennary chains 
composed of only n-glycoyl neuraminic acid which had not been detected in AGP from 
other species (Nakano, et al 2004). It was found here that bovine AGP reacted very 
strong with SNA indicating that the glycan chains of bovine AGP have abundant 
quantities o f a 2-6 sialic acid, however bovine AGP did not bind MAA suggesting that 
a2-3 sialic acid was not present in significant quantities on the oligosaccharide chains. 
The study carried out by Nakano et a i,  (2004) was not able to distinguish between 
positional isomers of sialic acid (Nakano, et al 2004). Examination of AGP from 
animals classified as having moderate mastitis bound significantly more of the 
fluorescently labelled SNA than control AGP indicating that more a2-6 sialic acid 
residues are present on AGP during the acute phase reaction. However animals with 
mild mastitis, although they had higher reactivity with SNA there was no significant 
difference when compared to the control animals or the moderate group. This may be 
due to the small sample groups or that the increase in a2-6 sialic acids is a gradual 
process as the severity of disease progresses.
In human disease a change in branching results in a change in sialic acid content 
because in human N linked glycan chains are almost always terminated with one sialic 
acid. Therefore an increase in branching would automatically be followed with an 
increase in sialic acid and on the other hand if  a decrease in branching was observed 
then a decrease in sialic acid would ensue. However the results here showed an 
increased reaction with Con A when mastitis was present suggests lower triantennary
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and higher diantennary chains are present, and so we would expect a decrease in 
sialylation. However in this study an increase in a2-6 sialylation was observed during 
mastitis, but it has been observed that the branches of the oligosaccharide chains 
attached to bovine AGP may have more than one sialic acid residue attached (Nakano, 
Kakehi, Tsai, & Lee 2004). It is possible that a decrease in branches and an increase in 
sialic acid could occur if the branches o f bovine AGP during an acute phase reaction 
contained increasing number of sialic acid linked by a2-6 bonds.
Although the fucose content of normal human AGP is relatively low it is commonly 
found to increase in diseases such as rheumatoid arthritis, acute inflammation and 
cancer. However fucose was not detectable on bovine AGP in control or mastitic 
samples. Human AGP was run along side bovine when probing with AAL as a positive 
control and as this was detectable in the blotted gels this would confirm that fucose was 
not present within the glycan chains of bovine AGP. Monosaccharide and 
oligosaccharide analysis with HPAEC-PAD would be a possible next step in this study.
In conclusion it was shown that the carbohydrate o f bovine AGP has increased numbers 
o f diantennary chains and increased numbers o f a 2-6 sialic acid residues expressed 
when mastitis is present.
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CHAPTER 5
S.The structural heterogeneity of bovine 
Haptoglobin in mastitis
5.1 Introduction
As outlined in Chapter 4 bovine mastitis is a major problem for farmers worldwide. 
Although bovine mastitis been investigated for many years numerous questions remain 
unanswered, one of which is, what are the changes in the components of milk and more 
specifically what changes occur in the whey proteins. The presence of blood proteins in 
the whey fraction of milk during mastitis has been widely accepted to be due to leakage 
from the blood system into the mammary gland. However in the last ten years, studies 
investigating the origin of proteins such as the acute phase proteins SAA and Hp in milk 
have shown that the mammary gland is itself capable of synthesising these proteins. In 
2001 McDonald reported that SAA present in milk was in fact a mammary associated 
isoform of SAA which is now referred to as M-SAA3 (McDonald et al. 2001). 
Therefore the aim of this investigation described in this chapter was to compare serum 
Hp with milk Hp in an effort to identify any mammary associated iso forms particularly 
related to glycan modification
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5.1.2 Milk Components
5.1.2.1 Introduction
Mastitis leads to a reduction in the useful components of milk and increases the levels 
o f undesirable elements. Overall mastitis results in a less acceptable product for the 
consumer and so the value of this mastitic milk is reduced (Hortet et al. 1999;Hortet & 
Seegers 1998;Yalcin et al. 2000). Bovine milk from a healthy gland contains 3.9% fat, 
3.3% protein, 5% lactose, and 0.7% minerals (Wong, Camirand, & Pavlath 1996). 
(Kehrli, Jr. & Shuster 1994;Lindmark-Mansson et al. 2000). Changes in milk 
composition during mastitis have been widely studied (Kitchen 1981;Watanabe et al. 
2000). The most documented change in milk observed during infection of the mammary 
gland is the increased number of somatic cells. This is accompanied by variation within 
the protein constituents of milk, including an influx o f serum proteins, such as bovine 
serum albumin (BSA) and acute phase proteins due to the increased capillary 
permeability or intra mammary synthesis of the infected gland. A substantial reduction 
in lactose and butterfat also occurs.
The changes in butterfat and lactose quantities are of great economic significance to the 
farmer as they make up the basis o f the milk price. During mastitis increased levels of 
the enzymes lipase and plasmin are produced and these breakdown milk fat and casein 
which therefore has a detrimental effect on manufacturing yield and keeping quality of 
the milk. A list o f changes seen in mastitis are outlined in Table 5.1
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Components Desirable/undesirable Effect of mastitis
Total proteins desirable Remains unchanged
Casein desirable decreases 6-18%
Lactose desirable decreases 5-20%
Butterfat desirable decreases 4-12%
Calcium desirable decreased
Phosphorus desirable decreased
Potassium desirable decreased
plasmin undesirable increased
lipase undesirable increased
immunoglobulins undesirable increased
Sodium undesirable increased
T a b le  5.1 D esira b le  and  u n d esira b le  ch a n ges seen  in th e  co m p o n en ts  o f  m ilk  w h en  th e  m am m ary  
g la n d  is in fected .
5 .1 .2 .2  L actose
The milk sugar lactose is a disaccharide o f a  or p glucose and p galactose. Glucose is 
produced by the liver and after it is transferred to the udder, a proportion of the glucose 
is converted into galactose. Then one molecule of glucose combines with one molecule 
of galactose to produce lactose by the action o f lactose synthatase. The lactose content 
o f milk varies between 3.5-5.5% (w/v). In milk lactose is free or bound into 
oligosaccharides. Milk lactose is capable o f reacting with free amino groups of 
proteins. Lactose is the main osmotic determinant o f milk therefore in order to maintain
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milk at the same osmolarity as blood, lactose concentration increases and decreases as 
the concentration of the other milk components vary (Blowey & Edmondson 2000).
5.1 .2 .3  Fat
Milk fat is formed in the udder secretory cells when fatty acids are esterified with 
glycerol and converted into the neutral fat called triacyl glycerol or triglycerides. Milk 
fat is a mixture of various fatty acid esters, the main group of which are the triglycerides 
(97-98%) (Blowey & Edmondson 2000).
5.1 .2 .4  Protein
Milk proteins include Usi, Us2 and K-caseins, P-lactoglobulin (p-LG), a-lactalbumin (a- 
LA), BSA, lactoferrin and immunoglobulins (Wong, Camirand, & Pavlath 1996).
The majority of protein in the milk is in the form of casein which is synthesised in the 
udder cells before transfer into the ducts, with approximately 80% of milk protein being 
casein and the remaining 20% being the whey proteins. Casein is a complex o f at least 
four components; a casein, p casein, y-casein and k  casein. Casein refers to that part of 
proteins that can be precipitated at pH4.6 and then separated from the whey. Casein is 
found only in milk to which it gives its white colour due to the casein complex 
reflecting light of all wavelengths. Casein occurs mainly as calcium caseinate in fresh 
milk. After precipitation of casein the supernatant is referred to as ‘whey’. P- 
lactoglobulin and a-LA are the major whey proteins found in bovine milk accounting 
for between 7-12% and 2-5% respectively of total protein content.
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Although p LG represents the major whey protein no definitive biological function has 
been described. p-Lactoglobulin is a member of the lipocalin family and shares 
similarity with retinol-binding protein which has led to suggestion of it having a role in 
transport of hydrophobic molecules (Sawyer et al. 1998). p Lactoglobulin also takes 
part in the phosphate metabolism of the mammary gland, a-lactalbumin is the second 
most abundant whey protein and is a small (Mwt 14 200), acidic (pi 4-5), Ca^^ binding 
protein, which is involved in lactose biosynthesis. It is one of two components of 
lactose synthase, which catalyses the final step in lactose biosynthesis in the lactating 
mammary gland (Permyakov & Berliner 2000).
5 .1.3 Changes in the milk components due to mastitis
5.1.3.1 Lactose
During periods o f mastitis lactose concentrations are reduced which results in increases 
in the concentration of sodium and chloride to maintain osmolarity and hence results in 
the bitter and slightly salty tasting milk often associated with mastitis ( 1995).
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5.1.3.2 Fat
Mastitic milk has increased levels of the enzyme lipase (Lin & Randolph 1977). This 
leads to degradation of the milk fat releasing fatty acids and thus results in the rancid 
flavour associated with mastitic milk. Increased levels of fatty acids can inhibit starter 
culture in cheese and yogurt manufacture so these industries need to use milk from 
cows which do not have mastitis.
5.1.3.3  E nzym es
Many indigenous enzymes increase in milk during bovine mastitis. Enzymes that are 
involved in the synthesis of milk decrease and enzymes related to inflammation are 
increased. Enzymes such as N-acetyl-p-D-glucosamindase (NAGase) which originate 
from phagocytes (i.e. the somatic cells) are increased exponentially while enzymes that 
originate in the blood such as plasminogen are also increased. The use of NAGase 
activity in the detection of mastitis has been investigated and found in many studies to 
reliably detect intramammary infection (Kitchen 1981;Mattila & Sandholm 1986) and 
to reflect the degree of inflammation (Mattila, Pyorala, & Sandholm 1986). The blood 
enzyme plasminogen is also increased in mastitic milk most likely due to leakage from 
the blood. It is then locally activated to plasmin, a proteolytic enzyme capable of 
degrading fibrin and caseins (Kaartinen & Sandholm 1987).
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5.1.3.2 Protein
Casein concentrations in bovine milk can drop by up to 18% during periods o f mastitis 
and the concentration of whey proteins are also decreased in mastitic milk, p- 
Lactoglobulin and a-LA can drop by more than 70% of their normal level during 
mastitis. The decomposition of the casein fraction is due to increased proteolytic 
activity rather than decreased synthesis. Unlike caseins however the major whey 
proteins are relatively resistant to proteolytic attack. Their reduction could be due in part 
to impaired cellular synthetic and secretory function, but is more likely due to leakage 
o f these proteins out of the milk and into the extracellular fluid (Auldist & Hubble
1998). This theory is supported in a study which reported elevated concentrations of a- 
LA in the blood of cows with increased SCC (Mcfadden, Akers, & Capuco 1988).
However as the concentration of milk proteins such as the caseins and whey proteins are 
decreased during mastitis increased levels of serum proteins are observed in the milk at 
the same time therefore total protein content may remain unchanged. However the milk 
is o f lower quality especially for cheese and yogurt manufacturers as the coagulation of 
casein is important as the starting process in the manufacture of these dairy products 
(Blowey & Edmondson 2000;Lindmark-Mansson et al. 2000;Verdier-Metz, Coulon, & 
Pradel 2001).
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5 .1.4 Acute ptiase proteins in milk
It is known that intramammary infection results in increased permeability of the blood 
mammary barrier. Many serum proteins have been measured in milk including 
albumin, alpha-1 antitrypsin (Sandholm & Mattila 1985), haptoglobin (Eckersall et al. 
2001 h), CRP (Hamann et al. 1997), and M-SAA3 (Eckersall et al. 2001). However 
recent work has focused on the major acute phase proteins Hp and M-SAA3 because 
they are not usually present in the serum or the milk from healthy cows.
The use of measuring the concentration of APPs such as Hp and M-SAA3 in milk as 
biomarkers for the earlier diagnosis of mastitis was suggested by Eckersall et a l, (2001) 
and Pedersen et a l,  (2003) (Eckersall et al. 2001;Pedersen et al. 2003).
Following the initial reports o f APP in mastitic milk the potential for APPs in the 
diagnosis of mastitis was quickly recognised and numerous studies have examined the 
APP response in naturally and experimentally induced clinical and subclinical mastitis. 
Eckersall et al 2001 reported that SAA and Hp were present in the milk from naturally 
occurring cases of clinical mastitis. In this study determination of the diagnostic values 
of APPs in differentiating between healthy and mastitic cows gave sensitivities and 
specificities for milk Hp 86% and 100% respectively and 93% and 100% respectively 
for milk SAA. The SAA levels correlated with severity of disease as they were able to 
differentiate between mild (clots in milk) and moderate (clots accompanied by visible 
signs of inflammation in the udder) mastitis.
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Pedersen et al 2003 reported elevated levels o f Hp and M-SAA3 levels in milk when 
cows where experimentally infected with S. uberis. Increased levels of SAA were 
detectable in both milk and serum 6hrs and 11 hrs post inoculation respectively whereas 
increased levels of Hp where detected after 1 Oh of infection in serum only. These 
observations support the potential role of milk APPs as good early indicators of 
mastitis. The finding that M-SAA3 and Hp levels in milk were elevated without 
elevation of serum concentrations suggested that not all APPs in milk are a result o f 
leakage from the blood system and may in fact be secreted more locally. A similar 
result was also reported by Hiss et al 2004 who showed that increased Hp levels in the 
milk were detectable 3 hrs post inoculation with LPS whereas changes in the 
concentration of Hp in the blood was not evident until 9 hrs post-inoculation (Hiss et al. 
2004). Eckersall et al 2006 also reported that increased levels of Hp and SAA where 
detectable before increased levels in milk (Eckersall et al. 2006). These results have 
lead to the hypothesis that the Hp present is milk is not simply due to leakage from the 
blood but that cells within the mammary gland are synthesising and secreting Hp.
Most studies examining the levels of APPs in bovine mastitis have focused on 
individual cows milk. More recently Akerstedt et al 2006 reported that Hp and SAA 
are detectable at quarter, cow and bulk tank levels (Akerstedt et al. 2006). Significant 
relationships were found between HP, SAA and SCC at quarter and cow levels however 
only between SAA and SCC at the bulk tank milk level.
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5.1.4 Extra hepatic expression of Hp
The principal site of haptoglobin synthesis is the liver (Urieli-Shoval et al. 1998) 
however extra hepatic expression has been reported for many species. In addition to the 
liver, Hp has been found to be synthesised in the lung (Yang et al. 1995), adipocytes 
(Friedrichs et al. 1995) endometriotic tissue (Sharpe-Timms et al. 1998;Sharpe-Timms 
et al. 2000a) the uterus (Hoffman et al. 1996) as well as the mammary gland of cows 
(Eckersall et al. 2001).
The finding that Hp levels in milk were increased before increases were evident in 
serum prompted Hiss et al 2004 to examine the expression of Hp mRNA from different 
regions of the mammary gland as well as liver using RT-PCR. Haptoglobin mRNA 
transcripts where detected by RT-PCR in RNA extracts from the teat, the cisternal 
region, the glandular parenchyma as well as the liver and Hp mRNA was upregulated 
following inoculation with LPS. Further support for mammary gland expression of 
APP’s was provided by Eckersall et al 2006 who reported increased expression of 
mRNA for SAA and Hp in both liver and mammary tissue 48h after infusion with S. 
aureus.
Yang et al (1995) investigated the presence of Hp mRNA in lung epithelium. This 
group reported results from an in vivo experiment in which an APR was stimulated in 
mice by treatment with lipopolysaccarride (LPS). Thirty hours after induction of 
inflammation with LPS, a four-fold increase in Hp mRNA was observed in the lung and 
was equivalent to the level observed in the normal unstimulated liver. In situ 
hybridization was used to investigate the cellular location of Hp mRNA expression. A
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strong signal for Hp mRNA was found on epithelial cells, while no significant signal 
was found in endothelium, smooth muscle cells, alveolar epithelium or macrophages. It 
was therefore concluded from this experiment, that Hp is synthesized by the respiratory 
epithelium.
Another similar in vivo experiment examined the response o f mouse adipose tissue 
subjected to LPS in order to induce inflammation, and demonstrated a significant 
increase in Hp mRNA. Thirty hours after LPS injection, a six-fold increase in Hp 
mRNA was seen in the adipose tissue. In situ hybridization confirmed that the Hp 
expression within adipose tissue was confined to adipocytes (Friedrichs, 
Navarij oashbaugh, Bowman, & Yang 1995). These findings suggest that adipose tissue 
may contribute to the presence of Hp in extravascular body fluids as well as in the 
serum.
Piva and Sharpe-Timms, (1999) showed that Endo-1 a unique glycoprotein that had 
previously been shown by the group to be synthesised and secreted by rat and human 
endometrial explants shared 99.4% homology with human Hp (Piva & Sharpe-Timms 
1999). Subsequently Sharpe-Timms et al (2000) looked at the expression and protein 
localization of endometrial haptoglobin using in-situ hybridisation and 
immunohistochemistry in endometriotic lesions (Sharpe-Timms et al. 2000;Sharpe- 
Timms et al. 2002). It was reported that Hp mRNA and protein were observed in the 
functionalis zone of endometrial stroma and the stroma of endometriotic lesions.
Ping et al 2005 reported that skin cells can synthesis and secrete haptoglobin. Using in 
situ hybridization it was shown that Hp mRNA was expressed in the epidermal
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kératinocytes, the epithelial cells of hair follicles and sebaceous glands of normal skin 
and various skin complaints. However using immunohistochemistry with antisera to Hp 
protein only stained positively in epidermal kératinocytes o f patients with inflammatory 
skin disorders such as psoriasis and erythroderma.
5.1.5 Extra Hepatic glycoforms of Hp
Following the research outlined above it is clear that Hp is not only synthesised by the 
liver but can be synthesised by many different cell types. It is apparent that 
extrahepatically expressed Hp differs from hepatically expressed Hp with most 
documented differences being due to differences within the carbohydrate moiety o f Hp. 
A study looking at human endometrial form of Hp with comparison to the hepatic form 
reported that Hp secreted by the endometrial tissue had an analogous nucleotide 
sequence to hepatic haptoglobin but was 3kDa smaller than hepatic Hp (Piva et al 
2002). Enzyme digestion carried out with recombinant flavobacterium 
meningosepticum N-glycase, which cleaves intact N-glycan chains from glycoproteins, 
resulted in both Hp isoforms appearing at 27kDa when analysed on a SDS-PAGE gel. 
Therefore it was concluded that the 3kDA weight difference between hepatic Hp and 
endometrial Hp was due to differences within the carbohydrate moiety with the 
suggestion that endometrial Hp carries one less glycan chain than hepatic Hp.
A study in rabbits looking at local production of haptoglobin following arterial balloon 
dilation reported that locally produced haptoglobin consisted of a unique set of 
glycoforms compared to haptoglobin synthesised by the liver. It was shovm that aterial
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Hp had a lower pi values than the hepatic Hp with the former having a pi at 4.5 and 
hepatic Hp being around pi at pH 5.5. It was also shown that arterial Hp had terminal 
mannose and fucose residues present whereas hepatic Hp did not have these residues 
present (Smeets et al 2003).
Mastitis is a major economical problem for farmers worldwide and research into this 
disease has been extensive. It has been known for many years that acute phase proteins 
are present in the milk, though it was originally thought that serum proteins such as the 
acute phase proteins where present in the milk due to leakage from the blood system. 
However more recently it was shown that the mammary gland itself has the ability to 
synthesis acute phase proteins such as Hp and SAA. The objective of this study was to 
determine if the glycosylation of mammary gland Hp is the same as hepatic Hp.
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5.2 Materials and methods
5.2.1 Materials
All reagents were purchased form BioRad (Hemel-Hempstead, UK) unless otherwise 
stated.
5.2.1.1 S am ples
Bovine serum haptoglobin was purchased from Life Diagnostics (USA). Milk 
haptoglobin was isolated from a pool of mastitic milk supplied by the Acute Phase 
Protein lab run by Professor Eckersall which had APP’s concentrations previously 
measured and with Hp > lOpg/ml
5.2.1.2 Isolation of HP from milk
Bovine hemoglobin agarose, guanadinium hydrochloride, phosphate, were purchased 
from Sigma Aldrich.
A Beckman model J2-21 centrifuge was used to separate the whey fraction. The Akta 
Fast Protein liquid chromatography system used to run the bovine haemoglobin affinity
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column and was purchased from Amersham Pharmacia Biotech (Buckinghamshire, UK) 
and controlled by a Compaq deskpro EN, which runs Unicom version 4 software.
5.2.1.3  SDS-PAGE/W estern blots
Criterion XT 4-12% precast gels, XT Mes running buffer, immunoblot PVDF 
membrane, extra thick criterion size blotting paper, 4-CN substrate. Sheep anti bovine 
haptoglobin was supplied by Life Diagnostics (USA) methanol was supplied by BDH. 
SDS-PAGE and western blots were carried in a criterion system supplied by BioRad 
(Hemel-Hempstead, UK)
5.2.2 Methods
5.2.2.1 SDS-PAGEAA/estern blot
SDS-PAGE was carried out using a 4-12% bis tris precast Criterion gel in the Criterion 
electrophoresis buffer tank. The gel was run using XT ( 2-N-Mopholino ethanesulfonic 
acid) MES buffer. Protein (5-lOpg) in 5-lOpl aliquots was added to equal volumes of 
sample buffer containing mercaptoethanol and heated at 95 °C before loading lOpl of 
the mixture to each well of gel. A protein plus prelabelled molecular weight marker 
was run along side samples in order to estimate the molecular weight. Separation o f the 
protein in the gels was achieved at 200V for 45-60 mins. Following separation the 
proteins were transferred to PVDF membrane which had previously been submerged in
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methanol. The transfer was carried out at lOOV for 1 h in transfer buffer. The 
membrane was then blocked with 10% dried milk (marvel) in Tris buffered saline buffer 
pH7.4 with 1% tween (TTBS) for 30 mins. Haptoglobin was then detected by 
incubation in a 1:1000 dilution of Life diagnostic anti-bovine Hp followed by 
incubation with a horse radish peroxidase labelled antibody to sheep IgG (1:1000 in 
TBS) and was then detected using a 4 CN substrate for peroxidase visibility. The 
membrane was washed 3X in TTBS for 5 mins between each step to remove excess 
reagents.
5. 2.22 Isolation of HP from milk
Pooled mastitic milk was centrifuged at 50,000 g at 4°C for 30 mins to remove cells and 
lipid. The infranatant was carefully aspirated and then applied to a 1ml haemoglobin 
affinity column equilibrated with PBS and the unbound proteins were washed through 
with approximately 10 CV of PBS or until the absorbance returned to baseline levels. 
Haptoglobin was eluted using 100% 4M GnHCl then the buffer was exchanged with 
phosphate buffer saline pH 7.4 using centricon centrifugal devices. Isolation o f Hp was 
confirmed by SDS-PAGE and western blotting.
5. 2.23 Lectin blots
Lectin blots were carried out according to the method outline in section 4.2.2.7, with the 
modification that electroblotting was carried out in a Criterion system using PVDF 
membrane, which was soaked in methanol before the transfer.
174
5.2.2.4 P N G ase  F treated
Bovine Hp (lOOpg) from serum and milk was digested with 100 units PNGase F (EC 
number 3.5.1.52) according to the method outline from the supplier in order to cleave 
the N-linked chains attached to the polypeptide backbone as described in section 
3.2.2.3.
5 .2 .2.5 MALDI-TOF Analysis
The protein band o f interest was excised from the gel after staining by Coomassie blue 
staining and transferred to the proteomics unit o f the University of Glasgow, (Dr R 
Burchmore) in the Sir Henry Wellcome Functional Genomic Facility, where the protein 
was digested with trypsin and analysed by matrix assisted laser desorption/ionisation­
time of flight (MALDI-TOF). The peptide mass fingerprint, obtained by MS was 
subjected to search by pasting the peptide masses into a protein database (MASCOT, 
Matrix Science), which uses a probability-based scoring system to define a significant 
match.
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5.3 Results
5.3.1 Immunoblotting of Hp
Comparison of the blot o f mastitic milk and serum from the same cow (Figure 5.1), with 
antisera to bHp showed 3 bands at 40kDa. 37kDa and 18kDa in mastitic milk whilst 
only the 37kDa and 18kDa bands were detectable in the serum.
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Figure  5.1 W estern  blot o f  serum  and milk from the sam e co w  prob in g  for the presence  o f  bovine  
h aptoglob in .  Lane I sh o w s  the precision plus m olecu lar  w e ight  m arker  lane 2 serum  and lane 3 
m ilk  from the sa m e  cow.
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5. 3.2 Isolation o f  Hp
In order to examine the carbohydrate moiety of milk haptoglobin it was first isolated 
using an affinity column of immobilised haemoglobin. Haptoglobin was initially 
retained on the column while fraction 3 shown in the FPLC trace in Figure 5.2 was 
found to be the haptoglobin containing fraction. Identification of the Hp containing 
fraction was carried out by SDS-PAGE and also confirmed by proteomic analysis by 
tryptic digest, MS and fragment fingerprinting (Figure 5.3 (37kDa band) + Figure 5.4 
(40kDa band)).
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Figure  5.2 A rep resen ta t ive  ch ro m a to g ra m  for the purification  o f  haptoglob in  from milk. T he  
(p ink )  line represents  the  e lution buffer.
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5.3.3 Effect of PNGase F digestion
In order to identify if the difference between the pHp chain of the milk and its serum 
counterpart is due to the amino acid or the carbohydrate moiety, oligosaccharide chains 
where cleaved from the polypeptide backbone using PNGase F. The polypeptide 
backbone was then run out on an SDS-PAGE gel in order to see the effect on the milk 
Hp. As seen in Figure 5.5A that milk haptoglobin (lane 3) has major bands at 37kDa 
and 18kDa while in serum multiple bands were seen when Coomassie blue stained. 
However following enzyme digestion serum and milk haptoglobin has a p chain 
molecular weight of approximately 30kDa. The bands seen at approximately 35kDa 
represent the PNGase F and the band seen at 37kDa in the serum is probably due to 
incomplete cleavage. The band at 18kDa in both is the a  Hp chain.
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Figure 5.5 A) S D S -P A G E  o f  isolated bov ine haptoglob in  from  serum  in lane 2 and bov ine  
haptoglob in  present  in m ilk in lane 3. B) sh ow s the S D S -P A G E  o f  bovine  serum  and m ilk  
haptoglob in  fo l low in g  en zy m e  digest ion  with P N G ase  F.
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5.3.4 Lectin binding of bovine Hp
The carbohydrate moiety of the pHp bands found in milk and serum were examined 
using lectins following western blotting (Figure 5.6). Figure 5.6A shows bovine 
haptoglobin from serum and milk which was probed with Con A for oligosaccharide 
branching (diantennary) examination and both milk and serum reacted strongly with 
Con A but only the lower (Mwt 37kDa) band o f milk pHp gave a reaction and the upper 
band of the doublet did not react with Con A. When bovine Hp from serum and milk 
was probed with SNA (Figure 5.6B) for the presence of a2-6 linked SA it was shown 
that both milk and serum bovine Hp reacted with SNA however it was also shown that 
that the 40kDa and 37kDa bands o f milk reacted with SNA. When bovine Hp was 
probed for the presence of fucose using AAL it was found that only the 40kDa band of 
milk Hp reacted with AAL see Figure 5.6C lane 2. Bovine Hp from milk and serum 
was also examined for the presence of a2-3 linked SA by MAA lectin however no 
reaction was seen.
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F igure  5.6 S h o w s the f luorescent  lectin blots o f  milk Hp versus serum  haptoglob in  from co w s A)  
a ga inst  Con A B) aga inst  SN A  C) against  AA L. T ra ck  1 IVlwt, T r a ck  2 m ilk Hp, T rack  3 Serum  Hp.
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5.4 Discussion
It has been extensively reported that Hp is a major acute phase protein in cattle 
(Eckersall 1995;Gruys, Obwolo, & Toussaint 1994;Schroedl et al. 2001). Until recently 
most studies looking at the concentration of bovine Hp in various disease conditions 
such as mastitis have focused on serum levels o f the protein (Conner et al. 1986;Conner 
et al. 1989;Hirvonen, Pyorala, & Jousimies-Somer 1996;Horadagoda et al. 
1999;Makimura & Suzuki 1982) however the discovery of Hp in milk (Eckersall, et a\
2001) means that a number of studies have recently focused on the levels present in 
milk. It was initially thought that the presence of serum proteins in the milk wholly 
originated from the blood and had simply leaked into the milk through a disrupted blood 
mammary barrier. However McDonald et al (2001) reported a mammary associated 
form o f SAA that was produced by mammary epithelial and was the SAA3 isoform. It 
has been reported that mammary associated SAA3 differs from hepatic SAA sharing 
only 80%similarity (McDonald et al. 2001).
Although Hp is present in milk during mastitis it remains unclear whether or not the Hp 
isoform in the milk is a mammary associated isoform of Hp that differs from Hp 
synthesized by the liver. For this reason milk and serum from a dairy cow with mastitis 
was probed for the presence of haptoglobin by western blotting with a polyclonal 
antibody to bovine haptoglobin. It was found that milk had three haptoglobin bands 
compared to two in serum. The a subunit showed no difference in Mwt between serum 
and milk. The extra band in milk creates a doublet at 37kDa and 40kDa whereas in 
serum only the band at 37kDa was present. The lower band of the doublet corresponds
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with p subunit band seen in serum. The novel band of the doublet seen in the milk 
could be due to de novo synthesis of Hp in the mammary gland. As the new band is a 
higher Mwt than the beta subunit o f serum, it is unlikely to be due to secretion 
modification as this would mostly likely lead to a lower Mwt due to deglycosylation. 
The presence of the second band of pHp could be explained as being the product of 
intra mammary synthesis (Eckersall, Young, McComb, Hogarth, Safi, Weber, 
McDonald, Nolan, & Fitzpatrick 2001a;Hiss et al. 2004). A remaining question is 
whether the mammary produces both the 37kDa and 40kDa isoforms detected in the 
milk or whether the 40kDa isoform is the sole produce o f the milk and the 37kDa form 
is a serum protein leaking from the circulation. However before this can be addressed it 
is important to verify that the 40kDa band is indeed Hp and identify the cause of the 
increase in size. To undertake this task, Hp had to be purified from mastitic milk and 
serum to allow analysis to proceed.
Haptoglobin has been isolated from the sera o f many species using many different 
approaches however many procedures have involved multiple steps. To date no one has 
published data outlining a method for the isolation ofHp from bovine milk.
Morimatsu et al, (1991) isolated bovine haptoglobin from sera by initially fractionating 
using ammonium sulphate followed by a complexed 3 step chromatography procedure 
making it time consuming and impractical (Morimatsu et al. 1991). Yang and Mao, 
1999 isolated porcine haptoglobin using a novel HPLC chromatography procedure 
using superose 12 gel permeation chromatography. An ammonium sulphate 
fractionation step was required before chromatography was carried out (Yang & Mao
1999). Haptoglobin was isolated from human plasma by Liau et al 2003, isolated 
haemoglobin from human blood was coupled to CNBr-activated sepharose-4b. Human
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plasma was then passed through the column with PBS. The haptoglobin remained 
bound to the hemoglobin column and was then eluted with 5M urea (Liau et al. 2003).
In the same year Hiss et al 2003 reported isolation of porcine haptoglobin from sera 
using a haemoglobin affinity column followed by gel filtration (Hiss et al. 2003) which 
was then repeated for the isolation of Hp from bovine sera (Hiss et al. 2004a).
In this study haptoglobin was isolated from bovine milk using a method similar to that 
used by Liau et al 2003 with the difference that in this method Guanadinium HCl was 
used to elute the haptoglobin rather than urea (Liau, Chang, Pan, Chen, & Mao 2003). 
Haptoglobin is however only present in cattle when an acute phase response is present 
therefore haptoglobin had to be isolated from milk from cows with mastitis rather than 
from healthy cows but such milk often has large clots making it incompatible with 
chromatography. Hence the centrifugal step before application to the FPLC system. 
The method of isolation used in this study was very effective and relatively simple 
having only two steps. The method enhanced the purity o f milk HP sufficiently from 
characterisation of the glycan component. However as the haemoglobin agarose started 
to near its shelf life, haemoglobin was also found in the haptoglobin containing fraction. 
Although the novel 40kDa isoform of Hp, seen in mastitic milk was identified by 
reaction with antisera to bovine Hp, there could be a possibility that the commercial 
antisera used was cross reacting with other proteins in milk. The identity of the upper 
band (40kDa) was verified by MALDl-TOF which showed that both bands of the 
doublet were indeed Hp.
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Enzymatic digestions and lectin binding blots were performed to determine if the 
difference in the Mwt of the novel (3 subunit is due to carbohydrate content or the 
polypeptide backbone and secondly to identify any differences between the 
carbohydrate moiety of bovine serum Hp and bovine milk Hp, which may provide 
insight to milk Hp functions.
The p chains o f human hepatic Hp each have four Asn-X-Ser/Thr sequons (Asn 23, Asn 
46, AsnSO, and Asn 80) all o f which may be occupied by N-linked glycan chains 
(Kurosky et al 1980: Black et al 1970). The carbohydrate content of hepatic Hp is 
approximately 20% of p chain mass (Black & Dixon 1970) and is found external to the 
protein, exclusively as N-linked, complex oligosaccharides chains (Kurosky et al. 
1980d;Tumer 1992) Digestion of bovine serum Hp and milk Hp using PNGase F to 
cleave the N-linked glycans from the polypeptide backbone revealed that the protein 
core of both the 37 and 40 kDa forms of pHp have a similar size of 30kDa and that 
approximately 20% of the 37kDa form of pHps and 25% of the 40kDa form of pHp was 
accountable to N-linked glycan chains. Therefore the size difference seen between the 
two p chains of milk Hp is due to differences within the carbohydrate chain. This is not 
unexpected as studies o f hepatically and extra hepatically expressed Hp have identified 
differences that are due to the carbohydrate moiety rather than the polypeptide backbone 
(Piva, Moreno, & Sharpe-Timms 2002).
Possible differences between the glycoforms of milk and serum Hp were examined by 
probing with the lectins SNA, Con A and AAL which are used for the detection of a2-6 
SA, diantennary branching and Fuc residues respectively. From the study it was shown 
that both bands of the milk p chain and the serum p chain had a 2-6 linked sialic acid
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present on their glycan chains as shown by binding with SNA. Only the 37kDa pHp in 
milk and serum reacted with Con A while the 40kDa pHp in milk had no reaction with 
this lectin suggesting the glycan chains attached to this p chain isoform are more highly 
branched than diantennary chains with perhaps three or four branches. This would 
account for the molecular weight difference between the two forms o f P chain seen in 
milk and is a novel glycosylation as Hp o f various species studied to date have been 
shown to have diantennary N-linked glycan chains. For instance HPLC analysis of 
glycans derived from immunopurified human Hp revealed the presence of diantennary 
complex glycans in a neutral, monosialylated and bisialylated forms and lower amounts 
of triantennary complex glycans that were present in disialylated and trisialylated forms. 
About 75% of charged Hp glycans were of diantennary complex structure some with 
one terminal sialic acid missing. Triantennary structures made up 25% and highly 
branched glycan pools did not exceed 1%. (Ferens-Sieczkowska & Olczak 2001).
The novel milk Hp isoform had fucose residues present within the glycan chains 
whereas serum Hp appeared to have no Fuc residues present as the latter had no reaction 
with AAL. Increased fucosylation is a common finding in disease states. This can be 
used to differentiate different diseases for example fucosylated Hp is useful for 
discriminating between active and inactive RA as 94% of patients with active RA have 
high fucose content on Hp versus 5% of inactive RA (Thompson et al. 1993;Thompson, 
Stappenbeck, & Turner 1989). Fucosylated Hp has also shown potential as a prognostic 
marker as it can be used to monitor disease activity in cancer. Levels of abnormally 
fucosylated forms Hp have been measured in blood specimens from women with 
carcinoma of the ovary or breast that are undergoing chemotherapy. The levels of 
fucosylated Hp increased if  the women had progressive disease and decreased if  they 
showed complete response to therapy (Thompson, Dargan, & Turner 1992a).
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In conclusion Hp in milk comprises two distinct forms a serum derived form and a 
mammary derived form. The mammary derived isoform of Hp has more highly 
branched glycoforms than serum Hp that carries a2-6 linked SA and Fuc residues.
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CHAPTER 6
6.Comparative investigation of the 
glycosylation of AGP
6.1 Introduction
Alpha-1-acid glycoprotein has been identified in the serum of all mammalian species 
studied to date including pig, cow, sheep, horse, dog, cat, rat, mouse and man. It has 
been shown that AGP from all of these species is heavily glycosylated with 3-6 N- 
linked glycans attached (Alava et al. 1997;Duthie et al. 1997f;Hunter & Games 
1995;Matsunaga, Sadakane, & Haginaka 2004;Pocacqua, Provasi, Paltrinieri, Gelain, 
Comunian, & Ceciliani 2005;Taira et al. 1992;Yoshima et al. 1981) Alpha-1-acid 
glycoprotein has been recognized as an important drug binding protein in chickens, 
dogs and cows as well as humans (Matsumoto et al. 2002;Sadakane et al. 2002). 
Alpha-1-acid glycosylation is often grouped as an immunocalin due to its 
immunomodulatory activities which have been discussed at length in chapter 1 with 
regards to human AGP. Very little work has been carried in the veterinary science field 
to identify the functional role of AGP in other species.
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The drug binding capabilities of AGP and the binding site of human AGP have been 
well characterised. It is now widely accepted that AGP is an important drug binding 
protein in the serum as it binds both endogenous and exogenous ligands. Some research 
has also been carried out on this topic in the other species. Matsumoto et a l, 2002 
carried out an experiment in order to examine the differences between the drug binding 
capabilities of bovine and canine AGP compared to human AGP. They reported that 
human AGP was capable o f binding basic and acidic ligands as well as steroid 
hormones whereas both bovine and canine AGP were only able to bind basic ligands 
and steroid hormones (Matsumoto, Sukimoto, Nishi, Maruyama, Suenaga, & Otagiri
2002). Son et a/.,(1998) also reported species specific differences in the binding of 
cow, dog, sheep and human AGP to lincomycin and clindamycin (Son et a l  1998).
Though many studies have reported immunomodulatory activities attributed to human 
AGP, recently bovine AGP has been studied by Ceciliani ei a l, (2007) who reported 
that bovine AGP was capable of inhibiting monocyte apoptosis. It was also shown that 
the inhibitor effect of bovine AGP on monocyte apoptosis was not only dependant on 
plasma concentration but also on the presence of sialic acid on the glycan chains 
attached to bovine AGP (Ceciliani et a l  2007).
A few studies have examined the glycan chains attached to AGP from various species. 
Kuster et a l, (1998) used an in gel digestion followed by MALDI MS to characterise 
the glycan chains attached to AGP from man, cow, sheep and dog. Major species 
specific variations in glycan moiety were reported. Cow, sheep, and dog were reported 
to have predominantly diantennary glycans within the carbohydrate moiety whereas 
human AGP had triantennary chains as a major glycan type. Alpha-1-acid glycoprotein
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from human and bovine was shown to express fucose residue and bovine and ovine 
AGP was reported to express NGN A and NANA.
Another study carried out by Nakano et a/.,(2004) investigated the glycan chains of 
AGP from human, bovine, ovine and rat AGP using MALDI-TOF. It was reported that 
all species showed distinctive variation with the glycan chains from AGP (Nakano, 
Kakehi, Tsai, & Lee 2004), Human AGP was reported to carry di-tri and tetraantennary 
carbohydrate some of which had a fucose residue substituted which was part of the 
SLeX epitope. It was reported that the most abundant glycan types attached to sheep 
AGP were mono and disialylated diantennary chains, however the presence of tri and 
tetra antennary chains were detectable but were minor. Unlike human AGP sheep AGP 
had both NGNA and NANA within its glycan chains. Nakano reported that bovine 
AGP carried predominantly diantennary chains though some o f the diantennary chains 
of bovine AGP were carrying three and four sialic acid residues and NGNA was the 
predominant sialic acid within the glycan chains.
It has been shown that biological functions of glycoproteins are dependant on the glycan 
chains attached to the protein. Therefore in order to truly understanding the biological 
function of a glycoprotein the structure of the glycan chains must be considered. 
Therefore it was the aim of this study to analyse the glycan chains attached to species 
such as cows, cats, and sheep and compare them to the more extensively studied human 
AGP.
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6.2 Materials and methods
6.2.1 Materials
6.2.1.1 S am ples
Feline AGP was isolated from ascitic fluid from cat 10 (section 2.3.1) kindly provided 
by Dr D Addie. Human, bovine and ovine AGP were purchased from Sigma (Poole, 
UK).
6 .2 .1 .2  M onosaccharide and oligosaccharide analysis
All reagents and suppliers are listed in section 3.2.1.2 for monosaccharide analysis and 
section 3.2.1.3 for oligosaccharide analysis.
6.2 .1 .3  Sialic acid analysis
N acetyl neuraminic acid and N glycoyl neuraminic acid were supplied by Sigma 
(Poole, UK)
Sodium hydroxide (NaOH) 50% (w/v) was purchased from BDH (Poole, UK) and the 
HPLC grade water was obtained from Rathbum (Walkerbum, UK).
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Neuraminidase (EC number 3.2.1.18) and buffers were supplied by New England 
Biolabs (Herts, UK). Ethanol was supplied by university stores.
Sialic acid analysis was carried out on a Dionex (California, USA) DX-500 High pH 
anion exchange chromatography system using pulsed amperometric detection (HPAEC- 
PAD), which utilizes a GP40 gradient pump and an ED 40 electrochemical detector 
controlled by a desktop computer running Peaknet software. Separation was carried out 
on a Carbopac-100 ™ column and guard column (250x4mm and 50x4mm respectively) 
purchased from Dionex (California, USA)
6.2 .1 .4  Isoelectric focusing
Clean lEF gel, Pharmalyte 2.5-5, Broad pi protein marker. Low pi protein marker, 
Ampholine PAg plate pH 3.5-9.5 Coomassie blue Tablets and electrode strips were 
purchased from GE healthcare (Buckinghamshire, UK). Orthophosphoric acid was 
supplied by Sigma (Poole, UK). Sodium hydroxide, acetic acid, urea and glycerol 
were purchased from BDH (Poole, UK).
Isoelectric focusing was performed using a LKB Ultrophor electrofocusing unit GE 
healthcare, (Buckinghamshire, UK) powered by a Consort E815 electrophoresis power 
supply from Sigma (Poole, UK).
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6.2.1.5SDS-PAGE
All reagents and suppliers are listed in section 2.2.1.3.
6.2.2 Methods
6.2.2.1 M onosaccharide and O ligosaccharide analysis
See section 3.2.2 for a detailed outline of the methods used to analyse the 
monosaccharides and oligosaccharides. Human, bovine and ovine AGP (lOOpg) and 
fAGP (66pg) was hydrolyzed by TFA and HCl prior to monosaccharide analysis, while 
lOOpg of human, bovine and ovine AGP and 50pg of fAGP were digested with PNGase 
F prior to oligosaccharide analysis.
6. 2.22 Sialic acid analysis
Human, bovine and ovine AGP (lOOpg) and 50pg of fAGP were digested with 100 
units o f neuraminidase in buffer supplied by the manufacturer in a total volume o f 20pl 
overnight at 36°C before being precipitated with 500pl ice cold ethanol. Ethanol 
precipitation was carried out as was detailed in section 3.2.2. The supernatant from the 
ethanol precipitation was removed and dried under vacuum using a centrifugal 
evaporator (Jouan) and reconstituted in 25pi of HPLC grade water and then injected on
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to the HPAEC-PAD system. The precipitant from the ethanol precipitation was 
retained for further analysis
6. 2.23 SD S-PAG E
See chapter 2 for detailed description of method (section 2.2.1.5)
6. 2.24 Lectin blots
Lectin blots were carried as described in section 4.2.2.7 with lOpg of AGP from each 
species being analysed.
6. 2.25 Isoelectric focusing
Isoelectric focusing was carried out using preformed polyacrylamide gels (clean lEF 
gel) on plastic backing rehydrated overnight with 7.5% v/v pharmalyte pH 2.5-5 or a 
preprepared ampholine PAg plate pH 3,5-9.5. Electrode strips were soaked with IM 
phosphoric acid and IM NaOH and placed overlying the gel at the anode and cathode 
side o f the gel respectively. Prefocusing was carried out at 650V, 30mA, 14 W for 20 
mins before samples were applied. Samples were applied 1 cm from the cathode end of 
the gel using sample application strips and focusing was carried out at 1200V, 25mA, 
lo w  for 2hrs 30mins to 3 hrs 30 mins dependant on sample composition. The gel was 
then fixed using a fixing solution made up of 2.9% (w/v) trichloroacetic acid and 0.85 
% (w/v) sulphosalicylic acid for 30-45 mins. The gel was the rinsed with destain
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solution made up of 25% v/v ethanol, 8% v/v acetic acid in dH20for five minutes before 
staining with Coomassie blue protein stain (1 R Tablet in IL of destain solution) which 
was heated to 60°C prior to application and stained for 15 minutes. After staining the 
gel was incubated in destain solution overnight or until most of the background stain 
had been removed. The gel was then preserved in a 10% (v/v) glycerol solution for 1 hr 
before being scanned and stored at 4®C. Isoelectric focusing in flatbed polyacrylamide 
gels separates proteins by establishment of a pH gradient which allows proteins to 
migrate to their isoelectric point (pi), which is the point at which the protein has no net 
charge. The isoelectric point of sample bands was determined using a mixture of 
markers of known low pi, o f which 1 Opl was applied to each gel. The migration from 
the cathodal end was plotted against the pi o f the markers to construct a calibration 
curve. Through measurement of the migration distance from the cathode for the sample 
bands the isoelectric point was calculated from the calibration curve.
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6.3 Results
6.3.1 Monosaccharide anaiysis
HPAEC-PAD analysis of the monosaccharides released from feline and bovine AGP 
showed very similar patterns on the chromatograms which can be seen in Figure 
6.1B+C and 6.1D+E respectively. The chromatograms seen in Figure 6.1 B+C for 
fAGP where duplicate runs of cat 10 section 3.3.1. These runs were carried separately 
from the feline AGP study described in Chapter 3. The chromatograms from both these 
species had four peaks representing the internal standard, N-acetyl glucosamine, 
galactose and mannose respectively. The chromatograms of the monosaccharides 
released from ovine (Figure 6.1 F+G) and human AGP (Figure 6.1 H+Ï) differed in that 
they both had five monosaccharide peaks. In sheep the fifth peak which was eluted 
after the internal standard but before the N-acetyl glucosamine (denoted by * in Figure 
6.1 F+G) and was identified as N acetyl galactosamine as N-acetyl galactosamine was 
run as a standard and eluted at the same time as the peak seen in sheep AGP. The fifth 
monosaccharide that was found in human AGP had the same elution time as peak one in 
the monomix and was therefore identified as fucose residues.
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6.3.2 Oligosaccharide analysis
HPAEC-PAD is also capable of determining differences in oligosaccharide profiles 
between individual samples. Oligosaccharide chains were released from AGP 
enzymatically using PNGase F. The detached oligosaccharides were separated from the 
protein in the sample by ethanol precipitation before being applied to the HPAEC-PAD. 
Oligosaccharide chains were primarily separated according to the amount of sialic acid 
residues present in each glycan chain. Thereafter the resolution of peaks within each 
charge band was on the basis of many subtle differences such as fucosylation, 
branching, and type of linkage between sialic acid and the galactose residue.
A standard oligosaccharide sample of bovine fetuin (Figure 6.2 A) was used to identify 
oligosaccharides carrying different numbers of sialic acid, with disialylated chains 
eluting between 20-30mins, trisialylated chains eluting between 30-40 mins and 
tetrasialylated at > 40 mins. Figure 6.2B+C shows the oligosaccharide chain profile 
chain of fAGP, which had oligosaccharide chains eluting between 20-40 mins, with 
three peaks between 20-30mins (disialylated) and three peaks between 30-40 mins 
(trisialylated). The oligosaccharide chains cleaved from human AGP (fig 6.2 H+I) 
showed a similar profile with all peaks being eluted between 20-40 mins. In contrast 
the oligosaccharide profiles o f the carbohydrate moiety o f bovine (fig 6.2 D+E) and 
ovine AGP (fig 6.2 F+G) showed a much more complex profile with over twenty peaks 
being eluted between 10 and 50 minutes after the initiation o f the run. The bovine AGP 
profile showed five peaks eluting between 10-20 mins (monosialylated), eight separate 
peaks between 20-30 mins (disialylated), 6 peaks between 30-40 mins (trisialylated) and 
at least 3 peaks between 40-50 mins (tetrasialylated). The oligosaccharide profile of
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ovine AGP showed a similar profile however subtle differences could also be observed, 
3 peaks were eluted between 10-20 mins (monosialylated), 6 peaks between 20-30 mins 
(disialylated), 6 peaks between 30-40mins (trisialylated) however the presence of peaks 
eluting between 40-50 mins remains unclear. Although the oligosaccharide profile of 
each species was unique, similarities could be seen as the oligosaccharides profiles from 
all species showed that disialylated oligosaccharide are predominant, followed by 
trisialylated oligosaccharides.
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6.3.3 Sialic acid analysis
Sialic acid was cleaved from the oligosaccharide chains attached to AGP from bovine, 
feline, ovine and human AGP using neuraminidase. Following enzyme digestion the 
sialic acids were subsequently characterised using HPAEC-PAD. Figure 6.3 A-I shows 
the chromatograms from HPAEC-PAD analysis of sialic acid. Figure 6.3A shows the 
chromatogram for standard N-glycoyl neuraminic acid in which a peak was observed at 
approximately 20 mins whereas the N-acetyl neuraminic acid standard eluted at 
approximately 5 mins (Figure 6.3 B). Comparison to these standards highlighted that 
bovine and ovine AGP both have large amounts o f both N-acetyl neuraminic acid and 
N-glycolylneuraminic acid (in Figures 6.3 E-F and Figure 6.3 G-H respectively). FAGP 
was also shown to have both N-acetyl neuraminic acid and N-glycolyl neuraminic acid, 
however there were only trace amounts of the latter were found. Human AGP only had 
N-acetyIneuraminic acid present in the glycan chains as a peak at 5 mins was the only 
one found (see Figure 6.3 I-J).
6.3.4 Lectin blot analysis of AGP.
From the lectin blot analysis of AGP it was shown that AGP from bovine, ovine, feline 
and human serum had high levels of a2-6 sialic acid present on the glycan chains (see 
Figure 6.4A) as SNA bound to all samples. It was also shown by reaction with Con A 
that all four species had diantennary chains within the carbohydrate moiety although 
human AGP reacted less with this lectin than AGP from the other species (Figure 6.4C 
lane 4). In contrast only human AGP reacted with AAL (Figure 6.4 B lane 5), 
suggesting that feline, bovine and ovine AGP had no fucose residues present within 
their carbohydrate moieties.
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Figure 6.4 Lectin blots for A) S N A  lane 1 M w t m arker,  lane 2 feline A G P  cat 14, lane 3 bovine  lane  
4 hum an lane 5 sheep  B) A A L  lane I M w t m arker, lane 2 fe line A G P  (C at  14), lane 3 bovine  AG P,  
lane 4 sheep A G P , lane 5 H um a n A G P  C) Con A Lane 1 M w t m arker ,  lane 2 feline A G P  cat  (?),  
lane 3 bovine, lane 4 hum an A G P , lane 5 sheep AG P.
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6.3.5 Isoelectric Focusing
Calculation of pi was based on the calibration over the pH range 3.5-9.5 ( Fig 6.5 A) and 
in the narrow range gels pH 2.5-5.5 (Fig 6.5B)
The lEF pattern of a glycoprotein can be influenced by both the amino acid composition 
of the polypeptide backbone and the presence of sialic acid residues within the 
oligosaccharide chains covalently attached to the protein. The influence of sialic acid 
residues on the pi was examined by treating the AGP from the four species with 
neuraminidase and running them on a 3.5-9.5 lEF slab gel (Figure 6.6).
When run on this broad pi lEF gel it was revealed that removal of sialic residues 
resulted in a shift towards the cathode end of the gel. Feline AGP and human AGP 
without prior neuraminidase treatment (Figure 6.6 lanes 2 + 7) showed a similar high 
migration focusing at the anodal end of the gel and were seen as a single sharp band 
while untreated bovine and ovine AGP were seen as a broad band at the anodal end of 
the gel with predicted pi ranges o f 3.42- 3.36 and 3.62-3.36 respectively (Figure 6.6 
lanes 4 + 9). A low pi lEF gel was used to focus in and determine the pi values for the 
glycoforms of feline (Figure 6.7 lane 2), bovine (Figure 6.7 lane 5), ovine (Figure 6.7 
lane 6) and human AGP (Figure 6.7 lane 3) prior to neuraminidase treatment. The pi 
were calculated as 1.6-2.8, 2.7-3.3, 3.2-2.8 and 2.3-3 for feline, bovine, ovine and 
human respectively. Following neuraminidase treated fAGP separated into four bands 
with pTs ranging from 3.84 to 4.36 while bovine AGP migrated to five pi values 
ranging between 3.65-4.64, neuraminidase treated human AGP had isoforms with pi
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values ranging between 3.62-4 (Figure 6.6 lane 8) while sheep AGP had a broad smear 
ranging between 3.6-4.65 (Figure 6.6 lane 10).
The results of this comparative study of the glycosylation of feline, bovine, ovine and 
human AGP are summarised in Table 6.1.
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Figure 6.5 A) T h e  calibration curve  for pl m arkers  used in the 3 .5-9 .S  IF F  gels B) the calibration  
curve  for  pl m arkers  used in the 2 .5-5 .5  IF F  gels
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Glycan
modification
Feline AGP Bovine AGP Ovine AGP Human AGP
Fucose N N N Y
GalNAc N N Y N
Monosialylated N N + N
Disialylated +++ +++ +++ ++
Trisialylated + ++ + ++
Tetrasialylated N N + N
NANA +++ ++ ++ +++
NONA + ++ ++ N
Con A +++ +++ +++ +
T able  6.1 D if ferences  w ith in  the  g lyean  cha ins  o f  A G P  from h u m a n ,b o v in e ,  ov ine  and fe line A G P .  
Y =  present  N =  not present  +  =  m in o r  or  w e a k  reactivity + +  =  m o d e r a te  ++ +  =  M a jo r  or  
strong  reactiv ity
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6.4 Discussion
The glycan chains covalently attached to glycoproteins play an essential role in a 
number of important functions including cell-cell interactions and modification of the 
non-specific immunity. Therefore to fully elucidate the structure-function relationship 
of a glycoprotein it is necessary to gain as full an understanding as possible of the 
glycosylation pattern of the glycoprotein. Thus it is important to determine the 
monosaccharide composition of the oligosaccharide chains as the presence or absence 
of terminal monosaccharides such as fucose and sialic acid can have a marked effect on 
the physico-chemical properties of the protein and in consequence on its function.
Alpha-1-acid glycoprotein is a glycoprotein and has been identified in most species 
including human, cow, sheep, dog, cat, chicken and rat but most studies on the structure 
and function of AGP have been carried out on the human protein. Nevertheless a few 
studies carried out in veterinary species have shown that AGP is also a functionally 
important protein in these species. Cecillani et a/.,2007 showed that bovine AGP was 
capable of suppressing spontaneous apoptosis of bovine monocytes. Drug binding 
studies have shown that AGP is an important drug binding protein in dogs, cows and 
sheep (Matsumoto, Sukimoto, Nishi, Maruyama, Suenaga, & Otagiri 2002).
The use of HPAEC-PAD as a tool to analyse the monosaccharide composition and the 
method of monosaccharide identification was previously discussed in Chapter 3. In this 
comparative study of AGP monosaccharide analysis the glycan content of AGP from 
further species were compared to that of feline as described in Chapter 3. This revealed
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that the monosaccharides within the glycan chains of bovine and fAGP showed similar 
patterns, both showing peaks representing Gal, GlcNAc and Man. Human AGP on the 
other hand also contained Fuc residues in addition to the three monosaccharides seen in 
bovine and fAGP. This finding is in agreement with Nakano et a/.,(2004) who reported 
human AGP carrying fucose residues (Nakano, Kakehi, Tsai, & Lee 2004). Kuster et 
al, (1998) reported fucose residues expressed on bovine AGP but this was not found 
here (Kuster B. et al. 1998). Fucose on human AGP is heavily influenced by the 
disease status of the individual. The bovine AGP use in this study was purchased from 
the same supplier as the study carried out by Kuster et a/.,(1998) so in theory should be 
from animals with the same health status nevertheless it is possible that the health status 
of the animals donating was different (Kuster B., Hunter A P, Wheeler S F, Dwek R A, 
& Harvey D J 1998). Using HPAEC-PAD technique it was not possible to determine if 
the Fuc residue in human AGP was part of a SLe X epitope.
Many studies have reported the presence of fucose residues on the glycan chains of 
human AGP and it has been shown in some instances to be part of the SLeX antigen. 
The absence of fucose residues on the AGP from other species may suggest that these 
AGPs do not carry the SLe X antigen. However it has been reported throughout this 
thesis that the quantity o f fucose residues and the expression of SLeX antigen is 
dependant on the pathophysiological condition of the patient and so the lack of fucose 
on the bovine, feline and ovine AGP may in fact be due to the disease status of the 
animals. It would be of interest to repeat this investigation with AGP from these 
species taken during an acute phase response.
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Ovine AGP also has an extra monosaccharide present within the glycan chains which 
was identified as GalNAc. N-acetyl-galactosamine is not a commonly found 
monosaccharide in human AGP although it was reported that GalNAc was expressed on 
human AGP when a patient had hepatitis C (Anderson et al. 2002a).
HPAEC-PAD was also successfully utilised in the separation of oligosaccharides 
cleaved from the polypeptide backbone using PNGase F. The principal behind the 
separation of oligosaccharides using HPAEC-PAD has been discussed at length in 
Chapter 3 and the same technique was employed to analyse the glycan chains cleaved 
from the protein backbone of bovine, feline, human and ovine AGP. Using this method 
it was evident that, although there were similarities in the oligosaccharide profile 
between species, each pattern was unique. All four species had disialylated glycan 
chains as the prevalent form o f oligosaccharide chains. Bovine AGP was the only 
protein that had a significant peak eluting 40 mins after the start of the run representing 
tetra-sialylated glycan chains. This is in agreement with Nakano et <3/.,2004 who also 
reported that bovine AGP carried diantennary chains containing four sialic acid residues 
although it was not possible to identify how many antennae where present on the 
glycans within the tetra sialylated group (Nakano, Kakehi, Tsai, & Lee 2004).
As testament to the flexibility of HPAEC-PAD it was possible to utilise the same 
HPAEC-PAD column to separate sialic acids without base labile groups NANA and 
NGNA using an acetate gradient (Manzi, Diaz, & Varki 1990). Prior to HPAEC-PAD 
the sialic acids had to be cleaved from the glycan chains using neuraminidase. The 
basis of separation is identical to that described for the separation of intact 
oligosaccharides (Chapter 3).
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The glycan chains of human AGP differed from all the other species in that the 
oligosaccharide chains only contain N-acetyl neuraminic acid whereas the other species 
also contained N-glycolyl neuraminic acid. Feline AGP only had trace quantities of N- 
glycolyl neuraminic acid whereas bovine and ovine AGP had approximately equal 
quantities of both sialic acid derivatives. Many groups have reported the lack of N- 
glycolyl neuraminic acid on human glycoproteins (Varki 2001) as well as the lack of 
sialyltransferase for NGNA. Different forms o f sialic acids act as specific receptors for 
various pathogens and the lack of N-glycoyl neuraminic acid on human glycan chains 
suggests that some potential pathogens that infect a host via binding to NGNA such as 
certain influenza viruses, rotaviruses and E.coli may in fact be unable to infect human 
hosts due to the lack of the specific SA receptor.
In human disease during the acute phase response the three common modifications that 
are reported on AGP are changes in the quantity of SA, diantennary branching and the 
expression of Fuc residues. There are several ways in which these three modifications 
can be examined but one of the quickest and simplest methods is by way of lectin 
binding.
In nature there are many lectins that recognise specific glycans which can be used to 
probe glycoconjugates for the presence o f specific epitopes. In this study SNA, Con A 
and AAL lectins where used to identify a2-6 linked SA, diantennary branching and Fuc 
respectively in human, bovine ovine and fAGP by way o f electroblotting. This study 
confirmed the HPAEC-PAD results by showing that only human AGP expressed fucose 
residues. Blotting with Con A showed that human AGP had less diantennary chains
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compared to the other species, however all species had considerable quantities o f «2-6 
linked sialic acid.
The net charge of proteins is ultimately decided by the relative proportions of amino 
acid residues with either positive or negative functional groups and, with regards to 
glycoproteins, the extent of sialic acid expression on the oligosaccharide chains.
The basis of protein separation by lEF is based on the existence of the isoelectric point 
(pi). All proteins have varying amounts of amino acid residues which have ionisable 
side chains which are dependant on the external pH. The isoelectric point is the exact 
pH at which the side chains have been ionised and the protein has no net charge, and at 
this point, due to the absence of charge, the protein has no electrophoretic mobility and 
hence remains static in the lEF gel (Righetti 1983). However the pi of a glycoprotein 
that carries SA on its glycan chains is not just determined by the amino acids but the 
presence of the negatively charged SA also is also a determining factor. In this study 
the effect o f SA on the pi o f AGP from human, bovine, ovine and feline was examined 
by running samples that had been treated with neuraminidase to remove SA alongside 
samples prior to neuraminidase treatment. It was found that removal of SA resulted in 
an increase in the p i’s o f all species examined, which was seen as a shift towards the 
cathodal end of the gel. Although SA was shown to be an influencing factor in the low 
pi o f AGP from human, bovine, ovine and fAGP, it was also apparent from the multiple 
bands seen after neuraminidase treatment that other factors were involved in 
determination o f AGPs’ pi value. One possible explanation for the multiple bands seen 
in the enzyme treated samples is the difference within the amino acid sequence. To 
date, 2 forms o f human AGP have been described that are due to the substitution of 22
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amino acids. Isoelectric focusing also revealed that feline and human AGP were more 
negatively charged than bovine and ovine AGP which had some bands which migrated 
more towards the anodal end o f the gel. However this pattern was even apparent 
following the removal of SA suggesting that the difference of pi values between the 
species is not completely due to differences in the quantity of sialic acid but is also due 
to the amino acid sequence.
In conclusion it was apparent that while the carbohydrate moiety of AGP from the four 
species shared similarity they were also unique, with differences evident in the SA, Fuc 
and branching quantities. Human AGP differed from bovine, ovine and fAGP as it 
contained fucose residues which were not detected within the oligosaccharide chains of 
AGP from the other species. Another difference between human AGP and the other 
species was the lack o f NGNA. Human AGP also appeared to have more highly 
branched glycan chains than AGP from other species which was revealed by probing 
with Con A lectin.
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CHAPTER 7 
7. General discussion
The aim of this thesis was to examine the structural heterogeneity of AGP in veterinary 
species. This chapter is to review the important findings from preceding chapters and to 
highlight areas which are worthy o f future research.
Glycosylation is an important modification to protein which occurs after translation. It 
has been extensively shown that the carbohydrate moieties of glycoconjugates play a 
crucial role in the functioning of the molecule so that even subtle changes such as the 
addition or the removal of one monosaccharide can have a profound effect on the ability 
of the glycoconjugates to function properly (Pos et al. 1990a;Pukhalsky, Shyian, 
Kalashnikova, Shmarina, Pukhalskaya, & Bovin 1998).
Acute phase proteins are a group of proteins that are produced mainly by hepatocytes in 
response to trauma infection or infections. Many of the APPs are glycoproteins and it is 
likely that the carbohydrate moiety of these proteins can influence their functions. 
Therefore in order to truly understand the importance of the APR and the APPs, the 
carbohydrate moiety o f the APPs should be fully elucidated.
Prior to this investigation very little research had been carried out in veterinary 
medicine to elucidate the structure or the function o f the carbohydrate moiety attached 
to the APPs of the domestic species. This thesis set out to examine whether changes in
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structural heterogeneity o f APPs occur and particularly whether they could be used as 
diagnostic markers in FIP in cats and mastitis in cows.
Feline infectious peritonitis is a well-known and widely distributed coronavirus induced 
systemic disease in cats, characterised by protein-rich effusions in body cavities and 
granulomatous inflammatory lesions in several organs (Kipar et a/.,2005 Montali and 
Strandberg, 1972: Napoleone et a/., 1997). Feline infectious peritonitis is now 
considered a very important disease world wide in cat populations. A few years ago it 
was reported that the AGP was significantly increased in the plasma o f animals 
suffering from FIP even when compared to animals with other pathologies (Duthie et 
a/., 1997).
The carbohydrate moiety o f any glycoprotein is susceptible to degradation in harsh 
conditions such as extreme pH, therefore isolation of glycoproteins when planning to 
examine subtle changes within the oligosaccharide chains, as in these studies, requires 
careful manipulation. It was with this in mind that an improved method for the isolation 
of fAGP was developed which was described in detail in chapter 2. This involved 
initial precipitation with PEG followed by a three step chromatographic procedure. 
Although the yield gave a 26% recovery other techniques which have been described 
for the isolation of AGP from the serum of other species were ruled out due to the 
likelihood of degradation of the terminal SA residues during the prolonged use of 
buffers at acidic pHs. The conditions of the method developed were similar to a method 
described by Smith et a l, 1994 for the isolation of hAGP which was shown to keep the 
oligosaccharide chains intact. The only differences between the method described by 
Smith et a l, (1994) and the method used in this study is first that a higher molecular
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weight PEG was used in this study and second the Sepharose red column used by Smith 
et al, (1994) was substituted for the cation exchange column used in these studies. 
Therefore it was presumed that the method developed for this study would be suitably 
gentle enough to avoid degradation of the terminal SA residues and so was employed 
for the isolation o f fAGP prior to analysis of the composition o f the oligosaccharide 
chains attached to the protein backbone.
Chapter 3 described the monosaccharide and oligosaccharide analysis o f fAGP using 
HPAEC-PAD, This technique has been increasingly used in the routine analysis o f the 
glycosylation of glycoproteins. The versatility of the technique permits the analysis of 
glycoproteins in terms o f both the oligosaccharide chains expressed and their 
monosaccharide content (Hardy and Townsend, 1988: Hardy et al, 1987: McGuire et al, 
1999^
Previous studies (Anderson et al. 2002f;French et al. 2002)have shown that the 
HPAEC-PAD method used for monosaccharide analysis in this thesis was capable of 
separating out Fuc, Gal, GlcNAc, Glu, GalNAc and Man. However it is not suitable for 
the analysis of SA for two reasons first the harsh degradation conditions used to cleave 
the monosaccharides degrades SA and second the elution conditions would not be 
suitable for SA due to its negative charge. Therefore another HPAEC-PAD method had 
to be used to examine SA.
Monosaccharide analysis of AGP from cats with FIP and cats characterised as non FIP 
using HPAEC-PAD revealed that the group of cats with FIP had statistically 
significantly higher expression of GlcNAc and Gal residues when compared to the
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group of cats with non-FIP diseases. This may be explained by increased branching or 
more N-linked chains. The ratio of GlcNAc to Gal residues which would be expected if 
fAGP, like human AGP carried only complex type N-linked glycans would be 4:2 for a 
diantennary chain, as 2 GlcNAc residues are within the common pentasaccharide core 
and the one residue per antennae whereas Gal is not present within the common core but 
is only found in ratio of 1:1 per antennae. Thus a possible explanation for the lack of 
continuity between the amount of GlcNAc and Gal expressed within the glycan chains 
o f fAGP may be that fAGP carries a combination o f complex, hybrid and high mannose 
type N-linked chains. The FIP group also had increased levels of mannose residues, 
however the increase was not statistically significant. The most interesting finding from 
the monosaccharide analysis of fAGP was that two cats (5 and 9) had fucose residues 
present on their oligosaccharide chains whereas no other cats including those in the non- 
FIP group, had any trace o f fucose. Increased expression of fucose residues has been 
examined on human AGP in various diseases such as RA and cancer and shown to be of 
use in determining the prognosis o f the disease. Unfortunately these cats where already 
deceased at the time of the investigation due to the high fatality associated with FIP and 
so it was not possible to take further samples to find a reason for the appearance of the 
fucose residue. Two possible explanations are first that the disease was at a more 
advanced stage when the sample was collected, and second that the cats had an 
underlying infection that was not noticed at the time o f inspection. To clarify this, it 
would be interesting to assess the expression of fucose residues on glycoproteins in cats 
of different stages of FIP and with various pathologies.
Following analysis o f the monosaccharide of fAGP it was important to determine how 
the monosaccharide formed the oligosaccharides chains attached to fAGP. Previous
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studies have shown that HPAEC-PAD can be successfully utilised as a qualitative but 
not quantitative tool to examine the structure o f the oligosaccharide chains attached to 
glycoproteins as well as monosaccharide analysis. Prior to oligosaccharide analysis 
using HPAEC-PAD the oligosaccharides have to be cleaved from the polypeptide 
backbone and in this study PNGase F was used for this purpose. Using HPAEC-PAD 
to examine oligosaccharides cleaved fAGP from cats with FIP and cats without FIP 
showed that in the latter case, all normal pool samples test two SA residues per chain 
whereas the cats with FIP had more complex HPAEC-PAD chromatograms with peaks 
representing oligosaccharides carrying one, two and three SA residues on the glycan 
chains. Each cat with FIP had two major peaks one representing a disialylated glycan 
oligosaccharides and one representing a trisialylated oligosaccharide which were eluted 
8-9 minutes apart. This method of analysis would be a lot more informative if each peak 
could have been identified to highlight how many antennae each glycan had as well as 
the type o f linkage between each of the monosaccharides. However it was not possible 
to run this type o f analysis due to the lack o f suitable standards available. This was a 
relatively small study but has shovm that the oligosaccharide fingerprint of AGP from 
cats with FIP and cats without FIP is significantly different. It would be important to 
repeat this investigation in a larger study population with more non-FIP samples and 
also cats with clinically similar pathologies. A more informative technique that could 
have been used to characterise the structure o f the glycan chains is mass spectrometry 
however this is a technically challenging and costly procedure and would have required 
a lot of optimization and for these reasons was not used. However this should be 
considered as an approach to be undertaken in future analysis of glycoproteins.
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Since it was shown in Chapter 3 that the glycosylation pattern o f fAGP is altered during 
disease and that is known that AGP from other species undergoes changes within its 
glycans during periods of inflammation it was thought possible that the same occurs in 
bovine mastitis. Therefore the probability of any changes within the glycan chains of 
serum AGP from healthy cows and cows with mild and moderate mastitis was 
examined using lectin blotting methods.
The chromatographic methods used to examine the structural heterogeneity o f fAGP 
where not used to analyse the glycan chains o f bAGP as time restraint meant that 
development and implementation o f a method for the isolation of bAGP was not 
possible, as a pure preparation is needed for HPAEC-PAD analysis.
The study found that bAGP from cows with moderate and mild mastitis had statistically 
significantly higher expression of diantennary chains than control cows. While cows 
with moderate but not mild mastitis have statistically significant expression of «2-6 
linked sialic acid when compared with control samples. It would be of interest to see if 
these structural alterations affect the function of bAGP.
It has been extensively reported that APPs such as SAA and Hp are expressed locally by 
the mammary gland in cows suffering from mastitis. Serum amyloid A produced in the 
mammary gland is a different isoform from that produced by hepatocytes however little 
work has been carried out to determine if  the locally produced Hp is structurally 
identical to the hepatocytes produced counterpart. Therefore the Hp produced in the 
mammary gland was compared to the serum Hp produced by hepatocytes to examine 
whether or not they are identical.
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Chapter 5 focused on looking at the structure o f Hp from the serum and milk of cows 
with mastitis in a bid to see if  the milk Hp is structurally similar to serum Hp. Western 
blotting revealed that the beta chain of milk Hp was a doublet whereas serum Hp was a 
single band. This suggested that milk Hp fraction may in fact have two isoforms. 
Therefore the difference between the isoforms was investigated employing an enzyme 
to remove the carbohydrate chains attached to Hp in order to determine if the difference 
was in the carbohydrate moiety or the amino acid sequence. The difference was found 
to lie within the carbohydrate moiety as following removal of the N-linked glycan 
chains with an endo-glycosidase (PNGase F) the doublet o f milk Hp seen prior to 
enzyme cleavage was not seen and the pHp from both the milk and serum Hp were the 
same size when examined on a SDS-PAGE gel. These results suggests the difference in 
Mwt between the doublet bands seen in the SDS-PAGE of milk Hp is a result of an 
increase in the weight of the glycan chains attached to the polypeptide backbone. The 
glycan chains where then probed with fluorescent labelled lectins and it was found that 
the pHp from milk expressed fucose residues which were not on the serum equivalent. 
It was also apparent that only the 37kDa band of the doublet had diantennary glycan 
chains attached with the 40kDa band presumably having tri and tetra antennary chains. 
The results o f this study suggest that the Hp present in milk is a mixture of 2 isoforms. 
Possibly these are liver derived Hp and a locally produced glycoform of Hp with altered 
glycosylation giving a higher Mwt. However this was a small pilot experiment and a 
more comprehensive study may be required in order to draw any definitive conclusions 
on the nature o f the |3Hp isoform. However this could be a very interesting area to 
explore in the future, and in particular the effect o f the different glycoforms on the 
function o f Hp. It may also be worthwhile investigating the expression of the locally
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produced Hp over a time course of the disease to determine if  the presence of fucose on 
the Hp could be used as a diagnostic marker for subclinical mastitis.
With the development of powerful tools to analyse the glycosylation of serum proteins 
the opportunity was taken to examine the carbohydrate of bAGP, fAGP, oAGP and 
hAGP, to provide an initial insight into the comparative structure of the 
oligosaccharides present on these molecules in normal conditions and to identify any 
species related differences. From this study it was apparent that the carbohydrate 
moiety of AGP is substantially different between species.
The comparative monosaccharide composition of AGP from healthy cows, sheep 
human as well as cats was assessed. All four species were different but the most 
notable difference was that only human AGP expressed fucose residues which was 
confirmed by blotting with AAL. However a study detailed by Kuster et <3 / . , (1998) who 
examined the glycan chains of hAGP, bAGP, oAGP and cAGP using mass 
spectrometry reported the presence o f Fuc residues on bAGP as well as hAGP, but may 
be due to differences in source material. Further studies on AGP from animals of 
definitive provenance are warranted.
The SA content of human, ovine and bovine AGP was examined using HPAEC-PAD 
(chapter 6) and it was demonstrated that all species examined with the exception of 
hAGP had both NGNA and NANA but this is not surprising it has been reported that all 
mammals with the exemption of humans and apes express NGNA as well as NANA in 
their glycoconjugates (Varki 2001). This technique can be used to quantify the amount 
o f NANA and NGNA present on the glycan chains of glycoproteins however this was
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not carried out due to the lack of adequate amounts of normal standards. This could be 
further investigated as previous studies have shown that the sialic acid content of fAGP 
is dependant on the disease status of the animal (Cecilliani et a/.,2004; Pocaque et 
a l ,2Q05).
Another notable finding from this study is that oligosaccharide profile o f AGP from the 
ruminants is more complex than that of human and cats with the former having a 
number of higher pi isoforms not present in the latter,
In conclusion the studies in this thesis have established that the structural heterogeneity 
o f acute phase proteins in veterinary species, like humans, is dependant on the disease 
status of the individual but further work is required to determine its usefulness in 
diagnosis of diseases such as FIP and mastitis and the effect of the changes on the 
biological functions of the APPs.
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